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Do your best to present yourself to God as one approved, a workman who does not need
to be ashamed and who correctly handles the word of truth.
2 Timothy 2:15 (NIV)
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DYNAMIC CHEMICAL SHIFT IMAGING FOR IMAGEGUIDED THERMAL THERAPY
Brian Allen Taylor, B.S.
Supervisory Professor: R. Jason Stafford, Ph.D.
Magnetic resonance temperature imaging (MRTI) is recognized as a noninvasive
means to provide temperature imaging for guidance in thermal therapies. The most
common method of estimating temperature changes in the body using MR is by
measuring the water proton resonant frequency (PRF) shift. Calculation of the complex
phase difference (CPD) is the method of choice for measuring the PRF indirectly since it
facilitates temperature mapping with high spatiotemporal resolution.

Chemical shift

imaging (CSI) techniques can provide the PRF directly with high sensitivity to
temperature changes while minimizing artifacts commonly seen in CPD techniques.
However, CSI techniques are currently limited by poor spatiotemporal resolution.
This research intends to develop and validate a CSI-based MRTI technique with
intentional spectral undersampling which allows relaxed parameters to improve
spatiotemporal resolution.

An algorithm based on autoregressive moving average

(ARMA) modeling is developed and validated to help overcome limitations of Fourierbased analysis allowing highly accurate and precise PRF estimates. From the determined
acquisition parameters and ARMA modeling, robust maps of temperature using the kmeans algorithm are generated and validated in laser treatments in ex vivo tissue. The use
of non-PRF based measurements provided by the technique is also investigated to aid in
the validation of thermal damage predicted by an Arrhenius rate dose model.
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Chapter 1:

Introduction

1.1 Thermal Therapies
Thermal therapies generally encompass all treatments based on the transfer of
thermal energy out of or into the body. The overall objective of these therapies is to
deliver a desired thermal dose to a target while minimizing the dose to normal tissues (1).
The use of thermal energy in medicine is not a new concept. During the reign of the
Roman Empire, facilities were created which contained hot baths in addition to the use of
dry and humid heat to treat diseases. An Egyptian papyrus, dated at approximately 3000
BC, described the use of heat in surgery and is possibly the earliest manuscript known in
thermal therapy.

In the nineteenth and twentieth centuries, “fever therapy” was

investigated to improve the immune response in certain pathologies (2).
The more modern discipline of thermal therapies came mostly from laboratories
in the 1970s that were interested in radiation biology and how temperature affects the
radio-sensitivity of cells (3).

A number of cell culture and in vivo tumor model studies

showed a cell-killing effect at temperatures above 41 °C (4). It was also found that the
exposure time to kill cells was shorter when higher temperatures were used. In the
1980s, key studies were reported that assessed the efficacy of thermal therapies (4-7).
The concept of thermal dosimetry was also introduced (8).
Although there were modest improvements in the ways to deliver heat into
tissues, the enthusiasm for these treatments dwindled in the 1990s. According to a
review published in 2006 by Habash (1),
1

“The problem that was faced by the thermal-therapy
community at that juncture was unrealistic thermal goals
because of lack of adequate equipment for delivering thermal
treatment and inability to measure the treatment delivered. A
combination of the above difficulties is still a challenge to the
design and implementation of successful clinical trials.”
Since the publication by Habash, there have been improvements in the delivery and
monitoring of these therapies (3). However, Habash’s review underscores the importance
of monitoring in order for thermal therapies to be effective.
Thermal therapies are typically divided into three categories.

In the low

temperature range, cryotherapy is used to freeze tissue with the goal of necrosis (9).
Hyperthermia is used where the temperature at a region of the body or the whole body is
raised to temperatures up to approximately 45 °C for an extended period of time (minutes
to hours) (10). Another category is thermal ablation where very high temperatures
(typically >50 °C) are used to destroy tissue in a conformal setting (3).
The main biological rationale for thermal therapies is based on cell-killing (4).
Studies have shown that protein denaturation is the most likely mechanism that causes
permanent damage to tissue (4, 11-14). When proteins denature, they are prone to
aggregation.

Without any molecular chaperones to aid in refolding the proteins, these

aggregated proteins can affect the structure and function of many macromolecules that
are vital for the cell’s survival (4, 15).
The aggregation of proteins caused by hyperthermic temperatures is thought to be
key to cells being more sensitive to radiation (12) and the efficacy of using both radiation
2

and thermal therapy is higher the closer the two are given in time.

If there is a delay of

radiation after thermal treatment, heat shock protein levels are higher and more proteins
are repaired and less aggregated making the cells more insensitive to radiation (16).
There is also an additive effect using hyperthermia and radiation.

Cells which are

hypoxic, have low pH values, and are in the S-phase in the cell cycle are sensitive to heat
and are relatively resistant to radiation.

Hyperthermia can also increase the blood

perfusion into cells thereby decreasing hypoxia and making the cells more radiosensitive
(17).
Hyperthermia has also been shown to increase the efficacy of some drugs,
including chemotherapeutic drugs (18).

Drugs that have chemical, rate-limiting

reactions are expected to be more efficient at higher temperatures due to thermodynamic
principles. For example, cisplatin alkylates DNA at a higher rate at higher temperatures,
thereby increasing its efficacy (19). As with radiation therapy, the increase in blood flow
in the tumor causes increased drug uptake and concentration which can aid in cell-killing
(18).
Hyperthermia has been studied used as an adjuvant in gene and immunotherapies. Gene therapy is defined as a treatment where genetic material is infused to
cells to modify cellular function. In cancer treatment, the material must affect cells
associated with the tumor and not in normal tissue. It must also not drastically affect the
immune system in the infected patient. Studies have shown that gene-infected cells are
more sensitive to hyperthermia. The increased temperature is expected to open the pores
3

of blood vessels to allow more genetic material to reach the tumor cells. It also increases
the protein production in the affected cells and enhances the immune system’s ability to
send the infected cells to the tumor (20-23).
In hyperthermia, it is important to note the narrow temperature ranges that are
needed for combination treatments with radiation and chemotherapy (24). This makes
the accurate and precise monitoring of temperature in vivo very important. If a certain
temperature is needed as an adjuvant to a therapy and going too high or too low in
temperature can affect outcomes, then it is very important to have precise and accurate
monitoring.
The goal of thermal ablation is to destroy a lesion using a high dose of thermal
energy (above 50 °C) in a minimally-invasive way without damaging vital nearby
structures. While protein denaturation does occur in this higher temperature range, and at
a faster rate than seen in hyperthermia, the main effect seen in these therapies is
coagulative necrosis. This has been studied as an alternative or adjuvant to conventional
surgery and can be used in conjunction to other treatments, such as chemotherapy and
radiation therapy, to treat localized disease. It can be a repeatable procedure and may be
suited for patients who are not good candidates for open surgery. There are also various
modalities to deliver heat to the target including focus ultrasound (FUS), radiofrequency
(RF) applicators, microwaves, and lasers.

The rapid heating of tissues to ablative

temperatures requires fast monitoring in order to control the treatment, conform to the
target and minimize thermal dose to critical normal structures (3).
4

In thermal therapies, it is important to model and determine where the thermal
damage has occurred to verify that the target lesion has been successfully treated. Thus,
damage prediction models have been developed to aid in treatment verification. In one of
the seminal papers on thermal damage, Henriques studied the thermal damage in pig skin
(25). He showed that the thermal damage from the denaturation of proteins follows an
Arrhenius rate process. The rate process can be described as a rate-of-formation kinetic
model of reaction products in a biochemical reaction. Briefly, molecules like proteins in
their native state, C, must reach an energy barrier, Ea, to be activated, C*, at a rate ka.
Some will relax back to the native state while some will denature at rate kd. This
denaturation rate can be described as

kd =

RT −∆RTG*
e
Nh

(1.1)

where R is the universal gas constant (8.315 JK-1mol-1 or 2.0 cal K-1mol-1), T is the
temperature, N is Avogandro’s number, and ħ is Plank’s constant. The speed of the
reaction is governed by Gibb’s free energy of formation, ∆G*. ∆G*= ∆H*-T ∆S* where
∆H* is the enthalpy of activation and ∆S* is the entropy of activation. ∆H* has an
activation energy, Ea, where ∆H* = Ea – nRT and n is the order of the reaction. Ea>>RT,
thus
−E

kd =

−∆H *
a
RT −∆RTH * ∆RS *
e
e = Ae RT = Ae RT
Nh

(1.2)

kd can be expressed by a first-order Bernoulli differential equation where
5

−

d [C ]
= kd [C ]
dt

(1.3)

and
−E

t
a
 C (0) 
RT (τ )
Ω = ln 
dτ
 = A∫ e
 C (t ) 
0

(1.4)

where A is the frequency factor and T(τ) is the temperature in degrees Celsius as a
function of time, τ (26).

Henriques selected rate coefficients so complete cellular

damage is indicated by an Ω value of unity.

Subsequent studies followed the one

reported by Henriques and investigated parameters for various temperature ranges and
tissues (27).
Almost 40 years later, Separato and Dewey proposed a method of measuring
thermal dose as an unit of time at 43 °C (8). The cumulative time equivalent at 43 °C, t43,
can be described as
tf

t 43 = ∑ R (43−T )∆t

(1.7)

t =0

where tf is the final time point, T is the average temperature at time interval ∆t , and R is
a constant (R=0.25 below 43 °C and R=0.5 at 43 °C and above).
The dependence of accurate and precise temperature measurements are evidently
seen in these models. Not only does the temperature need to be ascertained but also the
temperature history over several time points. This makes temperature monitoring very
6

important to accurately determine if and where thermal damage has occurred.

A

temperature error of 1 °C over several minutes can cause the estimated thermal dose to be
different than what was actually delivered. This may cause an over-treatment or undertreatment of the target. In addition, rapid monitoring is especially needed for hightemperature ablations to assure that temperatures are high enough to ablate the target as
well as to make sure nearby critical structures receive nonlethal thermal doses. This calls
for accurate and precise methods to measure temperature noninvasively to aid in assuring
that an acceptable thermal dose is delivered. This is where image-guidance becomes
important.

1.2 Image-Guidance of Thermal Therapies
Image-guidance has been shown to be critical in thermal therapies by providing
localization, planning, and post-treatment verification.

In addition, image-guidance

provides the potential for real-time monitoring during treatment delivery which can help
better conform thermal doses to the target while avoiding nearby critical structures and
healthy tissue (28).
Ultrasound (US) (29), computerized tomography (CT) (30), and magnetic
resonance (MR) (31) are imaging modalities which are capable of temperature feedback
during thermal therapy procedures.

Of these three modalities, MR has the desired

properties of providing adequate localization, planning, and post-treatment verification
using its wealth of soft-tissue contrast mechanisms without the use of ionizing radiation.
MR can provide fast imaging in any plane. Most importantly for temperature monitoring,
7

MR is fundamentally temperature sensitive since both the relaxation properties and
chemical environment of the spin system are tied to thermally dependent processes (32).
As a result, magnetic resonance temperature imaging (MRTI) is recognized as a primary
way to non-invasively provide rapid, quantitative temperature imaging in various tissues
in order to provide useful thermal dosimetry and monitoring for thermal therapy
procedures (33).
The most commonly employed quantitative MRTI method is based on the proton
resonant frequency (PRF) shift (34-36), which has been established and validated as a
technique for monitoring temperature changes for feedback and control of thermal
therapies in a variety of anatomical sites (37). A fast complex phase difference (CPD)
method (38) has been the preferred method to estimate the PRF shift indirectly. A major
advantage of CPD techniques for PRF-based thermometry is its high spatial and temporal
resolution (~1.5x1.5x4 mm3, <5 sec (39)).

However, there are several well-known

limitations in this technique. Intravoxel lipid contamination (40, 41), inter- and intrascan motion (42), tissue susceptibility changes (43) and static magnetic field drifts (44)
are artifacts that are commonly encountered.
An alternative to CPD methods is a direct method of measuring PRF shift via
chemical shift imaging (CSI) techniques (45-48), which has several advantages over CPD
techniques. One is that the water proton resonant frequency is measured separately from
other resonances whereas CPD measures the mixture of frequency components in each
voxel resulting in a variable response.

This immediately relieves the problem of
8

intravoxel lipid contamination, which requires saturation or suppression techniques in
CPD. Also, the lipid signal can be used as an internal reference to account for field drifts,
susceptibility and motion since it is relatively insensitive to temperature (37).
Researchers have developed CSI techniques to reduce artifacts seen in CPD
techniques. However, these studies have constrained themselves in both sensitivity and
spatiotemporal resolution by using interleaved shots to increase the spectral bandwidth to
adequately sample the MR signal and keep peaks such as lipid unaliased in the spectra
(45-47).

In addition, high receiver bandwidths are often used to shorten the echo-

readouts, and as an additional benefit, increases the spectral bandwidth to avoid aliasing.
Use of these high bandwidths decreases the SNR and reduces the sensitivity of these
techniques (45-47). A high echo-train length (ETL) has also been used to implement
Fourier-based spectral analysis, which also degrades spatiotemporal resolution (46, 47).
The proposed research is intended to build upon and address areas involved in
image acquisition and frequency estimation that has limited CSI techniques for MRTI.
We propose that by carefully undersampling the MR signal, which causes aliasing of the
lipid peak, we can allow lower receiver bandwidths to maintain a higher SNR at higher
spatiotemporal resolutions than previously reported. In addition, it is hypothesized that,
even with these relaxed parameters, the spatial, temporal and spectral resolutions
currently used for temperature monitoring will not be severely degraded using advanced
spectral processing techniques. Traditionally, 32 or greater samples have been acquired
so frequency estimates can be reliably performed using a fast Fourier transformation
9

(FFT) (45-47).
resolution.

The increased number of samples comes at a cost of spatiotemporal

Time-domain, frequency domain, and z-domain (via the z-transform)

approaches to spectral estimation have been shown to accurately measure frequencies
with limited amounts of data when a priori information of the signal is known (49). It has
been recognized that an ideal NMR signal is characterized as an autoregressive (AR)
process and a noisy NMR signal as an autoregressive moving average (ARMA) process
(50). It is expected that an ARMA modeling approach will be more robust than Fourier
transformation since the model accounts for both exponential decay and noise (50). The
autoregressive property of the signal can be used to directly model the parameters of the
signal including the PRF of each specimen in the signal. Other parameters, such as the
amplitude and damping factor (apparent spin-spin relaxation time, T2*) of each peak can
be simultaneously determined (50-54).
There are several potential advantages of implementing the proposed acquisition
parameters and spectral processing algorithms (ARMA modeling).

One possible

advantage is increased sensitivity to temperature changes compared to CPD techniques.
By collecting more echoes during the same repetition time (TR) period as the single-echo
CPD (38), this technique could potentially produce more accurate temperature estimates
with lower uncertainty. Additionally, the technique not only provides the ability to
remove lipid signal across the volume without suppression or saturation pulses, but also
provides the potential opportunity to use lipid as an internal reference for artifact
suppression for increased accuracy and precision.
10

There also lies the opportunity with a model-based methods of observing both the
T1-W images and T2* maps from each chemical specimen in addition to the PRF thereby
providing multi-parametric monitoring of the treatment target.

This potentially

culminates into an enhanced MRTI technique compared to what is now available. In
addition, all of this can be performed without dramatically sacrificing spatiotemporal
resolution, which is critical for monitoring thermal therapies.

1.3 Hypothesis and Specific Aims
The hypothesis of this work is that through the use of a multi-gradient echo
acquisition coupled with model-based spectral processing algorithms, CSI-based
temperature maps utilizing this method can be generated with higher accuracy and
precision compared to standard CPD techniques without sacrificing spatiotemporal
resolution. The specific aims of this work are to:
1) Develop, validate and characterize via simulation a model-based spectral
analysis algorithm for detection of water and lipid spectral frequencies with ≤
1.0 °C accuracy and uncertainty.
2) Investigate the influence of various MR acquisition parameters on the
sensitivity of detecting water and lipid frequency changes at high
spatiotemporal resolutions for temperature imaging
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3) Combine these approaches to acquisition and processing in order to develop
and validate 2D temperature mapping techniques for generating more accurate
and precise temperature estimates compared to CPD in phantom and ex vivo
tissues.
To accomplish these goals, a model-based spectral processing algorithm was
developed to accurately measure the PRF of each peak in a spectrum using a constrained
number of echoes to maintain spatiotemporal resolution. This technique was validated
using simulation over a range of SNR values and physiologically relevant water/lipid
spectral parameters. An appropriate range of acquisition parameters providing highly
sensitive PRF estimates in a rapid acquisition with adequate spatiotemporal resolutions
were determined (Chapter 4). Heating experiments were performed in a water/lipid
phantom as well as ex vivo bone marrow, brain, kidney, liver, and prostate tissue to
validate the accuracy and precision of the temperature measurements as well as measure
the dependence of T2* and T1-W amplitudes as a function of temperature (Chapter 5).
Finally, a mapping algorithm that utilizes the k-means clustering algorithm was
developed and validated to effectively provide a means by which to map water and lipid
spectral parameters separately to aid in temperature mapping (Chapter 5).
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Figure 1-1 Approach for rapid MR temperature imaging
Data collected from a high spatiotemporal resolution MGE acquisition was processed via ARMA modeling
to calculate multiple spectral parameters (PRF, T2*, amplitude). These parameters were inputs to a kmeans clustering algorithm to separate chemical species such as water and lipid which were used to create
highly accurate and precise temperature images.
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Chapter 2:

Magnetic Resonance Temperature Imaging

2.1 Introduction
MR is a fundamentally temperature-sensitive modality since the relaxation
properties of a spin system and local chemical environment are fundamentally
thermodynamic processes (32). Therefore, multiple temperature-sensitive parameters are
available; however, not all are equally useful for guiding thermal therapies. In this
chapter, temperature-sensitive MR parameters will be reviewed. Focus will be given to
the use of the proton resonant frequency (PRF) shift for temperature imaging, the
dominant technique, via complex phase difference (CPD) and chemical shift imaging
(CSI) techniques.

2.2 The Temperature Sensitivity of Intrinsic MR Parameters
There are a number of MR parameters intrinsic to tissue that can be exploited for
temperature measurements. Chief among them at clinical field strengths are diffusion of
water, proton density of water, T1 and T2 relaxation times, magnetization transfer, and the
PRF shift.

2.2.1 MOLECULAR DIFFUSION OF WATER
In MR, the diffusion coefficient, D, is used to describe the thermal Brownian
motion of molecules (55). The relationship of D to temperature is

D≈e

−

Ea ( D )

kT

(2.1)
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where Ea(D) is the activation energy of the diffusion of water. From differentiation, the
temperature dependence of water diffusion can be described as
dD Ea ( D ) − Ea ( D ) kT
=
e
dT
kT 2

(2.2)

Therefore, if two diffusion measurements, DT and DT+∆T, are made at temperatures T and
T+∆T, then the temperature change will be

∆T =

kT 2  DT +∆T − DT 


Ea ( D) 
DT


(2.3)

where it is assumed that Ea(D) does not change with temperature.
In the clinical application of MRTI, the temperature sensitivity is quite high at
about 2%/°C (33). However, the temporal resolution is relatively low and measurements
can be highly sensitive to motion. Line-scan (56) and single shot echo-planar imaging
(EPI) (57) has helped in reducing imaging time and in reducing artifacts due to motion.
Also the use of the diffusion coefficient is independent of field strength.
A compounding factor is observed when physiological changes occur in the tissue
during the thermal delivery. For instance, edema, protein denaturation and thermal
coagulation can change the diffusion coefficient and these events are difficult to isolate
from temperature changes (58).

It is also important to note that diffusion can be

anisotropic such as in white matter tracts in the brain and muscle fibers. Therefore, for
accuracy, the tensor that describes the anisotropic diffusion needs to be measured which
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increases the imaging time. It has been noted in a recent review that temperature
measurements in adipose tissue using the diffusion coefficient is difficult due to the low
values in lipid and different sensitivity compared to soft tissues (33). Lipid suppression
is recommended when diffusion measurements are used to estimate temperature changes.

2.2.2 PROTON DENSITY
The temperature-dependence of the proton density (PD) stems from the fact that it
depends linearly on the equilibrium magnetization, M0, determined by the Boltzmann
distribution where
N γ 2 h 2 I ( I + 1) B0
PD ∝ M 0 =
= χ 0 B0
3µ0 kT

(2.4)

N is the number of spins, γ is the gyromagnetic ratio (42.58 MHz/T for hydrogen
protons), ħ is Planck’s constant, I is the quantum number of the spin system (1/2 for
hydrogen protons), B0 is the magnetic flux density, µ0 is the permeability of free space, k
is the Boltzmann constant, T is the temperature (in Kelvin), and χ0 is the susceptibility.
Note that χ0 and T has an inverse relationship.

This is known as the Curie law.

Therefore, the change in susceptibility can be related to the temperature in PD-weighted
images. Note that the PD does not change with temperature but the ratio of parallel and
antiparallel spins, which will show as a change in susceptibility (33), is temperature
dependent. The temperature sensitivity of PD is inversely proportional to temperature
and ranges around -0.30 ± 0.01 %/°C from 37 to 80 °C (59). This is a relatively low
temperature sensitivity that requires high SNR. To isolate effects from changes in T1,
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very long repetition times are needed, which yields lower spatiotemporal resolution (60).
If lower TRs are needed, it may be difficult to isolate changes in PD with the relaxation
times (61).

2.2.3 SPIN-LATTICE RELAXATION TIME (T1)
The temperature-dependence of T1 has been well known from NMR studies (62)
and was one of the earliest parameters used for MRTI (63-67). Essentially, in tissues T1
depends primarily on dipolar interactions during rotational and translational motion of
molecules. This molecular motion is temperature-dependent thus T1 can be a means to
measure temperature. T1 can be described by the following first-order Arrhenius rate
process where

T 1 (T ) ∝ e

−

Ea (T1 )

kT

(2.5)

and Ea(T1) is the activation energy of the relaxation. It is known that T1 and temperature
dependence are tissue dependent. Generally, the temperature dependence of T1 can be
described as
T 1 (T ) = T1 (Tref ) + α (T − Tref )

(2.6)

where Tref is a reference temperature and α is the temperature sensitivity (dT1/dT). α has
been measured in several tissues with difference values including 0.97 %/°C in adipose
tissue (65) and 1-2 %/°C in soft tissue (63, 64, 66-68).
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Although measuring T1 requires a longer imaging time, the change in T1 can be
shown to be related to the change in signal from spin echo or gradient echo images.
Generally, the signal, S, can be described as

S (T ) ∝ M 0 (T ) sin θ

1− e

−TR

1 − cos θ e

T1 ( T )

−TR

(2.7)
T1 ( T )

where θ is the flip angle. The signal decreases with increasing temperature due to
increasing T1 and decreasing M0. By taking into account the small nonlinear temperature
dependence of M0, the change in S as a function of temperature can be described as
dS
dS S
=α
−
dT
dT1 T

(2.8)

which takes into account both the decrease in M0 and the increase in temperature or vice
versa. Therefore, by neglecting the small T2 (or T2* for gradient echo acquisitions)
temperature dependence and weighting in T1-W images, the change in signal in T1-W
images as a function of temperature can be described as
−TR

α TR (1 − cos θ ) e T 1
dS
1
=−
−
2
−TR
−TR
SdT
T1 (Tref ) 1 − e T 1 1 − cos θ e T 1 Tref

(

)(

)

(2.9)

It is important to note that changes in tissue properties, such as coagulation, can cause
changes in S which will affect temperature measurements (69).
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2.2.4 SPIN-SPIN RELAXATION TIME (T2 )
As with T1, there is an increase in T2 relaxation time with increasing temperature.
In observing the signal from a T2-W image with increasing temperature, there can be a
large sigmoidal decrease that can even remain during cooling of the tissue (70). This is
an important characteristic of irreversible tissue damage which is useful to define the
outcome of a thermal treatment.

Therefore, although T2 may not be good quantitative

means to measure temperature changes, it often plays a role in treatment verification in
high-temperature thermal ablations.

2.2.5 MAGNETIZATION TRANSFER (MT)
Generally, MT techniques use spectrally-selective RF pulse to saturate protons
bound to macromolecules which are normally not visible in MR due to very short T2 or
T2* values. During the RF pulse, the bound, saturated protons enter the primary pool of
water protons or transfer the magnetization to the primary pool (71). These exchanges
are temperature dependent. For example, MT-weighted signals were determined to be
tissue dependent, with some tissues showing relatively no change in signal such as in
adipose tissue and brain. In tissues where a change in signal was seen with temperature,
effects on MT-W images were nonlinear with either increasing signal (muscle, heart,
prostate, liver) or decreasing signal (blood) (72, 73). These variances in temperature
sensitivities do not make MT a readily reliable method for MRTI.

19

2.2.6 PROTON RESONANT FREQUENCY (PRF) SHIFT
2.2.6.1 Physical Basis

Temperature sensitivity of the PRF was first reported by a group led by Pople in
1958 (35) and later by Hindman (34). The temperature dependence in the PRF arises
from the hydrogen bonding between hydrogen protons and oxygen nuclei in water. In
tissue, water is the most abundant compound that contains hydrogen protons. When
temperature increases, the increased kinetic energy of the water protons result in a longer
hydrogen bond with other water molecules and a shorter covalent bond between the
hydrogen and parent oxygen atoms. This results in the proton lying in closer proximity to
the oxygen’s electron cloud, thereby changing the proton’s chemical shift, σ (Figure 2-1).
The PRF, f, can then be expressed as a function of the chemical shift where
f = γ B0 (1 − σ )

(2.10)

γ is the gyromagnetic ratio (42.58 MHz/Tesla for hydrogen atoms) and B0 is the applied

magnetic flux density. The chemical shift, σ, theoretically is related to the electronic
structure around the nucleus. Usually empirical approaches are used to describe the
chemical shift since theoretical calculation requires extensive knowledge of the electron
density in the ground and excited states of the molecule as well as the excitation energies.
Generally, the chemical shift is the contribution of the electrons surrounding the nucleus
as well as other surrounding molecules around the nucleus (74).
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Figure 2-1 Illustration of temperature effects on the PRF
As temperature rises, the hydrogen bonds (green line) between hydrogen and neighboring oxygen atoms
stretch, bend and break.

This causes the hydrogen to move closer to its own oxygen’s electron cloud

making it better shielded and changing the chemical shift, σ.

2.2.6.2 Temperature Sensitivity of the PRF

Measuring the PRF shift as a function of temperature or measuring the distances
between two spectral peaks to measure temperature has long been used in NMR in the
field of analytical chemistry. When compared to other MRTI-based parameters, the
temperature sensitivity coefficient of the water PRF is relatively the same for different
tissues is close to pure water which has a temperature sensitivity coefficient (TSC) of
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-0.010 ppm/ºC (34).

Many studies have been performed in vivo to measure the

temperature sensitivity of the PRF. McDannold presented a thorough review of the TSC
of the PRF using both CPD and CSI techniques. Most TSC values in several tissues have
been found to be between -0.009 to -0.010 ppm/°C (75).

This corroborates what

Hindman reported initially in pure water (TSC=-0.01 ppm/°C) (34). However, some in
vivo studies have measured values above and below this range. Peters et al. stated a
possible reason for the discrepancies is due to the temperature-induced changes in the
bulk magnetic susceptibility (76). This can also be affected by the orientation of the heat
source in relation to the magnetic field. Electrical conductivity of tissues can also change
the temperature dependence (77).
In fatty tissue, De Poorter et al. measured an overall TSC of -0.0097 ppm/°C with
a susceptibility constant of -0.0013 ppm/°C giving a corrected field shift of -0.0088
ppm/°C (43). In a separate study by a different investigator, when using lipid (bulk
methylene) as an internal reference, the TSC of the difference was measured and found to
be around -0.00852 ppm/°C (37).

A study using a line scan echo-planar spectroscopic

imaging (LSEPSI) technique on a mayonnaise and lemon juice phantom also found a
similar TSC when using bulk methylene as an internal reference (45).
Ex vivo tissues have shown little change in sensitivity when compared to in vivo
tissues (75, 78, 79). It is also important to note that the sensitivity does not change when
tissues coagulate, which is in contrast to what is seen in T1-based MRTI (37). This is
crucial for safety at high-temperature ablations to be able to measure temperature after
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damage has occurred to assure temperatures do not reach excessive levels to prevent
charring of tissue.
There is also growing interest in trying to use CSI for absolute temperature
estimations.

Currently, MRTI methods are most often used to measure changes in

temperature and not absolute temperature.

Absolute temperature estimation is an

established method in NMR experiments. For instance, in a sample tube, the shift
between ethyl (-CH2-CH3) or methyl (-CH3) protons to the hydroxyl (-OH) protons is
commonly used in the NMR setting. For MR, the goal is to quantify water, lipid and/or
metabolite peak locations and their relative differences between water between them to
make absolute temperature measurements. There have been studies where Nacetylaspartate and water was used to measure temperature in the brain with low spatial
and temporal resolution (80, 81). However, there are many factors that can affect the
distribution of the metabolite, lipid and water chemical shifts including intravoxel
temperature variations, pH, magnetic ion concentration, blood-oxygen level dependent
(BOLD) effect, J-coupling effects and susceptibility (37). According to a recent review
of MRTI, the “feasibility of absolute temperature imaging has not yet been established;
further detailed investigations will be required for that” (37).

This is a highly-desired

diagnostic imaging capability to detect highly metabolic or inflamed lesions which can be
at a higher temperature compared to the baseline temperature.
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2.2.6.3 Complex Phase Difference Techniques for Measuring the PRF

A fast CPD method (38) has been the preferred method to estimate the PRF shift
indirectly. To estimate the temperature change in a voxel, the difference between the
current phase image, Φ, and the reference image, Φref, can be related to the TSC
described as

∆T =

Φ − Φ ref
2π ⋅ α ⋅ γ ⋅ B0 ⋅ TE

(2.11)

where α is the TSC (ppm/°C) and TE is the echo-time (ms).
In CPD techniques with sufficient SNR (≥5), the uncertainty in the CPD image,
σ∆φ ,can be expressed as

σ ∆φ ≅

σ
A

2=

2
SNR A

(2.12)

where A is the magnitude signal, σ is the noise of the magnitude signal, which is assumed
to be approximately Gaussian distributed, and SNRA is the signal-to-noise ratio of the
magnitude image (82). A contrast-to-noise ratio in the phase difference image, CNR∆φ,
can then be defined by

CNR ∆φ ∝ ∆ϕ ⋅ SNRA ∝ TE ⋅ e −TE / T 2* ⋅ sin (θ ) ⋅

1 − e −TR / T 1
1 − e −TR / T 1 ⋅ cos (θ )

(2.13)

assuming a spoiled gradient-echo acquisition. Note that this is essentially the product of
the TE (which is proportional to ∆φ) and the SNR. The dependence of TE on the phase
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difference constrains the CNR∆φ to be optimal at TE=T2*, which can be shown by
differentiation of equation 2.13 (82).
A major advantage of the CPD technique for PRF-based thermometry is its high
spatial and temporal resolution (~1.5x1.5x4 mm3, <5 sec (39)).

Typically, fast

temperature imaging can be achieved with GRE acquisitions (38) or EPI (83). As stated
above, the optimal TE for CNR in CPD is at the T2* of the tissue. As a result, standard
GRE acquisitions have a relatively long TR which lowers spatial and temporal resolution.
If higher resolutions are needed, echo shifts are applied with TR<TE at an expense of
SNR (41). Alternatively, the use of EPI allows for longer TEs without sacrificing
resolution or SNR. Techniques using balanced steady-state free-precession (bSSFP) have
also been studied for PRF-based temperature mapping.

This is accomplished by

measuring a linear fit along several TEs acquired. However, the phase behavior was
found to be highly nonlinear with this technique so simple phase to frequency mapping is
not feasible (48).
Although CPD techniques are advantageous when high spatial and temporal
resolution is required, there are several well-known limitations of this technique.
Intravoxel lipid contamination (40, 41), inter- and intra-scan motion (42), tissue
susceptibility changes (43) and static magnetic field drifts (44) all cause artifacts that are
commonly encountered with CPD techniques.
It is important to remember that the PRF shift is a function of temperature due
primarily to changes in the hydrogen bonds between water molecules. These hydrogen
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bonds are absent for protons in lipid molecules, which are covalently bonded. Therefore,
the temperature sensitivity of lipid tissue is a stronger function of the macroscopic
susceptibility. The presence of lipid can alter the phase in CPD acquisitions which, in
turn, can affect temperature estimates. Common practice to address this is to simply
suppress the lipid signal (40, 41). Although lipid signal is suppressed, however, it does
not correct susceptibility effects that lipid can have on the nearby water molecules. The
effect of a mixed water and lipid environment cannot be handled completely with
suppression because lipid is still physically present in the tissue and can have an effect on
temperature estimation in the voxel via susceptibility effects.
As with most imaging techniques, intra-scan and inter-scan motion is another
common issue that must be addressed with CPD approaches. Intra-scan motion is motion
during the acquisition which results in view to view k-space errors seen as image blurring
and ghosting. Imaging times can be decreased to reduce intra-scan motion but at an
expense of SNR. Inter-scan motion is a more difficult problem to handle since images
are subtracted to obtain temperature estimates. It is important to note that motion not
only effects the spatial registration between scans but also the magnetic field which
changes the phase leading to errors in temperature estimation (33).

Multiple strategies

have been developed in an effort to overcome artifacts from inter-scan motion. For
respiratory motion, gating with mechanical respiration has been successful but this, of
course, is invasive (84). Gating with free-breathing has been used but it is challenging
when there is irregular breathing (85). The use of navigator echoes has also been studied
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as well as referenceless thermometry which estimates the background phase in the treated
area by fitting a polynomial extrapolated from unheated regions (86). These studies have
had limited success but according to a recent review of MRTI, “motion is the most
prevalent problem for temperature monitoring with PRF phase mapping (CPD) and the
main reason that has impeded its acceptance for clinical applications in areas that are
subject to motion” (33).
Macroscopic susceptibility changes in tissue can also affect the accuracy of
temperature estimates with the CPD technique (43). Susceptibility does change with
temperature, but when compared to the PRF as a function of temperature, this effect is
four to five times smaller in magnitude. It has been approximated as being linear with
0.0026 ppm/°C for pure water and 0.0016 ppm/°C in muscle (43). It has been found
though that the temperature dependence of the susceptibility is tissue-dependent (87) as
well as the orientation and geometry of the heating source (76). One possible method to
correct for susceptibility effects is to measure the PRF response to temperature in a
chemical specimen that is not sensitive to temperature changes. Lipid is such a specimen.
It is expected that lipid will experience susceptibility effects in the voxel. Therefore,
using lipid, or any covalently-bonded proton, as an internal reference to correct for
susceptibility is a possible means to improve temperature measurements (37).
Field drift is yet another effect that must be considered when the PRF is used for
MRTI. Temporal drifts in the local magnetic field due to increased gradient duty cycles
and eddy currents can change the PRF (88). Simple corrections are often possible by
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using a reference phantom at a fixed temperature (44). More elaborate corrections are
also possible using multiple reference phantoms to estimate the linear shifts across the
image (89). A method that calculates the apparent diffusion coefficient (ADC) and PRF
has also been proposed to correct for field drift (90). As with susceptibility, lipid or
another internal covalently-bonded proton reference can be used to aid in correcting for
field drifts (37).
2.2.6.4 Chemical Shift Imaging Techniques for Measuring the PRF

An alternative to the indirect CPD method is a direct method of measuring PRF
shift via chemical shift imaging (CSI) techniques (45-48). CSI has several advantages
over CPD techniques. One is that the water proton resonant frequency is measured
separately from other resonances whereas CPD measures the mixture of frequency
components in each voxel resulting in a variable response. This immediately relieves the
problem of intravoxel lipid contamination seen in CPD. Also, the lipid signal can be
used as an internal reference to account for field drifts, susceptibility and motion since it
is relatively insensitive to temperature (37). Therefore, CSI would be particularly useful
in areas with high lipid content, such as bone marrow, breast, and head and neck lesions
(45). In addition, it may be useful in patients with fatty-liver for minimally-invasive
treatments of liver lesions (91). It is also important to note that areas with little or no
lipid can also benefit from CSI-based temperature imaging since directly measuring the
water PRF can potentially result in higher sensitivity given appropriate SNR with
adequate spectral analysis techniques (45, 53). Therefore, researchers have worked to
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develop CSI techniques that increase the sensitivity and spatiotemporal resolution while
maintaining the ability to reduce artifacts seen in CPD. However, as mentioned in the
previous chapter, these studies have limitations for multiple reasons.
Magnetic resonance spectroscopic imaging (MRSI) was proposed for MRTI
before the CPD technique was introduced (46). However, the acquisition time needed for
the desired spectral resolution (with or without suppression) was deemed impracticable
for MRTI. For example, MRSI measurements using a small 32 x 32 matrix with a
spectral bandwidth of 10 ppm at 1.5T and a spectral resolution of 0.01 ppm (1 °C)
required 26 minutes per acquisition.
One approach to overcoming some of the time limitations of the MRSI approach
is to use echo planar spectroscopic imaging (EPSI) techniques. These techniques have
been proposed for temperature monitoring and prior studies have demonstrated that
temperature changes can successfully be monitored, lipid can be used as an internal
reference when present, and artifacts due to motion can be reduced (47). Although this
method was demonstrated to be considerably faster than conventional MRSI, initial EPSI
acquisitions still required 3 minutes to acquire a low spatial resolution temperature image
(5 x 5 mm2) on a 3.0T system. This is because the technique used 4 interleaved shots of
16 echoes (5.2 ms echo-spacing, total of 64 echoes) to achieve an effective echo-spacing
of 1.3 ms to avoid aliasing of the lipid signal due to a narrow spectral bandwidth. Data
interleaving resulted in a spectral bandwidth of 769 Hz (12.04 ppm) with a spectral
resolution of 12.0 Hz (0.188 ppm). In addition, spectra from the EPSI technique can be
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degraded by instability in the magnetic field and motion during the phase-encoding
process of the acquisition (37).
McDannold, et al. applied a line scan EPSI (LSEPSI) technique (92) to address
limitations to previous CSI-based MRTI techniques (45, 93). LSEPSI is a combination
of EPSI with a voxel-selective technique for column scanning (92).

This method

substantially improved the spatial and temporal resolution. Specifically, in an in vivo
breast scan at 1.5T, a 32 x 32 cm2 FOV was acquired in 4.2 seconds with a spatial
resolution of 5 x 5 x 5 mm3. However, this spatial resolution is still considered quite
poor compared to CPD methods (39). Thirty two echoes where acquired with a high
receiver bandwidth of ±64 kHz, which limited the SNR.
As stated in chapter 1, major contributors to the low spatiotemporal resolution in
these studies include interleaved echo trains and high receiver bandwidths to decrease the
echo-spacing to avoid aliasing of the lipid peak. In addition, high ETLs were used in
Fourier-based approaches to calculate the PRF.

The high ETL degrades the

spatiotemporal resolution. In the next chapter, we present an approach that will allow
spectral aliasing of lipid peaks to negate the need of interleaving echo trains and allow
reduced bandwidths for higher SNR. To further aid in increasing spatiotemporal
resolution and sensitivity, a model-based approach to calculate the PRF using
undersampled data will be presented. The combination of these acquisition and postprocessing techniques will be used to test our hypothesis.
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Chapter 3:
3.1

Theoretical Background for Dynamic
Chemical Shift Imaging

Introduction
In this chapter, the theory and background of the acquisition strategy, spectral

processing, and mapping are presented. First, gradient-echo imaging will be introduced
along with details of the acquisition implementation for rapid CSI.
processing of CSI data will be overviewed.

Next, spectral

In this context, the detailed theory of

autoregressive moving average (ARMA) modeling will be presented. Finally, details will
be outlined on how these spectral parameters, specifically the PRF for temperature
imaging, are mapped to images using a k-means clustering algorithm.

3.2

Rapid CSI from a Multi-Gradient Echo Acquisition: From
Theory to Implementation
Fundamentally, several conditions must be met in order to image the spatial

distribution of hydrogen protons for MRTI. A strong magnetic field, B0, is needed in
order to align a small majority of protons with the field. Radiofrequency (RF) pulses at
the resonance frequency, ω, are used to tip the spin population. As the population relaxes
back to equilibrium with the magnetic field, a small voltage is measured in an RF-tuned
receiver coil which is perpendicular to B0.
In the laboratory frame of reference in the absence of gradients and relaxation
effects, the signal from a 3D spin system, ρ(x,y,z), in a given volume, V, can be described
as

31

S (t ) ∝ ∫∫∫ ρ ( x, y, z )e− iω ( x , y , z )t dV

(3.1)

V

To spatially localize the signal, gradients are used that spatially vary the magnetic field
over the sample.
For an acquisition in the axial plane, the z-direction is assigned as the sliceselection direction.

A gradient is applied in this direction in conjunction with the

bandwidth-limited RF excitation pulse.

This creates a planar distribution of spins

described by
z0 +∆z / 2

I ( x, y , t ) =

∫

ρ ( x, y, z )e − iω ( x , y , z ) t dz

(3.2)

z0 −∆z / 2

where z0 is the center of the slice and ∆z is the slice thickness. The z-dependence in ω
can be related to the magnetic field, B0, and the slice encoding gradient, Gz, where

ω z = γ ( B0 + Gz z )

(3.3)

After the RF pulse, the spins in I can be localized spatially using gradients and encoded
in k-space. The relationship between a location in k-space at time, t, and the gradients in
the x and y directions is given by
t

k (t ) = γ ∫ G (τ )dτ

(3.4)

0
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In the collection of data in k-space, a phase encoding gradient moves collection of data to
one line in k-space. This is followed by a frequency encoding gradient that is applied
during the signal readout.
Mathematically, the signal at a location in k-space, S(kx,ky) can be given by
S (k x , k y ) ∝ ∫∫ ρ ( x, y )e − ix 2πk x e

− iy 2πk y

dydx

(3.5)

It is important to note that this equation gives the spatial frequency domain of the spin
distribution and a 2D Fourier transform can be used to represent the data in the spatial
domain (74).
Figure 3-1 displays the pulse sequence diagram for a fast gradient echo
acquisition typically used for standard CPD MRTI. A small flip angle RF pulse is used
during encoding of the slice selection gradient, Gz. The polarity of Gz is then switched to
account for de-phasing of the transverse magnetization.

The frequency encoding

gradient, Gx, is turned on to move across k-space. Gy is then applied for the phase
encoding before the positive gradient of Gx encodes the signal. A Gz gradient is then
applied to dephase residual transverse magnetization.
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Figure 3-1 Pulse sequence diagram for a fast gradient-recalled echo (FGRE) acquisition
This represents a balanced pulse and gradient schematic for a high spatiotemporal CPD acquisition. Note
that one echo is collected per TR.

In this research, the fast gradient-recalled echo (FGRE) acquisition was modified
to provide multiple echoes per TR for encoding the chemical shift (Fig. 3-2). As with
FGRE, the sequence is compatible with parallel acquisition techniques, such as SENSE,
to increase the speed of acquisition (94) and can acquire images in interleaved slice
acquisition mode or in a sequential slice acquisition mode with RF spoiling to cancel out
any residual transverse magnetization before the next TR period by modulating the phase
between successive RF pulses. Note that the TR is kept constant so there is no loss in
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spatiotemporal resolution compared to CPD from a FGRE acquisition. The ETL and ESP
are set in order to collect the selected number of echoes within the TR.

Figure 3-2 Pulse sequence diagram of a 2D unipolar MGE acquisition
The phase encoding gradient only pulses once per echo train. The frequency-encoding gradient can be
implemented in bipolar or unipolar mode. In the unipolar sequence shown above, when each echo is
acquired in a positive gradient readout, the free induction decay (FID) is sampled.

The sequence can be run using unipolar readout gradients with time-optimized
rewinder (i.e. flyback) gradients as shown in Figure 3-2 or using bipolar readout
gradients. In bipolar gradient mode, negative polarity readout data is time reversed in kspace prior to image reconstruction by Fourier transformation. Also in bipolar gradient
mode, N/2 spectral ghosting caused by timing errors between the positive and negative
readouts can be corrected by applying a calculated linear phase shift to the images
reconstructed from every other echo time (95). The moments of the signal are calculated
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in k-space. The phase shift is measured by the differences in the moment between odd
and even echoes in the bipolar readout (Figue 3-3).

Figure 3-3 Differences between bipolar and unipolar readout gradients with N/2 correction
Bipolar and unipolar readout acquisitions were performed on an agar phantom. Due to timing errors
between odd and even echoes, the bipolar readout gradient is susceptible to N/2 ghosts (top left). These
timing errors can be corrected by calculating the phase change in k-space (top right). Unipolar readout
gradients are immune to these errors but using unipolar gradients comes at an expense of larger ESP and
lower SNR (96).
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We made two fundamental changes in the conventional acquisition strategy for
fast CSI acquisitions. First, the echo-spacing (ESP) parameter was increased in order to
facilitate use of lower readout bandwidths to provide higher SNR. In the case of previous
3.0T CSI acquisitions, restraints on the ESP have usually resulted in the use of multiple
interleaved echo-trains in order to avoid aliasing (47). Because of the relaxed ESP
associated with this technique we can acquire multiple echoes within one TR acquisition
thus increasing the spatial and temporal resolution compared to previous CSI acquisitions
for MRTI. This causes aliasing of the lipid peak. However, in MRTI we are only
interested in the change in the lipid PRF and not the absolute position when measuring
temperature changes.
The second modification was to collect only the number of echoes that would fit
into the TR period of our standard CPD MRTI sequence. The artifacts associated with
this undersampling required innovative processing in order to resolve the lipid signal as
outlined in the following section.
To increase sensitivity, uncertainties in the PRF as a function of acquisition
parameters need to be determined. It is important to note that in PRF mapping, the
frequency difference, which is directly proportional to temperature, is not constrained to
TE=T2*, in contrast to CPD. For an homogenous voxel,

CNR ∆f ∝ ∆f ⋅ SNRA ∝ e−TE / T 2* ⋅ sin (θ ) ⋅

1 − e−TR / T 1
1 − e−TR / T 1 ⋅ cos (θ )

(3.6)
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which means that the sensitivity of measuring frequency changes is directly proportional
to the SNR of the source image from a gradient echo acquisition. This gives an image
metric where the sensitivity of the frequency changes can be measured and verified using
the spectral analysis technique as described in the next section.

3.3 Spectral Processing of CSI Data
In many 2D, high spectral resolution, low spatiotemporal resolution CSI
techniques, several chemical shifts including water, lipid, and metabolites such as choline
and N-acetyl aspartate (NAA) are mapped by adding a spectral dimension to the k-space
data to encode chemical shifts. For example, EPI gradients allow signal readouts which
encodes one spatial dimension and the spectral dimension at the same time. In 1983, Sir
Peter Mansfield, Nobel Laureate in Medicine for the development of MR, proposed EPI
for 2D CSI with a hybrid projection reconstruction method to bypass Fourier transforms,
which were slower computationally at that time (97).
Several studies have been done to build on what was proposed by Mansfield.
Initial implementations suffered from poor gradient performance and artifacts arose from
the convolution of spectral and spatial information.

Posse et al. improved this by

improving the orthogonalization of the spectral and spatial information to reduce artifacts
seen in 2D CSI (98). Rapid acquisition and relaxation enhancement (RARE) (92, 99,
100) and LSEPSI (101) have also been investigated to improve the spatial, temporal and
spectral resolution for spectroscopic inquiry.

Parallel imaging (102, 103) and

compressed sensing (104, 105) techniques have also been implemented to improve the
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spatiotemporal resolution of these otherwise low spatiotemporal, high spectral resolution
CSI techniques.
There are several methods to quantify spectra in various domains, including the
frequency domain, time domain and z-domain. Originally, MR signals were calculated
using continuous wave (CW) spectroscopy. These spectra were recorded by scanning the
frequency axis, which measured the intensity of the signal as a function of frequency
(106). Currently, MR spectra are obtained in the time domain with post-processing
typically by deconvolution of the resonance frequencies into the frequency domain via
Fourier transformation. The time-domain acquisition reduces scan time and increases
SNR compared to CW spectroscopy (107).
The Fourier transform (FT) is the most common method to measure MR spectra
by transforming the MR signal from the time domain to the frequency domain.
Generally, the transform can be represented as
∞

F (ω ) =

∫ f (t )e

− 2πiωt

dt

(3.7)

−∞

where ω is the frequency, t is time, and f(t) is the time-domain function. The FT is
bijective and invertible meaning that the signal can be measured in one domain and
transformed to another. Although the FT is commonly used, assumptions in Fourier
analysis impose restrictions on the quality of the spectra. In a discrete signal, the FT can
be represented as
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N −1

An = ∑ ak e

 i 2πnk 
−

 N 

(3.8)

k =0

where An is the discrete representation of the spectra from the time domain signal ak. As
seen in this equation, the spectra is dependent on the number of samples N. The spectral
resolution is inversely proportional to N (108). In rapid CSI for temperature imaging, N
needs to be relatively small to maintain high spatial and temporal resolutions. By using
the FT, this comes at a cost of degraded spectral resolution to measure changes in the
PRF (Fig. 3-3). In addition, if the data in the time domain has non-zero values at the end
of the acquisition, this causes apodization of the spectra, which can degrade peaks,
especially secondary peaks such as lipid.
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Figure 3-4 The effects of the number of samples on spectra using FFT
The spectral resolution is directly proportional to the number of samples in the signal. In this case, the lipid
peak is more difficult to discern with a lower number of samples. Spectral resolution can be improved by
collecting more samples. This typically comes at a tradeoff of decreasing spatiotemporal resolution.

It is important to note that the FT doesn’t make assumptions in the model that
describes the data (see equation 3.6). The only constraints on the signal is that the
integral of f (t ) from -∞ to ∞ exists and that any discontinuities in f(t) are finite (108).

Although this makes FT useful for a variety of applications, it has a disadvantage of not
incorporating prior knowledge of the signal. In addition, the FT is assumed as a single
sum, where in practice the signal has signal and noise components (50).
Several time-domain methods have been developed to analyze spectra. The main
goal of these methods is to minimize the differences between the measured data and the
signal model through a non-linear least squares problem. This depends on the particular
algorithm being able to find a global minimum in the data and avoid errors from finding
local minima. Generally, the risk of not finding the optimal solution using these methods
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increases when initial conditions are away from what is acquired in the signal. This often
requires heavy user interaction in order to manually obtain starting values for these
algorithms (109). Interactive algorithms such as variable projection (VARPRO) (110)
and the advanced method for accurate, robust and efficient spectral fitting (AMARES)
(111) are common MR quantification tools. VARPRO uses the Levenberg-Marquadt
(LM) algorithm (112), which was later replaced by AMARES when reviewers cited
greater flexibility. Baseline errors can also be handled with time-domain methods with
user interaction (109).
Visualization of spectra and fitting results are best shown in the frequency domain
(113). Compared to time-domain methods, frequency-domain methods have fewer model
parameters that need to be fitted. In this domain, methods can be separated as noniterative and iterative methods.

The most widely used quantitative method in this

domain is frequency-selective area under the peaks. However, with this method it is
difficult to discern overlapping peaks and high baseline signals. Additionally, low SNR
can degrade the ability for quantification (113). Singular value decomposition (SVD)
methods have also been developed, where only regions along a specific frequency are
used for analysis, resulting in faster processing times (114). In iterative processes, nonlinear least squares techniques via algorithms such as the LM algorithm (112) have been
used. Specifically, with the LM algorithm deGraaf and Bovee used the algorithm to
obtain in vivo proton spectra in the brain using prior knowledge of metabolites from in
vitro metabolite solutions (115). In addition, mixed Lorrentzian-Gaussian (or Voight)
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models were developed to fit the signal in the frequency domain. In both time and
frequency domain, algorithms are shown to be computationally expensive and/or requires
a priori knowledge of the spectra (116).
There are also “black-box” techniques where little interaction is needed from the
user which makes it attractive for rapid temperature imaging (50). These methods use the
z-transform where
N

∑
k =0

Z

N

f (k )δ (t − k ) ↔ ∑ f (k ) z −k

(3.9)

k =0

and δ is the Kronecker delta function.

Although these methods are commonly

characterized as time-domain methods, it is important to note that analysis is performed
in the z-domain where the frequency-domain is a subspace where Z { f (t )} = 1 .
Theoretically, in a MR signal containing water and lipid, x(t), can be represented
discretely as a sum of damped complex exponentials convoluted with a comb function,
that is,

x(t) = CW e


(

)

*
t
− 2π ifW +1/ T 2W

(

)

− 2π ifL +1/ T 2*L t

+ CLe



∗

n⋅TE

∑ δ ( t − m)

m=TE min

(3.10)

where CW,L is the complex amplitude for water (W) and lipid (L), respectfully, fW,L is
PRF, T2W,L* is the apparent spin-spin relaxation time, TE is the echo time and n is the
number of echoes. By taking the z-transform, equation 3.10 can be represented as
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X ( z ) = Z ( x(t )) =

n⋅TE

∑

CW e

(

)

*
t
− 2π ifW +1/ T 2W

n⋅TE

z −t +

t =TE min

∑

CL e

(

)

− 2π if L +1/ T 2*L t

z −t

t =TE min

(3.11)

Equation 3.11 can be rewritten as
n⋅TE

n⋅TE

*
− ( 2π ifW +1/ T 2W
−( 2π if L +1/ T 2*L ) −1 
) −1 
X ( z ) = ∑ Cw  e
z  + ∑ CL  e
z 

 t =TE min 

t =TE min
Note that this can also be represented as a geometric series where

t

X ( z) =
1− e

(

CW

*
− 2π ifW +1/ T 2W

)

z −1

+
1− e

(

CL

− 2π if L +1/ T 2*L

)

z −1

t

(3.12)

(3.13)

(49). Therefore, the poles of X(z) can provide the frequency and T2* information for
water and lipid. The complex amplitude of each exponential can be calculated using the
residue evaluated at each pole (51, 52). In general, equation 3.13 in the presence of
noise can be expressed as an autoregressive moving average (ARMA) process described
as
N −1

H ( z) =

B( z )
=
A( z )

∑β z

−n

n

n=0
N

1 + ∑α n z

(3.14)
−n

n =1

Finding the coefficients, αn and βn, involves solving a set of overdetermined equations.
One method to approximate the coefficients was proposed by Belkic using the Pade’
approximant (PA) based on a technique originally developed by Henri Pade’ (51, 117,
118).

While the PA is able to process low TE signals and expand to non-Lorentzian

spectra, it has limitations at low SNR. In addition, the PA demonstrates low performance
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with a low number of poles and zeros, especially if it less than the number of samples
(119).
Another analysis method is to use an iterative method which will potentially
converge to a more accurate and precise solution compared to analytical methods (120).
Thus, we propose a hybrid approach using Prony’s method (120) and the iterative
Steiglitz-McBride (SM) algorithm (121). Both algorithms are used in applications such
as digital filter design and communications and a detailed treatment of both algorithms
can be found in (120). The reasoning to use these algorithms include the minimal
interaction required by the user (50), relatively rapid processing time compared to nonlinear least squares methods (53), and performance in the presence of noise (121, 122).
Here the algorithms will be explained to show how these can be used to calculate the
coefficients and provide frequency, T2* and amplitude content for water and lipid.
Equation 3.14 can be represented as
b(t ) = h(t ) ∗ a (t )

(3.15)

since, as in Fourier theory, the convolution in the time-domain is a product in the zdomain. In matrix form, equation 3.15 is
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(3.16)

where N is number of chemical species and K is the number of echoes, and xn are the
samples in the time-domain. In Prony’s method, h(t) is partitioned and an error term, e, is
added where

β  
 e  =  H
 2

H1
M

 1 

H3  α * 

(3.17)

H1 contains N-1 rows, H2 is a column vector with K-N-1 terms, H3 is the remaining (K-N1) x N matrix and α* is simply a column vector of the denominator coefficients. This
separates the interdependence of α and β terms in order to find the solution. First, the α
terms are found by taking the pseudo-inverse to minimize e, that is,

α * = − ( H 3t H 3 )

−1

( H H ) = −H
t
3

2

#
3

H2

(3.18)

where t is the transpose operator and # denotes the pseudo-inverse operation. Once α* is
calculated, β can be simply calculated by

β = H1α

(3.19)
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Unlike Prony’s method, which works by minimizing the error in the
overdetermined set of equations, the SM algorithm seeks to iteratively minimize the error
between a model estimate (xd) and the measured signal (x). The algorithm uses an initial
estimate (from Prony’s method) and quickly iterates to a solution. Briefly, the algorithm
takes the first N columns of the matrix

Hα i = H ⋅ α

(3.20)

where H is the K x K-N+1 matrix as described in equation 3.16 and α is the initial
estimate. This partitioned matrix is denoted as Hα′ . Knowing that

xd = x + e = Hα i H α i +1 = Hα′ i β + e

(3.21)

As in equation 3.18 the error term, e¸ can be minimized where

α i +1 = ( H α i H ) Hα′ i β

(3.22)

β = ( Hα′ ) xd

(3.23)

#

and
#

Therefore, combining equations 3.22 and 3.23 gives

α i +1 = ( Hα i H ) Hα′ i ( Hα′ i ) xd
#

#

(3.24)

which provides an iterative solution. Once α is known, β can be calculated again by
using equation 3.19.
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Once coefficients, α and β, are known, the poles can be calculated as roots of the
denominator in equation 3.14.

If ρ1 and ρ2 denote the poles for water and lipid,

respectively, then the PRF of water or lipid (in ppm) can be expressed as

fW , L = −

Im ln( ρ1,2 ) 
2π ⋅ ∆t ⋅ γ B0

(3.25)

where ∆t is the time between echoes, γ is the gyromagnetic ratio and B0 is the applied
magnetic flux density. In addition, the T2* value of water or lipid can be expressed as

T2*,W ,L = −

∆t
Re[ln( ρ1, 2 )]

(3.26)

Finally, the complex amplitude of water and lipid can be computed separately using
where

CW ,L =

B( ρ1, 2 )
A' ( ρ1, 2 )

(3.27)

and

A′( z −1 ) =

dA( z −1 )
dz −1

(3.28)
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3.4

CSI Mapping using the k-means Algorithm
An important area of research in MR currently is the mapping of MR-detectable

nuclei with different chemical shifts. The techniques for accomplishing this range from
mapping multiple metabolites which is commonly used in various sites including brain,
prostate and breast (123) to several techniques that are used to separate lipid-based
chemical shifts from images to avoid obscuring underlying pathologies. This is a multifaceted problem that involves not only separation of chemical shifts spectrally but also
accurately mapping these parameters into images. The accurate mapping of chemical
shifts is necessary in MRTI so appropriate temperature sensitivity coefficients can be
applied to measure temperature (i.e. water must correctly be identified in order to
measure temperature changes and lipid must be indentified accurately to use as an
internal reference).
Essentially clinical CSI data for metabolic inquiry are currently processed by 3D
FFT with filtering and/or zero-filling of the k-space data or by spectral modeling. For
example, one method used exponential line broadening, Fermi filtering in the spatial
domains to reduce truncation, and water suppression through low-pass filtering of the
spectra in the time-domain (98). In addition to the processing of the spectral data, special
consideration is needed for mapping the chemical shifts spatially.

For instance,

corrections are needed for field inhomogeneities and gradient eddy currents. Typically,
data with unsuppressed water signal is acquired in order to calculate the field map to
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correct for field inhomogeneities. The water signal can also be used to scale the relative
concentration of other chemical shifts.
In CSI techniques for lipid and water separation, acquisitions and mapping
strategies are different since a limited number of chemical shifts are known a priori. The
motivation to separate the chemical shifts in lipid-water imaging is that the low T1 of
lipid makes it bright on many clinical imaging protocols. This can hide underlying
processes such as contrast-enhancement of tumors, edema, and inflammation. There is
also interest in knowing the lipid content in organs such as liver as well as using lipid
images to distinguish certain tumors such as lipomas. There are multiple techniques to
either remove lipid from the images or create “water-only” or “lipid-only” images.
One of the first techniques introduced to remove lipid from images is a chemical
shift selective (CHESS) acquisition (124). In these acquisitions, a saturation pulse is
centered at the dominant lipid peak frequency and the pulse flips the lipid protons 90°
into the transverse plane. The RF pulse is immediately followed by a crusher gradient to
spoil the transverse magnetization of lipid. The imaging acquisition is then acquired
leaving little time for lipid to recover longitudinal magnetization thus suppressing the
lipid signal in the image. However, this technique is sensitive to inhomogeneities in the
static magnetic field and in the RF pulse (B1), which can either leave lipid unsuppressed
or suppress water.
Another method is to selectively excite the water instead of suppressing the water
peak. These methods can excite protons in a particular spatial or spectral region. The
50

basic mechanism for these methods is to use RF pulses at specific intervals where lipid
magnetization is flipped onto the longitudinal axis while signal is collected from the
flipped water protons. As in CHESS sequences, these acquisitions are sensitive to field
inhomogeneities. The use of multiple pulses can also require longer TRs which will
increase imaging time. Unlike CHESS, it is relatively insensitive to inhomogeneities in
B1 (125).
Short TI inversion recovery (STIR) (126) is yet another method to suppress lipid
to visualize underlying pathologies. This method takes advantage that non-enhancing
tissue containing water has a longer T1 than lipid. An inversion pulse is implemented
followed by a time interval (TI) allowing the lipid magnetization to relax to the transverse
plane. Then an imaging acquisition is implemented, albeit with lower water SNR. An
advantage is that it is insensitive to field inhomogeneities and therefore it can be used in
large or off-centered FOV situations.
Instead of selectively suppressing or exciting chemical shifts, there is a class of
techniques based on the phase behavior between water and lipid. An early approach to
phase-sensitive lipid-water separation was developed by Dixon (127) and thereby the
techniques are commonly termed “Dixon Methods.”

By assuming a constant PRF

difference between water and lipid, Dixon proposed that collecting images at two specific
TEs can create images where lipid and water are in-phase and out-of-phase. By adding or
subtracting these images, “water-only” or “lipid-only” images could be created. This is
called a “two-point Dixon method.”

However, this method is sensitive to B0
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inhomogeneities. To address this, Glover (128) modified Dixon’s method to obtain three
echoes at specific TEs where the phase shifts between lipid and water were 0, π, and –π.
By using phase-unwrapping algorithms, field inhomogeneities can be removed. Both
methods, by Dixon and Glover, are insensitive to B1 inhomogeneities and can be used in
a variety of sequences including fast spin echo (FSE), GRE, and steady-state free
precession (SSFP) (129).
Several methods have also been developed to improve on these early Dixon
methods.

It was noted that three-echo Dixon techniques were redundant and that

methods are available to acquire field mapping with two echoes (130, 131). It was also
shown that lipid suppression is possible with one echo at variable TEs (132). One
method by Xiang used a region-growing algorithm instead of phase-unwrapping in
conjunction with an asymmetric TE acquisition with an analytical solution for water and
amplitudes (133). In addition, Ma et al. introduced a FSE method with phase-sensitive
partial Fourier reconstruction in addition to a rapid two-point FSE acquisition using
interleaved images (134). Ma also created a phase correction, region-growing algorithm
that relies on the spatial gradient of the phase (135). In this algorithm, the direction of
the phase is calculated by the magnitude and phase of surrounding voxels. Recently,
Dixon methods were used in conjunction with diffusion-weighted imaging for wholebody detection of cancer metastasis (136). Iterative decomposition of water and lipid
with echo asymmetry and least squares estimation (IDEAL) is another phase-sensitive
lipid-water separation technique that uses a least-squares approach of the multi-echo data
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to calculate the amplitudes of water and lipid (137). By assuming equivalency of the
water and lipid T2*, T2* estimates have been made with IDEAL (138). In addition,
multiple peaks of lipid have been mapped given the a priori information of the PRFs and
amplitudes via calibration (139).
In each of these CSI techniques, certain assumptions are made in order to
constrain the model to approximate a certain parameter. For example, the chemical shift
between water and lipid in these methods are assumed to be relatively constant. In the
presence of temperature changes, this is not the case. This assumption is made in order to
accurately approximate another parameter which is most often the relative magnitude of
each chemical shift.
As shown above, the PRF, T2* and amplitude of multiple peaks are calculated
without making assumptions such as a constant PRF shift between water and lipid or
equivalent T2* in water and lipid. Here we present a k-means clustering algorithm to
identify these peaks and reconstruct these parameters into images with water-only and
lipid-only field maps, T2* maps and T1-W imaging.

K-means clustering and other

clustering algorithms such as the fuzzy c-means algorithm are powerful techniques that
have been used to segment MR data typically from standard imaging techniques such as
apparent diffusion coefficient (ADC), T1, T2, and PD-weighted images as well as
functional MR data (140-143). In this work, we investigate how this algorithm can take
the multi-parametric data to segment and map different chemical shifts such as lipid and
water without relying on assumptions made in many CSI techniques.

With proper
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mapping, temperature changes can be accurately measured along with providing multiparametric visualization of the spectral data.
The k-means algorithm is an automated and computationally rapid clustering
algorithm that was first proposed by Lloyd in 1957 although he did not publish his work
until 1982 (144). The term “k-means” was first coined by MacQueen in 1967 (145). It
has a variety of applications in machine learning and statistics to partition data based on
defined variables.
Given a set of measurements (x1, x2, …, xn) where each measurement is a Ddimensional real vector, the k-means algorithm partitions the n observations into k
clusters given that k<n by minimizing an objective function, S, where
k

n

S = ∑∑ xi − c j

2

(3.29)

j =1 i =1

and xi − c j is the Euclidean distance between data point, xi, and it’s cluster centroid, cj.
First, random k clusters are assigned to all n observations and centroids are
calculated for each cluster. Data points are then assigned to the nearest centroid. Every
data point assigned to a certain centroid is assigned to the same cluster. Then, new
centroids are calculated from the new clusters. This process continues iteratively until
the centroid calculation converges for each centroid such that cj=cj-1. Figure 3-4 shows
graphically in two dimensions the functions of the algorithm. All spectral processing and
mapping was implemented using MATLAB (MathWorks, Natick, MA).
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Figure 3-5 Schematic of the K-means algorithm
The algorithm assigns random clusters from the observations and centroids are calculated for each k
cluster. Observations are then assigned to the nearest centroid. Then, new centroids are calculated from
the new clusters. This process continues iteratively until the centroid calculation converges by for each
centroid.
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Chapter 4:

Spectral Parameter Estimation and
Acquisition Parameter Analysis from a
Rapid Multi-Gradient Echo Acquisition

4.1 Introduction
This chapter thoroughly reports the results on the spectral processing and
acquisition parameters that are needed for accurate and precise temperature imaging.
First, spectral processing via a filtered Fourier method will be tested, which will outline
limitations in Fourier-based techniques for measuring spectra with a low number of
samples. Next, results from experiments testing the ARMA model as described in
section 3.3 will be presented (specific aim 1). The measurements from the ARMA
model will be used to find suitable acquisition parameters for accurate and precise
temperature imaging (specific aim 2). At the end of this chapter, there is a discussion to
place these results in context for temperature imaging.

4.2 Spectral Analysis using Fourier Windowing
4.2.1 MATERIALS AND METHODS
We investigated the assumption that, with careful selection of spectral filters, a
windowed FFT technique could possibly provide accurate water and aliased lipid peak
locations.

A simulated signal containing water and lipid at physiologically relevant

frequencies was generated. The amplitude of the lipid component was set to be one-tenth
the amplitude of water. For temperature monitoring using lipid, it was assumed that the
optimal location of the aliased lipid peak would be equidistant from the resonant water
peak and its N/2 spectral ghost to minimize contamination of the lipid peak from water
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sidelobes. The relation between the echo-spacing and the frequency difference between
water and lipid was analytically determined.
In addition, we used the Lorentz-Gauss transform which increases spectral SNR
and resolution by combining a Gaussian window and a positive exponential filter (146).
The Gaussian window, g(n), is defined as

g ( n) = e

N
1  n −1− 2 
− 

2 σ N
2 


2

(4.1)

where N is the total number of samples and σ is the ratio of the length between the two
points of inflection on the Gaussian to the length of the entire window.

To find a

suitable σ for this window, the frequencies and amplitudes of the lipid and water peaks as
well as the sidelobes were measured at different σ values. The optimal setting would be a
standard deviation that produces the lowest error in water and lipid frequency estimation
in simulation.
To increase spectral SNR for the FFT approach, a positive exponential filter,
exp(n/T2*), was used where the apparent spin-spin relaxation (T2*) can be quickly
estimated. Using simulation, the frequencies and magnitudes of the peaks were recorded
with and without this filter using the T2* of water-only, lipid-only and a calculated T2* of
the signal.
The product of both windows and the signal was zero-filled and Fourier
transformed to create the simulated spectrum. The location of the maximum value of
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each peak was calculated along with a moment calculation around each peak. These
values were compared to a Gaussian fit of the peaks as done by McDannold et al (45) and
also to frequency estimates from the Steightliz-McBride (SM) algorithm which is
described in the following section.

The time to calculate each spectrum using the

windowed Fourier method as well as the SM algorithm and Gaussian fitting of the peaks
were also recorded.

4.2.2 RESULTS
The relative distance of the lipid peak from the water peak and the N/2 ghosts at
physiologically relevant frequency differences were simulated to help determine the best
echo-spacing (ESP) for the acquisition prior to obtaining experimental data.

By

assuming that the lipid peak needs to be equidistant from the water and N/2 peaks at
different frequencies, the optimal ESP was determined to be:

ESP =

3
4δ w−l γ B 0

(4.2)

where δ w−l is the frequency difference of the water and aliased lipid peak (in ppm), γ is
the gyromagnetic ratio of hydrogen protons (42.58 MHz/T), and B0 is the static magnetic
field strength (in Tesla).
Simulations also demonstrated that the windowed Fourier spectral analysis using
the Gaussian window would be able to suppress spectral sidelobes while maintaining
water and lipid signal. The lipid peak with a physiologically relevant magnitude (10% of
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water) becomes more pronounced than the water sidelobes at a standard deviation of 0.73
and the sidelobe to lipid ratio continues to decrease below this value. The uncertainties in

δ w−l from 3.3-3.7 ppm decrease as σ approaches 0.4 then the uncertainties increase as σ
increases. Therefore, σ = 0.4 was used in the experiments involving the windowed
Fourier method.
Effects of the exponential window in simulation are shown in Table 4-1. The
lowest relative lipid and water peak magnitudes are seen when the T2* of lipid is used for
the window. However, the uncertainty in δ w−l was smallest (0.00144 ppm) when this
value was used. No matter which of the three T2* values were used, the exponential
window decreased the uncertainty in δ w−l .
Table 4-1 Effects of the exponential window on CSI spectra (53)

No Window
Water T2*
Lipid T2*
Calculated T2*

Relative Lipid Magnitude Relative Water Magnitude Lipid/Water Magnitude Ratio Error in δW-L (ppm)
0.181
0.154
0.225
0.00554
0.404
0.373
0.207
0.00159
1.000
1.000
0.191
0.00144
0.248
0.218
0.217
0.00198

The effects of the exponential window at different T2* values at a frequency difference between lipid and
water of 3.5 ppm. If the lipid T2* can be determined, it introduces the largest signal as well as the lowest
error in frequency estimation using a fast moment calculation.

Table 4-2 shows the uncertainty of δ w−l using a moment calculation with various
values of spectral zero-filling, using the maximum value of each peak in a 1024-point
spectrum, the SM algorithm’s calculation, and in the Gaussian fits. The error shown is
the root-mean-squared error over a simulated δ w−l of 3.3-3.8 ppm. The time to calculate
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one spectrum was also recorded to reflect the relative speed of each technique, which is
variable depending on the processing speed of the computer system being used. The SM
algorithm produced the lowest uncertainty of δ w−l , with only a small increase in
processing time relative to Fourier-based processing. This time also was less than the
time required for fitting a Gaussian to each spectrum.

The moment calculation

demonstrated the trade-off between accuracy and processing time. In the experiments
with short acquisition times, a moment calculation using 1024 points was used in the
windowed Fourier calculations since only a small improvement in resolution (0.7 x 10-4
ppm) was seen with a greater processing time (1.5 ms/spectrum) at 2048 points.
Processing was on a 4Gflop CPU processor.
Table 4-2 Processing computing performance in simulation (53)

Processing Method
Moment
512
1024
2048
Peak Maximum
Steiglitz-McBride
Gaussian Fit

-4

Uncertainty in δW-L (10 ppm)

Processing Time (msec/voxel)

23.0
20.1
19.4
23.6
0.02
15.8

10.8
11.1
12.6
10.6
16.6
59.2

The uncertainty for various processing methods with processing times in msec/voxel in these calculations.
The processing times are to demonstrate the relative speed of each method. In this study, images were
masked where only voxels with high signal relative to noise are processed.
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Figure 4-1 The effects of the Lorentz-Gauss transform on MFGRE-CSI spectra
(a) Unfiltered FFT in the phantom calibration ROI at 23.5 °C (dashed line) and 37.8 °C (solid line) with the
presence of N/2 ghosts and sidelobes. (b) FFT spectrum with N/2 correction and Gaussian window (σ=0.4)
applied resulting in minimization of sidelobes and N/2 ghosts with a mean reduction of peak magnitude of
50.5%. (c) FFT spectrum with the same N/2 correction and Gaussian window with an addition to the
TE

exponential window ( e

30.9 ms

) which increases both lipid and water peak magnitudes to 84.8% of the

unfiltered peak magnitudes. Reprinted with permission from the American Association of Physicists in
Medicine, (53).

4.3 Frequency, T2* and Amplitude Estimation with ARMA Modeling
4.3.1 MATERIALS AND METHODS
The SM algorithm was tested, using Prony’s method as an initial estimate, on
simulated signals for one- and two-peak systems. In the one-peak system, acquisition
parameters included spin lattice relaxation time (T1), which was set at 500 ms, and
T2*=60 ms. The TR was fixed at 70 ms to maintain consistent temporal resolution. The
minimum TE was set to 2 ms, with an echo-spacing of 3.3 ms. The two-peak system
added a lipid signal that had 25% of the amplitude of the water peak. For the lipid peak,
T1=300 ms and T2*=30 ms (74). A flip angle of 37° (the Ernst angle for lipid signal (74)
was used. All other parameters were the same as those in the one-peak system. To
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simulate noise in both systems, Gaussian noise was added to real and imaginary channels
of the complex time domain signal. The SNR was defined as the amplitude of each
spectral component divided by the standard deviation of the magnitude noise. Using ten
samples at SNR=2 and ETL=4, the standard deviation of the water PRF was 0.6174 ppm.
If we want 95% confidence that the mean is off by at most 0.01 ppm, then the number of
samples needed is
2

 t σ   2.262 ⋅ 0.6174 
n =  9,α / 2  = 
 = 19504
0.01

 e  
2

(4.3)

Therefore, to obtain the measurement uncertainty, we performed 20,000 random trials at
each SNR value (147). Accuracies and uncertainties of the spectral parameters (chemical
shift, T2* and complex amplitude) were calculated using the SM algorithm for an ETL of
up to 16 echoes to determine, as a function of SNR, how the number of acquired echoes
at a fixed ESP affected the accuracy and precision of the measured spectral parameters.
The Cramer-Rao lower bound (CRLB) was used to provide a comparative
theoretical basis of the uncertainty independent of the spectral processing technique.
This was used to test the performance of the algorithm in terms of precision. The CRLB
is defined as the minimum achievable variance for an estimator (148, 149). The CRLB
for this model (the sum of complex damped exponentials) has been analytically defined
in a one peak system and can be numerically determined for a multi-peak system as
described by Kumaresan and Tufts (54). Detailed background and theory on the CRLB
can be found in appendix A.
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If an MR signal with only one peak is present, then the minimum uncertainty in
the PRF, given by the CRLB, can be defined as

σ f ,CRLB =

1
2π ⋅ SNRA

p0
p0 p2 − p12

(4.4)

where
N −1

p j = ∑ ( ESP ⋅ k ) ⋅ e
j

−2⋅ ESP ⋅k

T2∗

(4.5)

k =0

and SNRA is the SNR of the first echo (54).
The uncertainties of the amplitudes, chemical shifts, and T2* values using the SM
algorithm were compared to the CRLBs to ascertain the precision of the algorithm in the
presence of noise. Correlation coefficients between simulation values and the CRLBs
were calculated for each parameter in both the one- and two-peak systems.
The effects of ESP and T2* were simulated in the one-peak system with ETL=16.
The uncertainty values for the chemical shift, T2*, and amplitude from 20,000
measurements were determined as a function of ESP and T2* and represented on surface
maps.
We also performed simulations to measure the sensitivity of detecting secondary
peaks in noise. In these simulations, the signal parameters were the same as those in a
two peak system with an ETL=16, but the amplitude of water was changed to correspond
to SNR for water of 10-50.

Measurements of sensitivity were made at different
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secondary peak SNR levels to determine at which SNR the secondary signal could be
detected. This enabled the effects from water SNR, lipid SNR, and lipid/water ratios to
be analyzed.

4.3.2 RESULTS
Precision of the SM algorithm on simulated data demonstrated a high correlation
between the uncertainties in chemical shift and amplitude and the CRLB values for
SNR>5 and ETL>4. When uncertainties approached the CRLB, the algorithm performed
near optimum at the theoretical lower bound of the uncertainty for the given model.
Figure 4-2 displays the uncertainties in the signal-peak model using the SM algorithm for
the chemical shift, T2*, and amplitude estimates as a function on of SNR for ETL of 4-16
echoes.

Solid lines represent the CRLBs for each simulation.

As expected, he

uncertainty of the estimates decreased as the SNR and number of echoes increased. T2*
measurements generally showed lower correlation (slightly higher uncertainty than the
CRLBs), primarily at lower SNR values, than other spectral parameters. This effect was
expectedly exacerbated when using truncated ETLs (<8) which yield a reduced TEmax.
For example, the uncertainty of measured T2* from simulations began to exceed the
CRLBs at SNR<10 for ETL=8 and SNR<30 for ETL=4 (Figure 4-2). Table 4-3 shows
the correlation coefficients between the simulated data and the CRLBs. In agreement
with Figure 4-2, the chemical shift and amplitude showed very high correlation
coefficients (Pearson’s R2>0.9990), with the correlation of the T2* measurements
between simulation and the CRLBs decreasing as the number of echoes decreased.
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Figure 4-2 Single-peak simulation and CRLB results
Simulation and CRLB results for 4 (crosses), 8 (squares), 12 (triangles), and 16 (circles) echoes. This
simulation used 20,000 trials. Estimates for chemical shift achieved an uncertainty at the CRLB for SNR≥5
for each ETL (4–16 echoes) (a). The uncertainties in T2* for ETL=16 achieved the CRLB for all SNRs >5
(b). As the ETL decreases, the uncertainty diverges from the CRLB. For instance, at ETL=8, the
uncertainty is higher than the CRLB at SNR<10.Compared with the chemical shift (a) and T2* (b), the
uncertainties of the amplitudes in the simulation and their CRLBs are less dependent on the number of
echoes (c). Reprinted with permission from the American Association of Physicists in Medicine, (150).
Table 4-3 Correlation coefficients between simulation and the CRLB in an one-peak signal

Number of Echoes
4
8
12
16

Chemical Shift
0.9997
0.9997
0.9996
0.9994

T2*
0.7919
0.8886
0.9944
0.9996

Amplitude
0.9996
0.9998
0.9999
0.9999

Correlation coefficients between simulation and the CRLB in a water-only signal over multiple echo-train
lengths. The uncertainties in chemical shift and amplitude have a very high correlation with the CRLB, as
does the uncertainty in T2* at ETL=16. However, correlation between the uncertainties in T2* and the
CRLB decreases as the number of echoes decreases. Reprinted with permission from the American
Association of Physicists in Medicine, (150).
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The measured uncertainty of the chemical shift and T2* estimates demonstrated
an inverse proportionality to the ETL, as expected from the derivation of the CRLBs (54).
For SNR = 20, the dependence of the chemical shift and T2* on the number of echoes had
a relationship of N-1.01 (Pearson’s R2 = 0.990) and N-1.02 (Pearson’s R2 = 0.980),
respectfully, where N is the number of echoes. The amplitude estimates exhibited less
dependence on the number of echoes with a N-0.22 relationship (Pearson’s R2 = 0.982).
Simulations also showed agreement between the spectral parameter uncertainties
and the CRLBs in a two peak model representing water and lipid. Figure 4-3 is a plot of
the uncertainties and corresponding CRLBs for a simulated two-peak model of water and
lipid for ETL=16.

Corresponding correlation coefficients are shown in Table 4-4.

Uncertainties in the chemical shifts of both water and lipid signals approached the
CRLBs and maintained high correlation coefficients.

As observed in the one-peak

simulation of water, T2* values diverged more from the CRLBs than did other spectral
parameters. Uncertainties in the lipid chemical shift and T2* values were demonstrably
higher, even for the same SNR. Uncertainty in the amplitudes showed little difference
between water and lipid.

This result was consistent in a range of water and lipid

concentrations. Further, as seen in the one-peak model, the uncertainty of each peak’s
spectral parameters increased as the number of echoes decreased.
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Figure 4-3 Simulation and CRLB results for a two-peak signal of water and lipid
This simulation used 20,000 trials. Estimates for the chemical shift of both water and lipid achieved an
uncertainty at the CRLB (a). The uncertainties in T2* for both peaks reached their CRLBs. The T2* of lipid
(30 ms) was set to half of that of water (60 ms) (b). The CRLB for the amplitudes of both water and lipid
were similar when represented as relative uncertainties (c). The uncertainties provided by the algorithm had
a similar result. Reprinted with permission from the American Association of Physicists in Medicine,
(150).

Table 4-4 Correlation coefficients between simulation and the CRLB in a two-peak signal

Number of Echoes
4
8
12
16

PRF
0.9753
0.9758
0.9810
0.9886

Water
T2*
0.5813
0.6667
0.7294
0.9638

Amplitude
0.9997
0.9999
0.9999
0.9999

PRF
0.9530
0.9566
0.9721
0.9551

Fat
T2*
0.4811
0.5495
0.6811
0.8435

Amplitude
0.9968
0.9984
0.9994
0.9999

Correlation coefficients between simulation and the CRLB in a lipid-water signal over multiple echo-train
lengths. As with the one-peak (water only) signal, the uncertainties in chemical shift and amplitude have a
high correlation with the CRLB for both water and lipid. The uncertainties in T2* correlate less with the
CRLB as the number of echoes decreases. Reprinted with permission from the American Association of
Physicists in Medicine, (150).
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Surface maps illustrated the impact of T2* and ESP on a one-peak model with
ETL=16 (Figure 4-4). Generally, the uncertainties were lower as T2* increased and the
ESP decreased. Areas below the black line in Figure 4-4 (a-c) indicate areas where the
TE of the last echo (TEmax) was larger than the simulated T2*. As expected, if collected
echoes had TE values greater than the value of T2*, then the uncertainty of that estimate
increased.

Figure 4-4 ESP and T2* effects on the uncertainty
Surface maps demonstrate the effects ESP and T2* (for a single-peak signal at SNR=20) have on the
uncertainties for chemical shift (a), T2* (b), and amplitude (c). Areas below the black line represent where
the ETL TEmax>T2*. This causes an increase in uncertainty, which is more evident on (b) and (c). ESP>1.0
ms can provide low uncertainties as long as the ESP is short enough not to sample above the T2* of the
tissue. Reprinted with permission from the American Association of Physicists in Medicine, (150).
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In addition to precision, we also used simulations to test the accuracy of the SM
algorithm. Table 4-5 summarizes the measured accuracy of the estimates provided by the
SM algorithm in a simulated water signal at SNR=20. These estimates are presented as
the root-mean squared error (RMSE). The algorithm maintains high accuracy for the
chemical shifts (<0.01 ppm) and amplitudes (<1.0%) for an ETL of 4-16. This was
consistent down to SNR=5. T2* values also maintained high accuracy but increased to
≥1% (0.6 ms) for ETL<5 at SNR=20. For each parameter, the accuracy decreased with

decreasing ETL and SNR, as expected. Accuracies in the two-peak signals for the lipidwater simulation are summarized in Table 4-6. The RMSE values were higher for the
water parameters in the lipid-water signal than those for the parameters of water in the
water-only signal. However, accuracy was high for both chemical shift and amplitude,
<0.01 ppm and <1%, respectfully, for ETLs of 4-16. At ETL≤6, the RMSE of T2* was ≥
6% for the longer T2* peak (water). As expected, T2* measurements required a larger
ETL to lower the bias when the ESP was fixed.
The sensitivity of second peak detection in noise was also investigated using
simulations. Using lipid as a model for the second peak, it was observed that the
sensitivity of locating the secondary peak depended on the relative SNR between the
peaks as well as the individual SNR of each peak.

In a model with a simulated water

signal and SNRs of 10-50, the simulated lipid peak was consistently detectable down to
an SNR of 2.64 ± 0.48 for lipid/water amplitude ratios of >0.05.
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Table 4-5 Parameter accuracies in a water signal at a SNR of 20

Number of Echoes
4
5
6
7
8
12
16

Water PRF (ppm)
0.000185
0.000136
0.000105
0.0000844
0.0000724
0.0000429
0.0000316

Water T2* (% Error)
5.65
1.03
0.493
0.246
0.194
0.107
0.0760

Water Amplitude (% Error)
0.0402
0.0402
0.0382
0.0364
0.0347
0.0301
0.0282

Accuracies (root-mean squared error) determined through simulation of 20,000 independent trials with a
water signal at a SNR of 20. High accuracy is achieved for the chemical shifts and amplitudes from four to
sixteen echoes. T2* values also has high accuracy but increases to > 1% (0.6 ms) at ≤5 echoes. Reprinted
with permission from the American Association of Physicists in Medicine, (150).

Table 4-6 Parameter accuracies in a water/lipid signal at a SNR of 20
Number of Echoes Water PRF (ppm) Water T2* (%Error) Water Amplitude (%Error) Lipid PRF (ppm)
4
0.0083
42.1
0.425
0.0077
5
0.0067
38.4
0.322
0.0066
6
0.0047
6.52
0.227
0.0047
7
0.0027
0.474
0.136
0.0027
8
0.0021
0.225
0.106
0.0021
12
0.00047
0.113
0.0395
0.00048
16
0.00018
0.0802
0.0293
0.00021

Lipid T2* (% Error)
16.6
0.426
0.347
0.302
0.263
0.166
0.131

Lipid Amplitude (% Error)
0.932
0.785
0.478
0.281
0.219
0.0887
0.00715

Accuracies (root-mean squared error) determined through simulation of 20,000 independent trials with a
water/lipid signal at a water SNR of 20. The accuracy of chemical shift is within 0.01 ppm and that of
amplitude is within 1% RMSE for ETLs of 4–16. At ETL≤6, the RMSE for both T2* values is high,
especially for the longer T2* peak (water). Reprinted with permission from the American Association of
Physicists in Medicine, (150).

4.4 Analysis of Acquisition Parameters
4.4.1 FLIP ANGLE
4.4.1.1 Materials and Methods
It is expected that for a homogenous voxel, the lowest σ ∆f should occur at the Ernst

angle defined by
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(

θ = cos −1 e

−TR

T1

)

(4.6)

since SNRA is highest at this angle in a gradient echo acquisition. To validate this, an
agarose phantom (1.5 % w/v) was made with distilled, de-ionized water to minimize

variation in the metal ion content of the water, which can lower relaxation times and
affect SNR measurements. Another phantom (agarose 1.5 % w/v) was made with 90%
lemon juice and 10% mayonnaise to create homogenous lipid-water spectra throughout
the phantom. A plastic vial of vegetable oil was also scanned on the 1.5T clinical
scanner.

The phantoms were stored in the MR scanner room overnight so their

temperature would be equalized to that of the room. The T1 and T2* values were
estimated in a 3 x 3 voxel ROI in each phantom. An MGE acquisition was performed
(ETL=16 echoes; minimum TE (TE0)=2.0 ms; ESP=3.3 ms; TR=69 ms; rBW=244
Hz/pixel; acquisition matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 sec/image;
parallel imaging acceleration factor=2). The flip angle was varied from 5° to 90° in 5°
increments.

Assuming a one-peak model for the pure water and lipid phantoms,

frequency maps were made and σ ∆f as well as SNRA were measured in the same ROI
where the T1 and T2* measurements were made. The SNRA measures as a function of
flip angle were compared to theory using the T1 and T2* measurements in both water and
oil phantoms (SNR of a spoiled gradient echo acquisition, SNRA). In addition, the
uncertainty in ppm was plotted against 1/SNRA. The slopes were compared where
1/SNRA is the variable and the slope is the proportionality which is a product of all the
constants in the equations 4.4 and 4.5. In the SNRA and uncertainty plots, measurements
71

and theory were compared using a Student’s t-test assuming equal variances (F-test
verified). A two-peak model was used in the lipid-water phantom with separate field
maps created for water and lipid and σ ∆f of each field map was measured. For each
phantom, the uncertainty of the T2* and amplitude maps were measured as well.
4.4.1.2 Results

Figure 4-5 displays the uncertainties in the PRF (ppm), T2* (ms), and amplitude
(CoV) as a function of flip angle in the pure water agarose phantom. The Ernst angle was
calculated to be 31.8 ± 0.3° (T1 = 409.5 ms) in the ROI where the uncertainty
measurements were made.

Generally, as SNRA increased, the uncertainty of each

spectral parameter decreases, as expected. Figure 4-6 contains the measurements from
the vegetable oil, which had a measured Ernst angle of 74.2 ± 0.4° (T1=52.2 ms).
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Figure 4-5 Flip angle dependence on uncertainty and SNRA measurements in an agarose phantom
Uncertainties in the PRF (ppm), T2* (ms), and amplitude (CoV) were measured as a function of the flip
angle. SNRA was also measured at flip angles between 5 - 90° at 5° increments. Generally as SNRA
increased, the uncertainty in each parameter decreased. The Ernst angle was measured as 31.8 ± 0.3°.
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Figure 4-6 Flip angle dependence on uncertainty and SNRA measurements in a vegetable oil
Uncertainties in the PRF (ppm), T2* (ms), and amplitude (CoV) were measured as a function of the flip
angle. SNRA was also measured at flip angles between 5 - 90° at 5° increments. As with the agarose
phantom, as SNRA increased, the uncertainty in each parameter decreased. The Ernst angle was measured
as 74.2 ± 0.4°, which is expectedly higher than what was measured in the agarose phantom due to a shorter
T1 (52.2 ms).

Figure 4-7 displays the SNR of water and oil as a function of flip angle in addition
to the SNR dependence in the uncertainty. Using the calculated T1s and T2*s (409.5 ms
and 63.4 ms for water, 52.2 ms and 25.4 ms for oil), the calculated SNR matched the
measured values (p=0.14 and p=0.43 for water and oil, respectively). The bottom plots
measures the uncertainty in ppm as a function of 1/SNR which is shown in equation 4.23.
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Using ESP=3.3 ms, ETL=16, and measured T2*, the constant from equation 4.4 was
compared to the slope of the measured data. Again, there were no statistical differences
showing that the uncertainty follows what is predicted by CRLB analysis (p=0.24 and
p=0.09 for water and oil, respectively).

Figure 4-7 SNR and uncertainty measurements in phantom with comparison to CRLB theory
Top: Using the calculated T1 and T2* values, the calculated SNR matched the measured values (p=0.14
and p=0.43 for water and oil, respectively). Bottom: The bottom plots measures the uncertainty in ppm as
a function of 1/SNR which is shown in equation 4.4. Using controlled acquisition parameters and T2*
measurements, there were no differences between the measurements and CRLB analysis.
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Figure 4-8 displays the parameter uncertainties in the lipid-water (mayonnaiselemon juice) phantom.

At flip angles of 30° and above, the uncertainties of each

parameter stayed relatively constant.

Figure 4-8 Flip angle dependence on uncertainty and SNRA measurements in a lipid-water phantom
Uncertainties in the PRF (ppm), T2* (ms), and amplitude (CoV) were measured as a function of the flip
angle. Generally, uncertainties were lowest at higher flip angles. This data suggests that higher flip angles
are needed when lipid and water are both present in the voxel.
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4.4.2 ECHO-SPACING
4.4.2.1 Materials and Methods
In the Fourier approach, large spectral leakage, manifested as sidelobes, made the
echo spacing become confined to a small range so peaks do not overlap. The ARMA
modeling approach may allow more flexibility in the echo spacing allowing even lower
bandwidths and, therefore, higher SNR. Experiments were performed to determine the ESP
that reduces the uncertainty without peak overlapping. To test this, the lipid-water phantom

(1.5% w/v) was scanned on a 1.5T clinical scanner with the echo-spacing varying from
3.3 to 4.3 ms (ETL=16 echoes; minimum TE (TE0)=2.0 ms; TR=69 ms; FA=30°;
rBW=244 Hz/pixel; acquisition matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5
sec/image; parallel imaging acceleration factor=2) at room temperature. σ ∆f values of
water and lipid were recorded as a function of ESP in a 3x3 ROI.

Data analysis

determined the low values of σ ∆f in both water and lipid while discerning ESP values to
avoid due to peak overlapping.
Simulations were also performed to ascertain the effects of SNR on the precision
when the peaks are close together due to increasing ESP. Using the same simulation
protocol as in the SM algorithm simulation study, the ESP was varied from 3.4 to 4.2 ms
as a function of SNR. The uncertainties in the water and lipid PRF were determined.
4.4.2.2 Results

The uncertainties in temperature (using -0.0097 ppm/°C for water and -0.0088
ppm/°C for the difference PRF) are shown at various ESP values (Figure 4-9). The
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uncertainties remain under 1.0 °C for water and 2.0 °C for when lipid is used as a
reference at ESP of 3.3 to 3.8 ms. At 3.9 ms and above, uncertainties increase largely
due to the inability to precisely ascertain the lipid peak. Note that the uncertainty in the
water peak does not go above 1.0 °C except at 4.0 ms where the value is 2.1 °C. At 4.1
ms, the uncertainty in the water peak PRF goes to 0.9 °C although the lipid PRF
uncertainty is relatively high at 7.5 °C.
Figure 4-10 shows the uncertainties in the T2* and amplitude for each peak. As
with the PRF, the peak overlaps affect the secondary peak (in this case lipid) more
compared to the dominant peak (in this case water).

Figure 4-9 Influence of ESP on the precision of temperature estimates
Uncertainties in temperature are shown as a function of ESP. The water PRF relatively maintains precision
indicating that the dominant peak can still be detected precisely even when peaks overlap. The precision of
the secondary peak, which is lipid in this case, loses precision. From this plot, the uncertainty of the lipid
PRF becomes quite high when the ESP is 3.9 to 4.3 ms. Error bars represent the standard deviation of the
measurements.
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Figure 4-10 Influence of ESP on the precision of T2* and amplitude estimates
Uncertainties in T2* (left) and amplitude (right) are shown as a function of ESP. As with temperature, the
water relatively maintains precision. The precision of the secondary peak, lipid, loses precision. From
these plots, the uncertainty of the lipid parameters becomes high when the ESP is 3.9 to 4.3 ms and, thus,
should be avoided if precise lipid estimation is needed in areas where water is dominant (such as the liver).
Error bars represent the standard deviation of the measurements.

Figure 4-11 shows the influence of the ESP and SNR on the PRF uncertainty. As
SNR increases, the ability to ascertain the water and lipid PRF increases even if the peaks
are close together. Therefore, if two peaks are close together due to the actual physical
properties of the signal or an ESP where lipid aliases over water, higher SNR can
distinguish the two peaks.
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Figure 4-11 PRF precision as a function of SNR over variable ESP
As SNR increases, the precision of the PRF estimates increases. Even at an ESP where the lipid aliases
into the lipid peak (4.2 ms), the water PRF can be measured with high precision. Therefore, if ESP values
are chosen that may cause the lipid to alias to the water, higher SNR is needed to precisely measure the
primary peak PRF.

80

4.4.3 ECHO TRAIN LENGTH
4.4.3.1 Materials and Methods

When SNR is high, then the ability to reduce the ETL is possible to either
increase spatiotemporal resolution or increase the number of imaging planes. To test this,
the agar water and lipid-water phantoms were scanned on a 1.5T clinical scanner
(minimum TE (TE0)=2.0 ms; ESP=3.3 ms; TR=69 ms; FA=30°; rBW=244 Hz/pixel,
acquisition matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 sec/image; parallel
imaging acceleration factor=2) with ETL values of 4, 8, 12, and 16.
In addition, a second series of scans were obtained with the agar phantom using
similar acquisition parameters except that the TR was adjusted where it would be the
minimally allowed TR for a given ESP and ETL. The TR values chosen for ETL values
of 4, 8, 12, and 16 were 14.1, 28.0, 41.0, and 54.0 ms, respectively. These resulted in
acquisition times of 0.9, 1.8, 2.6, and 3.5 seconds, respectively. The uncertainties of the
PRF, T2* and amplitude were measured as a function of ETL.
4.4.3.2 Results

At a constant TR, the uncertainty in the measurement of each spectral parameter
was found to be inversely proportional to the ETL (Figure 4-12). This is expected since
the more samples obtained, the more likely the ARMA model can approximate the signal.
Interestingly, even at an ETL of 4, the uncertainty was less than 0.01 ppm which is
consistent what was seen in simulation (see Table 4-5). As long as the T2* extends the
longest TE (see Figure 4-4), the precision of the T2* measurements increases with ETL
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much as what is expected with exponential fitting of magnitude data. Also note that the
dependence in the amplitudes is comparably less dependent on ETL in regards to PRF
and T2*. This is also consistent to what was seen in simulation (see section 4.3.2).

Figure 4-12 Influence of ETL on the precision of spectral estimates in a water phantom
Uncertainties in PRF (top left), T2* (top right) and amplitude (bottom) are shown as a function of ETL. At
a constant TR, the uncertainty in the measurement of each spectral parameter was found to be inversely
proportional to the ETL. This is consistent with the simulations (150).

In the presence of lipid, the precision of each parameter stayed relatively constant
at ETL values of 8, 12, and 16. When 4 echoes were used, the uncertainty of each
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parameter increased. For temperature imaging, it appears that 8 echoes or more could
possibly be used in planes where lipid and water are present in the same voxels.

Figure 4-13 Influence of ETL on the precision of spectral estimates in a lipid-water phantom
Uncertainties in PRF (top left), T2* (top right) and amplitude (bottom) are shown as a function of ETL in a
lipid-water phantom.

The uncertainty in the PRF is relatively constant from 8-16 echoes which suggest

that 8 echoes could possibly be used in voxels with lipid and water for temperature imaging. There is
higher uncertainty, however, in the amplitude estimates at 8 echoes.
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Figure 4-14 shows the uncertainty in the spectral parameters when a shortened TR
is used to increase the temporal resolution and maintain spatial resolution. Compared to
the constant TR, the uncertainties were higher due to lower SNR. The uncertainties in
the PRF at ETLs of 4 and 8 were statistically different (p<0.01 ppm and p=0.02,
respectfully). When compared to the same ETL, all the T2* and amplitude uncertainties
where statistically different (p<0.01). As an illustrative example of how SNR plays a
factor in the uncertainty, Figure 4-15 shows the constant TR case compared to the shorter
TR acquisition where SNR losses due to the change the TR are accounted for.

Figure 4-14 Influence of ETL on the precision of PRF, T2*, and amplitude estimates
Uncertainties in PRF (top left), T2* (top right) and amplitude (bottom) are shown as a function of ETL. At
the shortest TR for the given ETL, the uncertainty in the measurement of each spectral parameter was
found to be inversely proportional to the ETL. This dependence is higher than when a constant TR was
used. The T2* of the phantom was 63.4 ms.
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Figure 4-15 Uncertainties in the amplitudes with SNR compensation
At a shorter TR, the SNR of the acquisition will be lower. If the SNR of the constant TR acquisitions are
decreased by compensating for the difference in TR, then it matches what was measured in the lower TR
acquisitions. In other words, the lower TR acquisition suffers an SNR loss and this directly increases the
uncertainty, as expected. In the amplitude estimate, the uncertainty in the lower TR scans are due purely
from a difference in SNR.
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4.4.4 PERFORMANCE OVER VARIABLE T2*
4.4.4.1 Materials and Methods
To test the precision of the temperature estimates over a range of T2* values, seven
agar phantoms were created with varying concentrations of superparamagnetic iron oxides
(SPIOs) which effectively changes the T2* of phantom (151). The T2* of each phantom was
determined via exponential fitting using a standard SPGR sequence with varying TE. Using
the determined acquisition parameters and spectral processing algorithms, field maps were
made from all seven phantoms scanned (ETL:4-16; minimum TE (TE0)=2.1 ms; ESP=3.3

ms; TR=69 ms; FA=30°; rBW=244 Hz/pixel, acquisition matrix=128x128; voxel
volume=1.6x1.6x4.0 mm3; 5 sec/image; parallel imaging acceleration factor=2). σ ∆f
SNRA was measured in a 3 x 3 voxel ROI in each phantom. σ

∆φ

was be measured in each

ROI as well at each echo. Both σ ∆f and σ ∆φ will be divided by the TSC to represent the
uncertainty in temperature.

A Student’s t-test with equal variances (F-test tested) was

employed to test for differences in the two precision values. If σ ∆f < σ ∆φ for each ROI , then
the proposed technique will show increased sensitivity at that T2* value. Using the SNR of
the first echo and the measured T2*, the CRLB was also calculated.

4.4.4.2 Results

Table 4-7 displays the uncertainty in the CSI and CPD measurements (the lowest
over all the echoes) in each phantom. The CSI technique at least matched the CPD
technique in terms of uncertainty and actually performed better at 6.4 and 21.2 ms
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(p<0.05).

In every case, the CSI measurements matched the CRLB at the 95%

confidence interval. Note that the CPD measurement was at the echo of least uncertainty.
As will be discussed in the next chapter, the T2* changes with temperature so the TE
chosen for CPD methods may not be optimal over the entire course of treatment. In the
CSI method, we measured high precision without constraining to specific TE values (see
equations 2-13 and 3-6).0 This data also supports published data obtained in ex vivo
kidney tissue (53), which investigated the noise characteristics between CPD and this CSI
technique.
Table 4-7 Noise characteristics of CSI and CPD over a range of T2* values

T2*

CRLB (°C)

Unc. CSI
(°C)

Unc. CPD
(°C)

p-value

6.4

1.52

1.21 ± 0.39

2.13 ± 0.74

0.03

12.9

0.21

0.20 ± .02

0.24 ± 0.07

0.24

14.6

0.17

0.18 ± .02

0.23 ± 0.09

0.21

21.2

0.11

0.11 ± 0.02

0.20 ± 0.06

0.02

47.1

0.07

0.07 ± 0.01

0.10 ± 0.05

0.18

51.6

0.07

0.06 ± 0.02

0.09 ± 0.04

0.25

63.4

0.07

0.07 ± 0.01

0.09 ± 0.03

0.38

The CSI technique at least matched the CPD technique in terms of uncertainty. At 6.4 and 21.2 ms, the
uncertainty with the CSI technique was lower when compared to CPD. Each CSI noise measurement
encompassed the CRLB at the 95% confidence interval while this was not always the case with CPD.
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4.5 Discussion
What makes this work different from previously published work (37, 45-48, 152) is
not the sequence itself, but rather the approach taken in setting acquisition parameters,
the efficient use of the imaging time and data generated, and the approach to postprocessing of the low resolution, aliased spectral data.
Our simulations and results from phantom studies demonstrate that processing
algorithms discussed in this study can measure these frequency shifts with a high degree
of accuracy even when the lipid peak is aliased, and that the SM algorithm is useful in
overcoming the limitations of conventional windowed Fourier-based methods.

The

relaxation of the ESP constraint gave us the ability to use lower receiver bandwidths
allowing higher SNR. Also, while only a few echoes were used, the relaxed ESP helped
maintain reasonable spectral resolution. Additionally, the frequency difference between
water and lipid is well known in the range of temperatures used for thermal therapy, so
the ESP can be determined and ued to avoid problems with N/2 ghosts associated with
bipolar readout gradients and aliasing the lipid peak too close to the water peak.
Another assumption we made was that we could accurately monitor peak shifts
using only 16 echoes.

While this could be accomplished using windowed Fourier

techniques and peak finding routines, we applied a non-Fourier technique based on
ARMA analysis of the data in order to provide a more robust method for finding peaks,
as well as estimating the T2* and amplitude for each peak. This is in contrast to well-
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known lipid-water separation techniques where peak amplitude quantification is of
primary concern (128, 135, 137).
We observed robust performance of the SM algorithm in accuracy, uncertainty,
and secondary peak detection across a range of SNR values for a very low number of
echoes. The use of minimal samples represented as a rational polynomial in the zdomain, which has been shown to converge exponentially as the number of echoes
increases (118), is important because this allows the acquisition either to run faster with
less computational overhead or to facilitate the acquisition of multiple slices within the
same TR period. For example, using the minimum TR possible with an ETL=8 and
ESP=3.3 at 1.5T, acquisitions could be performed in less than two seconds. Three slices
could be encoded in less than six seconds.
In addition to choosing a low number of echoes, the choice of other acquisition
parameters, such as the ESP, can affect the accuracy and precision of the measurements.
We have shown that choosing ESPs that extend TEmax past the T2* of the tissue increases
the uncertainty in the measurements (Figure 4-4). In low T2* tissues or where there is
low SNR in the later echoes, those echoes should be dropped since an increase in
uncertainty has been observed. For instance, in a signal with a T2*=10 ms, TEmax=51.2
ms and SNR=20, sampling 16 echoes gave an uncertainty of 0.0154 ppm whereas
sampling 8 echoes reduces the uncertainty to 0.0044 ppm. Therefore, for signals with
low SNR (<5) at the later echoes, it is better to exclude those echoes and proceed with a
lower ETL than to include them.
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Theoretical calculation of the CRLB demonstrates that the uncertainty is inversely
proportional to the SNR, a relationship corroborated by simulation and phantom
measurements. Therefore, MR acquisition parameters, such as the flip angle, should be
chosen to increase the SNR of the peak of interest. For instance, in a one-peak system,
the flip angle that provides maximum SNR is the Ernst angle. For two-peak systems in
which information from both peaks is desired, acquisition parameters should be tailored
to help increase the SNR of the secondary peak, which was assumed here to be the
smaller of the two. If TR is fixed for optimal timing, the flip angle could be used to
provide optimal modulation of the secondary peak signal.
Given adequate SNR, the acquisition used in this work could provide T2* maps of
8-10 slices in a single breathhold (<20 s) using ETL=8, while also providing inherent
lipid suppression. A recent study in liver constrained the solution of the estimated tissuebased T2* for water by assuming equivalent T2* values for water and lipid, owing to a
heavy iron overload (138). The authors concluded that this assumption may not be
reasonable. The technique investigated here could potentially be used to separate these
T2* values directly, without any assumptions on the chemical shift or T2* equivalency,
thereby allowing identification of separate T2* values for water and lipid. Another
potential application is quantitating the distribution of superparamagnetic iron oxides
(SPIOs) (153). These particles have been suggested for use in thermal therapy, and such
therapies could potentially benefit from the temperature imaging capabilities of our
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technique as well (154).

Our data shows that precision can be maintained through a

wide range of SPIO concentrations.
Our simulations and phantom experiments also show that for the same imaging
time and parameters, this technique is more precise than current CPD techniques over a
wide range of SNR values because it maintains better accuracy and precision across a
variety of T2* values and thus improves sensitivity of temperature imaging (Fig. 4-16).
Therefore, our data supports the hypothesis for increased accuracy and precision
compared to CPD.
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Figure 4-16 The uncertainty in temperature versus imaging SNR for a signal containing 25% lipid
The simulation (n = 20,000 samples) for evaluating the uncertainty in the signal for water using the SM
algorithm (circles) is compared with CRLB results (solid line). Note that our algorithm stays close to the
CRLB over a wide range of SNRs. For reference, the CPD results are shown for an optimal TE (TE=T2*) at
the same bandwidth as the 16-echo sequence (black diamonds) and at one half this bandwidth (white
diamonds) as would more likely be used. This case also assumes that the CPD can perfectly remove the
influence of the lipid signal, which is unlikely; thus, it stands as a "best case" scenario for CPD against our
technique. As can be seen, in addition to providing lipid-water separation, the fast CSI approach easily
outperforms the CPD approach across a large range of imaging SNR values for the same imaging time.
Reprinted with permission from the American Association of Physicists in Medicine, (150).
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Chapter 5: Fast CSI Temperature Measurements in
Phantom and Ex Vivo Tissues
5.1 Introduction
The MR acquisition strategies and spectral processing algorithms discussed in
chapter 4 were applied to thermal therapies in phantom and ex vivo tissues. The overall
goal in this chapter is to show the increased accuracy and precision compared to
calculating the complex phase difference (CPD) as well as to show the advantages of this
technique for multi-parametric monitoring. First, calibrations of the PRF shift with
temperature change in a lipid-water phantom as well as ex vivo canine bone marrow,
brain, prostate, kidney and liver tissues were performed. These calibrations will be
reported and discussed with emphasis on how the presence of lipid can affect the water
PRF shift. Next, the temperature responses of R2* and signal amplitude are measured in
these tissues. These parameters, which are simultaneously measured with temperature,
are investigated for their usefulness in thermal therapy monitoring.

5.2 PRF Calibration in Phantom
5.2.1 MATERIALS AND METHODS
A phantom containing 50% lemon juice and 50% mayonnaise (by volume) (45)
was used in order to test the temperature monitoring capabilities of the MGE acquisition
and SM algorithm in voxels containing homogenous lipid and water signals. The mixture
was contained in a 50 ml plastic vial and placed in a calorimeter consisting of two
insulated cups.

A fluoroptic temperature monitoring fiber (M3300, Luxtron, Santa
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Clara, CA) was placed in the phantom and the entire apparatus was placed in an 8channel high resolution brain array (MRI Devices, Waukesha, WI) for imaging on a 1.5T
clinical MR scanner (Excite HD, GE Healthcare, Waukesha, WI). The fluoroptic fiber
was localized using T1-W images. For this calibration experiment, the acquisition time
was slowed to 10 seconds per acquisition to reduce the number of images acquired during
the entire 15 minutes of continuous scanning. The MGE acquisition used a parallel
imaging acquisition (SENSE) with an acceleration factor of 2. The minimum TE was set
to 2.6 ms with an ESP of 3.3 ms (303 Hz spectral bandwidth) for the 16 acquired echoes.
The TR was 140 ms and the acquired voxel volume was 0.78 x 1.6 x 3.0 mm. The flip
angle was set to 60° to increase the lipid signal. The receiver bandwidth to achieve the
desired ESP was ±41.7 kHz (325 Hz/pixel) with a matrix size of 128 (phase encodes) x
256 (frequency encodes). After acquisition of 3 baseline scans, 300 ml of 90°C water
was poured through a tube into the calorimeter. The imaging plane was chosen so that
the flowing water in the image was in the frequency encode direction to avoid artifacts in
the phase-encode direction associated with the aliasing from the SENSE-parallel imaging
acquisition. In addition, the volume of water used was limited to keep the water signal
from appearing in the coronal slice we were monitoring.
A 2x2-voxel region of interest (ROI) was selected at the point in the image at the
end of the fluoroptic probe. The SM algorithm was also employed to estimate the water
and bulk methylene PRF shifts. Peak shifts estimated by the technique were plotted
against the temperature measured by the fluoroptic probe in order to calculate the
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temperature sensitivity coefficient in ppm/°C. Linear fits were calculated for the plot
using least-squares regression.
Maps were created using the CPD method at the echo time close to the lipid T2*
(TE = 32.6 ms). A Student’s t-test was used to find statistical significance between the
temperature readings from these three methods and the fluoroptic fiber’s measurements.

5.2.2 RESULTS
Temperature calibration curves for the lipid-water phantom experiment using the
SM algorithm are shown in Figure 5-1.

The temperature sensitivity coefficients

calculated for each curve were -0.0096 ± 0.0003 ppm/°C (Pearson’s R2 = 0.995) and 0.0007 ± 0.0005 ppm/°C (Pearson’s R2 = 0.436) for water and lipid, respectively. The
temperature sensitivity coefficient based on the difference between the lipid and water
peaks was -0.0088 ± 0.0005 ppm/°C (Pearson’s R2 = 0.994) and this value is similar to
published data when the water PRF accounted or corrected for susceptibility (37, 43, 45).
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Figure 5-1 The temperature calibration curves of the lipid-water phantom
The lipid and water curves are shown in (a) and the difference between the two peaks, δ w−l , in (b). A
strong linear dependence can be seen in the water peak and the difference between the peaks.” The
temperature sensitivity coefficients calculated for each curve were -0.0096 ± 0.0003 ppm/°C (Pearson’s R2
= 0.995), -0.0007 ± 0.0005 ppm/°C (Pearson’s R2 = 0.436) and -0.0088 ± 0.0005 ppm/°C (Pearson’s R2 =
0.994) for water, lipid and the difference in the PRF values, respectively. Reprinted with permission from
the American Association of Physicists in Medicine, (53).

96

Temperature measurements with and without using a lipid reference as well as the
CPD measurements were obtained (Fig. 5-2). The calculations were performed using the
same ROI where the calibration data was measured. During the calibration, the hot water
poured into the calorimeter caused a large shift in the mixture’s water and lipid resonance
frequencies. This caused the RMSE for the CPD and water CSI temperature readings to
be 21.3 °C and 20.3 °C, respectfully.

These two measurements were significantly

different when compared to the fluoroptic fiber measurements (p<0.0001).

However,

when lipid was used as an internal reference the temperature remained accurate when
compared to the fluoroptic fiber measurements. The RMSE between the lipid-referenced
CSI and the fluoroptic fiber was 0.44 ± 0.34 °C. There was no statistically significant
difference between the CSI using lipid as a reference and the fluoroptic fiber
measurements over all the time points.

97

Figure 5-2 The measured change in temperature in the lipid-water phantom over time
Field shifts from the pouring water causes the CPD (∆T(∆φ)) and CSI (water frequency only, ∆T(δW)) to be
21.3 °C and 20.3 °C, respectfully. The CSI using lipid (∆T(δW-L)) as a reference corrects this error.
Reprinted with permission from the American Association of Physicists in Medicine, (53).

5.3 PRF Calibration in Ex Vivo Tissue
5.3.1 MATERIALS AND METHODS
Canine bone marrow, brain, kidney, liver and prostate tissue were treated with a
water-cooled applicator housing a 980-nm laser fiber with a 1-cm diffusing tip powered
by a 15 W diode laser source (BioTex Inc., Houston, TX) on a clinical MR scanners at
1.5T (Excite HD, GE Healthcare, Waukesha, WI) and 3T (TwinSpeed Excite HD, GE
Healthcare, Waukesha, WI). A fluoroptic temperature probe (M3300, Luxtron, Santa
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Clara, CA) was inserted in order to provide an absolute measurement of temperature. In
each ablation, the multi-gradient echo (MGE) acquisition was used (1.5T: ETL=16
echoes; minimum TE (TE0)=2.0 ms; ESP=3.2 ms; TR=69 ms; FA=30-40°; rBW=244
Hz/pixel, acquisition matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 sec/image;
parallel imaging acceleration factor=2. 3T: TE0=2.1 ms; ESP=1.8 ms; rBW=325
Hz/pixel). Echoes were acquired with identical polarity gradients separated by flyback
rewinder gradients.
A 2 x 2-voxel ROI adjacent to the sensitive region of the fluoroptic probe was
chosen and the PRFs were measured as a function of temperature to calculate the
temperature sensitivity coefficient (TSC). The water PRF was measured for all tissues.
For bone marrow, water and bulk methylene proton resonances were measured at 1.5T
while terminal methylene and methyl peaks were included in studies at 3.0T. Slope,
intercept, and correlation coefficient measurements were calculated for each temperature
sensitivity calibration using linear least-squares regression analysis. The temperature
estimates using the calculated TSC were correlated to the fluoroptic probe measurements.
Estimates were also compared to CPD-measured water PRF calibration using a paired
two-tailed Student’s t-test.

Estimated uncertainties (noise) from each calculated

parameter in bone marrow were measured as the standard deviation and compared with
the calculated CRLB for the acquisition, which represents the theoretical lower bound of
the uncertainty (54, 150). Temperature uncertainties calculated from the measured TSC
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and PRF uncertainties were compared to temperature uncertainties from the complexphase difference using the echo from the MGE acquisition with the least uncertainty.

5.3.2 RESULTS
In bone marrow, water, bulk methylene, terminal methylene and methyl peaks
were resolvable at 1.5T and 3.0T. Figure 5-3 demonstrates representative modeled
spectra from ex vivo bone marrow observed using the spectral parameters derived from
the SM algorithm at 1.5T (a) versus the unfiltered FFT spectrum (with 1024 zero padded
interpolation) and the modeled spectra at 3.0T (b). The SM algorithm rapidly and
accurately located water and lipid chemical shifts despite the low spectral resolution of
the acquisition, which caused large sidelobe contamination in the Fourier analysis.
Although spectral apodization techniques could be employed with the FFT technique, the
tradeoff is one of spectral resolution versus sidelobe interference. In (b), as temperature
rises, the water peak shows a notable shift in the PRF compared to the three lipid peaks.
Spectra obtained from a point resolved spectroscopy (PRESS) (TE/TR: 144/2000)
acquisition show the unaliased lipid peaks and the water peak (c).
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Figure 5-3 Representative measured bone marrow spectra from 16-echo MGE and PRESS
At 1.5T (a) a 4-peak ARMA modeling (solid) versus unfiltered FFT (1024 point interpolation) (dashed).
As previously confirmed (17), ARMA peak locations do not suffer from truncation artifacts. At 3.0T (b)
four-peak model at 17.0°C (solid) and 42.5°C (dashed) demonstrates temperature dependent water PRF and
temperature independence of lipid peak PRFs. For comparison, a spectrum from a PRESS acquisition is
shown in (c).

As expected, excellent correlation with fluoroptic temperature measurements
were observed in the water PRF but not in the lipid PRF. The data in Table 5-1
quantifies temperature relationships observed during calibrations at 1.5T over the
temperature range of 17.2 to 57.0 °C. Figure 5-4 demonstrates the change in the water
(squares) and bulk methylene (diamonds) PRF as a function of fluoroptic temperature
measurement at 1.5T. The TSC of the difference between the water and lipid PRF values
in both calibrations were found to be statistically equivalent (-0.87x10-2 ± 2.7x10-6
ppm/°C (R2=0.942), -0.87x10-2 ± 4.6x10-4 ppm/°C (R2=0.961) and -0.85x10-2 ± 3.2x10-4
(R2=0.920), 0.17 < p < 0.99).

Using these TSC values, the RMSE between the

temperature estimates and the fluoroptic probe was 0.39 ±0.21°C (Range: -0.29 – 0.90
°C) for calibration 1, 0.96 ± 0.25°C (Range: -0.54 – 1.13 °C) for calibration 2 and 0.54 ±
0.13 °C (Range: -0.84 – 0.93 °C) for calibration 3. If the temperature measurements were
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made using water PRF without lipid correction along with the TSC of the water PRF
only, the RMSE values were 1.03 ±0.12 °C (Range: -1.36 – 1.69 °C), 2.11 ± 0.24 °C
(Range: -1.41 – 2.69 °C) and 1.31 ± 0.31°C (Range: -1.22 – 2.91 °C) for calibrations 1, 2
and 3, respectively. The CPD RMSE was 2.34 ± 0.25 °C, which was statistically
different from the CSI measurements (p<0.001).
Table 5-1 Measured PRF temperature sensitivity coefficients from three bone marrow calibrations
at 1.5T

Chemical Shift
Water
Bulk Methylene
Difference

-2

-4

-1.07x10 ± 1.0x10
(0.981)
-2
-4
-0.20x10 ± 1.0x10
(0.438)
-2
-4
-0.87x10 ± 2.7x10
(0.942)

Temperature
Sensitivity Coefficient
2
[ppm/°C] (R )
-2
-4
-1.11x10 ± 2.4x10
(0.974)
-2
-4
-0.24x10 ± 1.5x10
(0.738)
-2
-4
-0.87x10 ± 4.0x10
(0.961)

-2

-4

-0.98x10 ± 1.3x10
(0.969)
-2
-4
-0.12x10 ± 1.1x10
(0.440)
-2
-4
-0.85x10 ± 3.2x10
(0.920)

The difference is between the water and bulk methylene PRFs which is consistent between calibrations and
agrees with lipid-water phantom data (45, 53).
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Figure 5-4 Temperature calibration curves for one bone marrow calibration at 1.5T
The temperature sensitivity coefficients (TSCs) of the water (squares) and lipid (diamonds) PRFs were 0.98x10-2 ± 1.3x10-4 (R2=0.969) and -0.12x10-2 ± 1.1x10-4 (R2=0.440), respectfully.
-2

By taking the

-4

difference of the two PRFs as a function of temperature, the TSC was -0.85x10 ± 3.2x10 (R2=0.920).

The temperature measurements from the CSI technique compared to the true
temperature calculated by the fluoroptic probe in calibration 1 are shown in Figure 5-5.
The slopes of the regression lines for the water-bulk methylene temperature readings and
the water PRF were 0.999 ± 0.021 ppm/°C (R2=0.987) and 0.988 ± 0.072 ppm/°C
(R2=0.942) with intercepts at 0.03°C and 1.01°C, respectfully. For comparison, the solid
line shown has a slope of unity. If the difference in the water PRF alone was used for
temperature monitoring, it would tend to overestimate the temperature (p<0.001).
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Figure 5-5 Temperature measurements from the CSI technique compared to the true temperature
calculated by the fluoroptic probe.
The RMSE for the susceptibility-corrected temperature readings and the water PRF readings were 0.393 °C
and 1.031 °C. The slopes of the regression lines for the water-lipid temperature readings and the water
PRF were 0.999 (R2=0.987) and 0.988 (R2=0.942) with intercepts at 0.030°C and 1.014°C, respectfully.
For comparison, the line shown in the figure has a slope of unity.

The measured uncertainties in the spectral parameter estimations made using the
2-peak model at 1.5T are summarized in Table 5-2. Values in parentheses are the
calculated theoretical uncertainty for the acquisition provided by the CRLB.
measured uncertainties agree with the CRLB at the 95% confidence interval.

The

Using the

calculated TSC values, the temperature uncertainty was calculated as 0.58 ± 0.09 °C
when the difference of the water and lipid PRF values was used for temperature
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measurements. Comparably, the uncertainty in the CPD was measured as 1.46 ± 0.19°C
using the echo from the acquisition with the least uncertainty (TE=14.8 ms) (p<0.01).
Table 5-2 Measured uncertainties in the estimated spectral parameters in bone marrow at 1.5T

Parameter
Water (CRLB)
PRF (ppm)
0.00355 ± 0.00054 (0.004)
T2* (ms)
2.27 ± 0.51 (2.22)
Amplitude (CoV)
0.023 ± 0.009 (0.018)

Bulk Methylene (CRLB)
0.00191 ± 0.00035 (0.002)
0.48 ± 0.14 (0.57)
0.017 ± 0.004 (0.015)

The CRLB is within the 95% confidence interval in each of the parameters.

The mean spectral parameter estimations measured at 3.0T resulting from
application of a 4-peak model in bone marrow are also summarized in Table 5-3. The
TSCs of these peaks over a temperature range of 18.4 to 57.2 °C are shown in Table 5-4.
As with the 1.5T calibrations, the water-bulk methylene TSC was statistically equivalent
(p=0.11). Using the temperature sensitivity of the difference in the water and bulk
methylene PRF, the RMSE values compared to the fluoroptic probe were 0.19 ±0.06°C
and 0.59 ± 0.24°C for the two calibrations. Using CPD with a TE of 9.1 ms, the RMSE
was 1.89 ± 0.15°C. This was statistically different from the CSI RMSE (p<0.001). The
noise in the temperature estimates using bulk methylene as an internal reference was
measured at 0.78 ± 0.08 °C. The noise in the temperature estimates were higher, 2.87 ±
0.05 °C and 3.21 ± 1.12 °C, when using the lower SNR terminal methylene and methyl
protons, respectively, as internal references. Using the mean of all three lipid peaks as a
reference, the uncertainty was lower at 1.00 ± 0.02 °C. Using the water peak only with its
measured TSC, uncertainty was 0.91 ± 0.38 °C. Uncertainty in the CPD was measured as
105

1.93 ± 0.70°C using the echo with the least uncertainty (TE=9.1 ms) (p<0.01 when
compared to CSI with lipid as a reference).
Table 5-3 Measured PRF, T2* and amplitude values with associated uncertainties for water, bulk
methylene, terminal methylene and methyl protons using a four-peak model at 19 °C

Chemical Shift
Water
Bulk Methylene
Terminal Methylene
Methyl

PRF (ppm)
4.6856 ± 0.0091
1.1856 ± 0.0074
2.0285 ± 0.0044
0.8631 ± 0.0153

T2* (ms)
56.2 ± 8.9
9.5 ± 0.2
3.6± 0.4
18.1 ± 0.7

Amplitude (Normalized)
0.575 ± 0.054
1.000 ± 0.014
0.297 ± 0.014
0.369 ± 0.062

Peaks were identified in the expected locations (155). The water T2* is within range of previous T2
measurements in bone marrow (156).

Table 5-4 Measured PRF temperature sensitivity coefficients from multiple protons at 3.0T

Chemical Shift
Water
Bulk Methylene
Terminal Methylene
Methyl
Water – B. Methylene

TSC [ppm/°C] (R2)
-1.03x10-2 ± 1.4x10-4 (0.978)
-0.15x10-2 ± 0.9x10-4 (0.904)
-0.19x10-2 ± 2.7x10-4 (0.211)
-0.70x10-2 ± 3.1x10-4 (0.618)
-0.88x10-2 ± 3.0x10-4 (0.917)

-1.28x10-2 ± 2.3x10-4 (0.981)
-0.42x10-2 ± 3.1x10-4 (0.972)
-0.44x10-2 ± 4.4x10-4 (0.487)
-0.84x10-2 ± 4.7x10-4 (0.816)
-0.86x10-2 ± 2.3x10-4 (0.964)

As with the 1.5T calibrations, the difference between the water and bulk methylene PRFs are consistent to
literature (45, 53). Temperature sensitivities of terminal methylene and methyl protons are also listed.

Table 5-5 displays the TSC of each of the tissues along with the temperature
range measured in the calibration.

All TSC are within the 95% confidence interval of

what has been measured in soft tissue (-0.0097 ppm/°C with an exception of -0.0098
ppm/°C for brain (157)). In calibrations, where the temperature exceeded the break point
for thermal damage, there were no shifts in linearity.
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Table 5-5 Temperature sensitivity coefficients in various non-fatty tissues
Tissue Type
Brain
Prostate
Kidney
Liver

Temp. Range
(ºC)
25-59
32-59
35-54
35-51

Temp. Sensitivity
(ppm/ºC) (R2)
-0.0102 + 0.0005 (0.998)
-0.0099 + 0.0004 (0.995)
-0.0103 + 0.0006 (0.994)
-0.0098 + 0.0002 (0.984)

TSC values were within the expected values in soft tissues. There were no shifts in linearity in the PRF.

Table 5-6 displays the RMSE and uncertainty of each tissue using CSI and CPD.
CSI had lower RMSE and uncertainty compared to CPD which supports our hypothesis
of greater precision and accuracy using the CSI technique.
Table 5-6 Temperature accuracy and precision in various non-fatty tissues
Tissue Type
Brain
Prostate
Kidney
Liver

CSI RMSE
(ºC)
0.96 + 0.14
0.24 + 0.09
0.29 + 0.05
0.58 + 0.16

CPD RMSE
(ºC)
1.69 + 0.24
1.09 + 0.40
2.03 + 0.67
1.25 + 0.10

p-value
0.01
0.02
0.01
<0.01

CSI Unc.
(ºC)
0.23 + 0.11
0.20 + 0.09
0.28 + 0.24
0.32 + 0.08

CPD Unc.
(ºC)
0.56 + 0.14
0.66 + 0.10
0.86 + 0.17
0.88 + 0.11

p-value
0.03
0.02
0.02
<0.01

In support of our hypothesis, the accuracy and precision in temperature measurements in non-fatty tissues
were statistically higher with CSI compared to CPD.

5.3.3 DISCUSSION
In calibration experiments at 1.5T and 3.0T in tissues containing lipid, PRF TSC
values consistent with previous studies (43, 45) were observed when the difference
between the water and bulk methylene PRFs are used for temperature estimation. In fatty
tissue, De Poorter et al. (43) measured an overall TSC of -0.0097 ppm/°C with a
susceptibility constant of -0.0013 ppm/°C giving a corrected field shift of -0.0088
ppm/°C, which is consistent with results reported here. McDannold et al. (45) measured
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similar TSC values in a mayonnaise-lemon juice phantom which was designed similarly
to our phantom study. As expected, using water PRF shift alone did not result in
consistent temperature sensitivities due to varying degrees of susceptibility and drift
between experiments. For example, at 3.0T in bone marrow the water PRF was highly
linear with temperature (R2=0.981).

However, its TSC was approximately 15-19%

higher in one calibration than what was seen at 1.5T. When the difference between the
water and bulk methylene was taken to effect to correct for susceptibility, the TSC was
measured as -0.0086 ± 0.0002 ppm/°C, within the 95% confidence interval of the
measurements taken at 1.5T. Using the measured TSC by taking the difference between
water and bulk methylene protons, we measured accurate temperature readings in each
experiment (0.44 °C in phantom; 0.96 °C, 0.39 °C, and 0.54 °C in bone marrow at 1.5T;
0.19 °C and 0.59 °C in bone marrow at 3.0T). It is very important to note that this
susceptibility effect on the temperature sensitivity of lipid-containing tissue is
independent of whether or not lipids are suppressed.

In addition, although the RMSE

and uncertainty were lower compared to single-echo CPD, one could reduce the
acquisition time and/or bandwidth (to increase SNR) to improve accuracy and precision
with CPD techniques. This would not, however, account for susceptibility or field drift
effects that were seen in the water PRF measurements.
The phantom and bone marrow study exemplifies the advantage of having a lipid
peak as a reference when relatively large susceptibility or field shifts occur. There was
no large susceptibility shifts seen in the non-fatty tissue in brain, prostate, kidney and
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liver compared to the bone marrow. This may be due to the interfaces in the cortical
bone and the added susceptibility from the high lipid content in the marrow. From these
measurements, there appears to be an increased susceptibility effect from the presence of
lipid which makes measurements difficult with CPD.
To our knowledge, no MR thermometry study has investigated the temperature
sensitivity of multiple lipid peaks simultaneously with this level of spatiotemporal
resolution. It was found that although the terminal methylene peaks and methyl peaks
could be resolved in bone marrow at 1.5T, the uncertainty was on the order of 0.03-0.08
ppm making calibrations difficult to ascertain with confidence. At 3.0T, each of the four
peaks had sufficient SNR and spectral resolution for precise measurements so that the
temperature dependence of each component of the lipid peak could be analyzed. When
using lipid for an internal, temperature independent, reference, highest accuracy and
precision was demonstrated with bulk methylene for PRF-based reference thermometry.
This was primarily due to a smaller uncertainty in the measurement and is likely due to
the higher SNR of bulk methylene compared to the other lipid protons.
In many lesions in fatty tissue, the primary component will be water, especially in
the center of the lesion. If no lipid is present, we expect high precision with temperature
measurements as seen in our simulation outlined in chapter 4. However, toward the
borders of the lesion voxels may contain lipid. It is important that lipid is taken account
for in order to accurately measure the temperature, identify the borders of the ablative
region, and verify if the entire lesion received an adequate thermal dose.

Also,
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extrapolating the lipid field map into the lesion, much like what has been done with
referenceless thermometry (158), could possibly be performed to improve temperature
estimates in bone lesions and warrants investigation.
As in our simulations, our phantom and ex vivo data support our hypothesis that
this CSI technique provides higher precision and accuracy compared to the CPD
measurements. However, as seen in the bone study, it is important to identify the peaks
correctly in order to apply the appropriate TSC. The next chapter will address this by
evaluating an algorithm which identifies water and lipid peaks and maps their spectral
parameters to aid in improving temperature imaging.

5.4 Multi-Parametric Analysis in Ex Vivo Tissue
5.4.1 MATERIALS AND METHODS
Canine bone marrow, brain, kidney, liver and prostate tissue were treated with a
water-cooled applicator housing a 980-nm laser fiber with a 1-cm diffusing tip powered
by a 15 W diode laser source (BioTex Inc., Houston, TX) on clinical MR scanners at
1.5T (Excite HD, GE Healthcare, Waukesha, WI) and 3T (TwinSpeed Excite HD, GE
Healthcare, Waukesha, WI). A fluoroptic temperature probe (M3300, Luxtron, Santa
Clara, CA) was inserted in order to provide an absolute measurement of temperature. In
each ablation, the MGE acquisition was used (1.5T: ETL=16 echoes; minimum TE
(TE0)=2.0 ms; ESP=3.2 ms; TR=69 ms; FA=30-40°; rBW=244 Hz/pixel, acquisition
matrix=128x128; voxel volume=1.6x1.6x4.0 mm3; 5 sec/image; parallel imaging
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acceleration factor=2. 3T: TE0=2.1 ms; ESP=1.8 ms; rBW=325 Hz/pixel). Echoes were
acquired with unipolar gradients separated by flyback rewinder gradients. ROIs (2 x 2
voxels) were chosen in areas that reached ablative temperatures (≥54 °C) with each pixel
processed individually. Using the calculated TSC values from water (and bulk methylene
PRF, if present, as an internal reference), the changes in the PRFs were converted to
temperature changes and added to the baseline temperature provided by the fluoroptic
temperature probe; thereby providing absolute temperature readings.
In at least five ROIs in each tissue type, the water R2* was measured. As will be
shown in the results, each plot of R2* displayed an inflection point. Blinded by the
temperature and thermal dose data, data points were labeled as 0 before the inflection
point and 1 after the inflection point with respect to time on the R2* plot. The inflection
point was defined as the point after a local maximum or minimum R2* with five
consecutively decreasing or increasing values after the local maximum or minimum.
Next, binomial logit analysis was used to fit the data as a function of thermal dose. The
probability, P, of the logit curve is defined as

P=

1
1 − eα + βΩ

(5.1)

where α and β are coefficients determined by the fit.
The dose was calculated from the Arrhenius rate model for thermal damage where
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t

Ω = ∫ Ae

− Ea
RT (τ )

dτ

(5.2)

0

A is the frequency factor, Ea is the activation energy, R is the universal gas constant
(8.315 JK-1mol-1) and T(τ) is the temperature in degrees Celsius as a function of time, τ
(26). A and Ea values were chosen to predict protein denaturation (A: 3.1 x 1098 s-1, Ea:
6.3 x 105 J mol-1) (25). Ω≥1 signified tissue damage and this threshold has been used in
previous studies (159, 160). The dose was recorded where the probability of the fit
equaled 0.5 (also known as LD50). The fraction of damage cells (C(τ)/C(o), equation
1.4) was also calculated. The purpose of this measurement was to characterize the signal
change as a function of thermal dose to determine if the changes occurred where damage
was expected to occur. The slopes of lines were measured before and after the inflection
point with respect to temperature and compared using a two-tailed Student’s t-test with
equal variances (as determined by an F-Test).

5.4.2 RESULTS
Figure 5-6 displays the logit fits for each of the tissues along with a logit fit for all
the tissues combined. Table 5-7 also shows the LD50 with uncertainty. In each case, an
Ω of 1 was within the 95% confidence interval for LD50. In the formulism by Henriques

(25), this value was used to signify irreversible damage by protein denaturation.
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Figure 5-6 Logit fits for bone marrow, brain, liver, prostate and kidney tissue
Using binomial logit analysis, the probability of 0.5 that a R2* change occurred were at thermal dose values
known to cause irreversible damage as shown by Henriques (25). The black line is the logit fit. The blue
solid and dashed lines are the LD50 values and the standard error, respectively. The circles are binary data
points for the curve fitting. Note that there are several binary points beyond Ω=2 (Range: 0-1.49x107). N
is the number of binary points. This shows that the R2* changes are occurring where damage is expected to
occur.
Table 5-7 Measured LD50 values for various tissues with associated confidence intervals

Tissue

LD50 (Ω)

95% CI

α (A.U.)

β (A.U.)

C(τ)/ C(0) [1-exp(-ΩLD50)]

Bone
Brain
Liver
Protate
Kidney
Combined

0.77
1.10
0.85
0.97
1.07
1.01

(0.47,1.07)
(0.92,1.27)
(0.62,1.08)
(0.83,1.11)
(0.92,1.22)
(0.94,1.08)

-4.18 ± 1.09
-3.20 ± 0.50
-6.40 ± 1.05
-3.50 ± 0.60
-2.73 ± 0.35
-3.26 ± 0.25

5.41 ± 2.23
2.91 ± 0.72
7.56 ± 2.11
3.61 ± 0.95
2.55 ± 0.52
3.24 ± 0.37

0.54
0.67
0.57
0.62
0.66
0.64

95% CI

p-value

(0.37,0.66)
0.03
(0.60,0.72) <0.001
(0.46,0.66)
0.01
(0.56,0.67) <0.001
(0.60,0.70) <0.001
(0.61,0.66) <0.0001

The dose threshold of Ω=1.0 was within the 95% confidence interval for each tissue. C(τ)/C(0) represents
the fraction of cells that are damaged. The p-values calculated from the logit fit shown that the fits were
statistically significant in each case.
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As an example of the signal change in lipid tissue, the R2* values and signal
amplitudes of water and each lipid in bone marrow were plotted along with the Arrhenius
rate estimate for irreversible tissue damage as a function of temperature in Figure 5-7.
The slope between 17 °C and 54 °C was 2.8 ± 0.1 %/°C (R2=0.965). At 54 °C and above,
the slope was -1.6 ± 0.2 %/°C (R2=0.917). Each of these slopes were statistically
different from one another (p<0.0001). For bulk and terminal methylene there is an
asymptotic decrease in R2* until Ω approached unity. There was also a change in the
methyl R2* slope as Ω approached unity. In the amplitude measurements, a shift in the
slope can be observed in the water peak. At temperatures where Ω <1, the slope was 0.4
± 0.1 %/°C (R2=0.824). At temperatures where Ω ≥1, the slope was -1.0 ± 0.2 %/°C
(R2=0.905). In the lipid peaks, the temperature response reduced in the bulk methylene,
terminal methylene and methyl peaks by 75%, 88% and 80%, respectively, at the same
temperature region.
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Figure 5-7 Temperature response water R2* (a) and amplitude (b) as well as the lipid R2* (c) and
amplitude (d) of bone marrow at 3.0T
The dashed line in each plot represents the Arrhenius dose model calculation (A: 3.1 x 1098 s-1, Ea: 6.3 x
105 J mol-1) (25). Changes in the slope can be seen when the Arrhenius dose, Ω, approaches 1.0, which
signifies damage to the tissue.

Figure 5-8 demonstrates what was typically seen in non-lipid tissue. This is a
case from brain tissue. Table 5-8 lists temperatures where the break points occurred
according to Arrhenius rate model analysis along with the slopes between these
temperatures.

In all tissues except prostate, there was a statistically significant

(p<0.0001) change in the R2* slope when damage is predicted to occur. This was more
evident when compared to the amplitude slopes.
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Figure 5-8 The water R2* (a) and amplitude (b) temperature response of brain tissue at 3.0T
As with the bone marrow, changes in slope can be seen when Ω approaches 1.0. The break points in the
parameters were seen at 57.1 ± 1.2 °C. This corresponds to temperatures where phase changes are seen in
the protein state.
Table 5-8 Temperature break points (Ω >1) with linear regression slopes above/below these points.
R2* Slope (%/ °C)
37 °to Break Point (BP)

Amplitude (%/ °C)
37 °Cto BP

Tissue

Temperature at Ω=1

Bone

54.2 ± 1.2

2.8 ± 0.1 %/ °C(R2=0.965)

-1.6 ± 0.2 %/ °C(R2=0.917)**

0.4 ± 0.1 %/ °C(R =0.824)

-1.0± 0.2 %/ °C(R2=0.905)**

Brain

57.1 ± 1.2

5.5 ± 0.4 %/ °C(R2=0.945)

-4.3 ± 0.6 %/ °C(R2=0.792)**

-0.4 ± 0.1 %/ °C(R2=0.799)

-1.0 ± 0.2 %/ °C(R2=0.803)*

Liver

52.2 ± 0.4

0.7 ± 0.3 %/ °C(R2=0.852)

-1.2 ± 0.1 %/ °C(R2=0.894)**

-0.8 ± 0.3 %/ °C(R2=0.874)

-0.9 ± 0.2 %/ °C(R2=0.924)

Prostate

57.0 ± 1.0
57.0 ± 0.4

0.2 ± 0.1 %/ °C(R2=0.872)
2.1 ± 0.5 %/ °C(R2=0.625)

0.4 ± 0.1 %/ °C(R2=0.565)

-0.4 ± 0.2 %/ °C(R2=0.851)

-0.5 ± 0.1 %/ °C(R2=0.944)

-1.0 ± 0.4 %/ °C(R2=0.717)**

-0.7 ± 0.3 %/ °C(R2=0.823)

-0.7 ± 0.1 %/ °C(R2=0.857)

Kidney

Above BP

2

Above BP

* p<0.05,** p<0.001 compared to slope before the break point

5.4.3 DISCUSSION
With this fast CSI technique, other parameters (peak-specific R2* (1/T2*) and T1W amplitude) can also be measured to provide an important opportunity to look at
changes as a function of temperature. Estimated spectral parameters were evaluated as a
function of the higher temperatures that would be encountered during ablative therapy
delivery using the calibrated PRF shift of water-bulk methylene or water alone. It is
important to note that we did not see changes in linearity in the PRF at high temperatures
(see Figure 5-4), which is consistent to previous studies where high linearity was found
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up to 80 °C (37). In this analysis, we did see changes in linearity of R2* and amplitude
data during heating (60, 72).

We have previously noted significant changes in the

temperature dependence of these parameters in the range where the Arrhenius rate model
predicts damage (25, 26) thereby demonstrating that it could be a useful dosimetry tool.
For example, when the temperature history results in Ω≥1, there was a consistent, sharp,
measureable change in the slope of the R2* of water versus temperature.
The molecular mechanisms for these changes are not exactly clear and
understanding the relationship between the dynamics and structure of proteins and the
surrounding water is a current challenge (161). Possible theories to these changes due to
the protein denaturation include the change in the dipolar coupling between water
molecules and denatured proteins (162). Additionally, release of water in the hydration
layers of the denaturing proteins may explain the decrease in R2* (161).
Water and lipid R2*-corrected amplitudes also exhibited similar non-linearities in
the same temperature ranges as seen in Figure 5-7 and 5-8. These changes were more
evident than measuring changes in the overall T1-W signal (from the first echo of the
acquisition), which has also been shown here and previously to be non-linear with
temperature in this range, presumably due to irreversible protein conformation changes
(72). It is important to note that these changes in slopes were seen with and without R2*
correction over physiologically relevant temperatures (37 °C and above).
Therefore, it appears that using the multiparametric spectral estimates may return
information on physical tissue changes taking place, such as conformational phase
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transitions of proteins, which directly influence the proton chemical macroenvironment
and, thereby, relaxation as observed in R2* mapping and T1-W signal changes. These
observations warrant further investigation in vivo and in other tissues, particularly in the
presence of heat sensitization agents which might be used to lower the therapeutic
window as direct validation of protein denaturation and it may be extremely useful in the
investigation of thermal approaches to ablation as well as drug delivery or enzyme
activation.
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Chapter 6:

Spectral Parameter Mapping with the kMeans Clustering Algorithm

6.1 Introduction
As seen in the previous chapter, the CSI technique accurately and precisely
determines the PRF, T2* and amplitude of each peak. These parameters can be inputs
into the k-means algorithm to help distinguish peaks since each spectral peak will be
differentiated by at least the PRF and the other parameters may aid in improving the
sensitivity and specificity of peak identification for 2D mapping of temperature for
interventions. The algorithm will be explained and parameters will be tested using a
highly-controlled mathematical phantom. After suitable parameters are found, they are
used in the analysis of data from several ex vivo and in vivo tissues.

6.2 Processing Strategy
First, the image is partitioned to equal-sized regions (4x4, 16x16, 32x32 voxels,
etc.). In each voxel in the regions, the primary PRF, T2* and amplitude values are
mapped to a 3D plot where T2* values and amplitudes are normalized. The centroid of
all the points in the plot is then calculated as well as the sum of distances between the
points and the centroid. The same calculations are made again using 2 centroids via the
k-means algorithm. If the sum of distances are less with the two centroids and the
centroids are at distances apart where water and lipid is expected to be (3.3-3.8 ppm),
then the clusters are designated water or lipid (see Figure 6-1). This process continues
for each region in the image.
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After the entire image is processed, the ranges of water and lipid centroids are
recorded. On the frequency axis in the 3D plot, the range of PRFs is expanded by a
constant, g, to account to regions experiencing slightly higher or lower magnetic flux
densities. Each voxel is then recalculated using a 2-peak ARMA model. If both peaks
fall within the PRF regions, then the spectral parameters are mapped. Expansions on T2*
and amplitude values were not utilized since these values can vary due to relative
concentration of each chemical specimen. Finally, any voxel remaining was calculated
with a 1-peak ARMA model with peak identification determined by the PRF and T2*
ranges described above. Figure 6-1 shows a schematic of how the algorithm works on a
mathematical phantom, which is described in the next section.
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Figure 6-1 Mapping using k-means
The image is separated into regions. First, regions that contain both water and lipid are located. The
spectral information from those areas is used to train the algorithm to look for primary and secondary peaks
to create maps of each chemical specimen.
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Figure 6-2 Representation of two regions analyzed by the k-means algorithm using the mathematical
phantom – step 1
The red region represents an area with water only. The green region contains water and lipid. When the
centroid is calculated from the primary peaks, the sum of distances between the data points and the centroid
can aid in determining if one or two peaks are present. Frequency expansions can be added to increase the
range of PRF values the algorithm will seek for primary and secondary peaks.
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6.3 Testing of the CSI k-means Clustering Algorithm Using a
Mathematical Phantom
6.3.1 MATERIALS AND METHODS
To test the algorithm in highly controlled conditions, a mathematical phantom
was developed in MATLAB (MathWorks, Natick, MA) and is shown in Figure 6-3. In
the phantom, areas of water, lipid and mixed water/lipid were created within different
sized regions.

Large areas of each water/lipid combinations were also created to

determine how the algorithm handles large areas of only one chemical shift, which is
commonly seen in vivo.

Figure 6-3 Mathematical phantom design
The phantom contains areas of water, lipid and mixed water/lipid voxels under varying sizes. The phantom
was designed to work under varying areas of water and lipid.

Three metrics were used to measure the performance of the algorithm. If a peak
was identified in the voxel then the voxel is counted as positive. If no peak is identified
then the voxel is counted as negative. The sensitivity of identifying the correct peak was
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defined as the true positive rate (tested positive/ true positive). Specificity was defined as
the true negative rate (tested negative/ true negative). The Dice similarity coefficient
(DSC) (163) was also used. Given two images, A and B, where A is the true image and B
is the measured image, the DSC is the metric of how the two images overlap where

DSC =

2 A∩ B
A+ B

(6.1)

The sensitivity, specificity, and DSC were measured as a function of field
inhomogeneity across the FOV, size of the regions, expansion in the frequency axis on
the 3D plots and SNR.

Each mapping experiment went through 5 trials. The field

inhomogeneity was incorporated into the phantom spatially by multiplying the signal by a
complex exponential that smoothly varied as a function of position on the x-y plane. The
field inhomogeneity was measured from 0.2 to 4.0 ppm. Region sizes by powers of 2 (4,
8, 16, 32, 64, 128) were measured at a field inhomogeneity of 1.13 ppm and a frequency
expansion of 0.1 ppm. Frequency expansions up to 1.0 ppm were evaluated at the same
SNR at a 1.13 ppm field inhomogeneity. When suitable frequency expansions and region
sized were determined, the sensitivity, specificity and DSC were measured as a function
of SNR.

6.3.2 RESULTS
Figure 6-4 displays the sensitivity, specificity, and DSC as a function of field
inhomogeneity across the entire FOV for the water and lipid maps. The specificity and
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DSC for water and lipid was greater than 0.999 up to a field inhomogeneity of 1.42 ppm.
Sensitivity measurements for the water and lipid maps were above 0.999 up to 2.83 ppm.

Figure 6-4 Sensitivity, specificity and DSC results as a function of field inhomogeneity
Both water and lipid maps maintained high sensitivity (>0.999) up to a field inhomogeneity in the FOV to
2.83 ppm. Specificity and DSC values for each peak were at the same high values to 1.42 ppm. Each
measurement decreased at higher field inhomogeneities.

Error bars were on the order of 0.001 so they

were not shown on the figure.

The size of the regions used in algorithm appears to have an effect on the
sensitivity, specificity and DSC. Figure 6-5 shows the values for water and lipid as a
function of region sizes. As seen in this figure, sizes between 8x8 to 16x16 maintained
high sensitivity, specificity and DSC values. Under 8x8 voxels, errors occurred in the kmeans algorithm due to a low number of data points.
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Figure 6-5 Sensitivity, specificity and DSC results as a function of region size
High sensitivity, specificity and DSC values were measured at regions sizes of 8x8 and 16x16. At higher
region sizes each metric decreased in value. Most errors at these larger region sizes stemmed from
misidentified regions of after the range of PRF values were identified. A lower number of water and lipid
centroids increased the likelihood that peaks were identified due to a lower-sampled range of values. The
k-means algorithm still separated out the peaks effectively as outlined in Figure 6-3. In this figure the field
inhomogeneity was 1.13 ppm.

At 0.1 ppm and above, the sensitivity, specificity and DSC values of the maps
were highly linear with the amount of frequency expansion allowed as shown in Figure 66. Using linear least-squares regression analysis, the water specificity and DSC curves
were -0.0499 ± 0.0003 ppm-1 + 0.9984 ± 0.0018 (R2=0.9497,) and -0.0061 ± 0.0002 ppm1

+ 0.9998 ± 0.0007 (R2=0.9501), respectively. The sensitivity was measured as 1.0 from

0.1 to 1.0 ppm. Interestingly, the sensitivity at ppm=0 was 0.719 ± 0.001 showing that
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some voxels containing water were missed if no frequency expansion was used. For the
lipid maps, the specificity and DSC curve fits were -0.0778 ± 0.0005 ppm-1 + 0.9977 ±
0.0024 (R2=0.9973) and -0.2067 ± 0.0008 ppm-1 + 0.9774 ± 0.0037 (R2=0.9993),
respectively. From 0 to 1.0 ppm, the sensitivity of the lipid map was above 0.998 even
when there was no frequency expansion.

Figure 6-6 Sensitivity, specificity and DSC results with a frequency expansion in the 3D plots
Sensitivity was not affected as long as there was some expansion in the frequency axis to look for voxels
that had PRF values outside of the range the algorithm calculated in regions with water and lipid. In the
maps, if g=0, then some water voxels were missed since their PRF values lied just outside the range which
was calculated in the image. However, as g increases then the specificity and DSC decrease. In this plot,
the field inhomogeneity was 1.13 ppm with a 16x16 region size.
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Figure 6-7 shows the sensitivity, specificity and DSC as a function of SNR. As
SNR increases, each metric asymptotically approached 1.0. At SNR≥10, each parameter
was at 0.95 or above.

For mapping of two chemical shifts, a SNR of 10 and above

should produce high sensitivity and specificity.

For this plot, there was a field

inhomogeneity of 1.13 ppm with a 0.1 ppm frequency expansion.

Figure 6-7 Sensitivity, specificity and DSC results at low SNR
The DSC values and sensitivity of the mapping algorithm asymptotically approached 1.0 at a SNR of
approximately 10. Specificity was high even at low SNR of 5. SNR values of 10 and above are sufficient
for sensitive and specific mapping under moderate field inhomogeneity (~1.0 ppm).
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Table 6-1 summarizes how each parameter affects the sensitivity, specificity and
DSC of the mapping algorithm. It can be noted that each parameter, with the exception
of the frequency expansion, approaches unity as the limit approaches zero (field
inhomogeneity, region size) or infinity (SNR).
Table 6-1 Parameter dependence on the algorithm’s sensitivity, specificity and DSC
Parameter
Field Inhomogeneity
Region Size
Freq. Expansion
SNR

Change
↑
↑
↑
↑

Sensitivity
↔ then ↓
↔ then ↓
↔
↑ then ↔

Specificity
↔ then ↓
↔ then ↓
↓
↑ then ↔

DSC
↔ then ↓
↔ then ↓
↓
↑ then ↔

Most parameters showed an asymptotic behavior toward unity as the parameter approached zero or infinity.
Generally, a low field inhomogeneity, region size and frequency expansion with high SNR is near-optimal
conditions for the k-means mapping algorithm.

6.4 Demonstration of the k-means Mapping Algorithm in an In Vivo
Swine Liver Model
6.4.1 MATERIALS AND METHODS
To test this algorithm with a near-realistic clinical scenario of a liver ablation, the
MGE acquisition was utilized on swine being examined in a MR protocol study. The
animals used in this study were handled in accordance with the Institutional Animal Care
and Use Committee. For each pig, three axial slices were obtained through the liver (16echoes, TR/TE0/ESP=500/1.8/3.0 ms, flip angle=45 , receiver bandwidth = 244
Hz/pixel, acquisition matrix = 128 x 128, acceleration factor = 2, voxel size = 1.6 x 1.6 x
4.0 mm3, acquisition time = 32 s).
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Based on our simulation results, region sizes of 16x16 voxels were used with a
frequency expansion of 0.1 ppm. The PRF, T2* and amplitude were all input parameters
for the k-means cluster analysis. Images where then qualitatively compared to lipidwater images generated using a two-point, region growing, Dixon technique (FSPGR, 2echoes, TR/TE1/TE2=175/1.8/4.3 ms, flip angle=80 , receiver bandwidth = 244
Hz/pixel, acquisition matrix = 256 x 224, acceleration factor = 2, voxel size = 1.3 x 1.3 x
8.0 mm3, acquisition time = 22.4 s/image) (135). Note that there was a difference in
spatial resolution between this technique and two-point Dixon technique which made
direct, quantitative, voxel by voxel comparisons difficult to ascertain. There was also
breathing between the two acquisitions which also makes voxel-based comparisons
difficult. Therefore, the generated images were qualitatively examined based on accurate
mapping of known lipid-water tissues as well as the algorithms performance as predicted
by simulations.

6.4.2 RESULTS
Figure 6-9 displays images processed by our technique with comparison to the
Dixon-processed images. PRF, T2* and amplitude maps were created of water and lipid
(bulk methylene). Note that the Dixon technique identified intra-peritoneal organs (liver,
stomach, spleen) as lipid. Using the MGE acquisition incorporated with the SM and kmeans algorithms the organs were correctly mapped into the water image. One error seen
in our mapping routine is an area of susceptibility on the anterior portion of the spleen.
Figure 6-10 displays an axial slice where the k-means algorithm and Dixon technique
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matches well.

Motion between the two scans limited the ability for quantitative

comparison on a voxel-by-voxel basis.

Figure 6-8 CSI mapping in porcine in vivo with artifact in Dixon imaging
PRF, T2* and amplitude maps of lipid and water were created using the MGE acquisition with the SM and
k-means algorithm. In addition, a Dixon-based method using a robust region-growing algorithm is shown
(135).

In this axial slice, the liver, spleen and stomach were mapped to the lipid image. The k-means

algorithm correctly mapped these organs to the appropriate water image. Three slices were collected and
the Dixon technique mapped the organs to the appropriate map as did the k-means algorithm.
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Figure 6-9 CSI mapping in porcine in vivo
PRF, T2* and amplitude maps of lipid and water using the MGE acquisition with the SM and k-means
algorithm in addition to Dixon-based lipid-water images. Qualitatively, there is good agreement between
the two types of processing paradigms. Quantitative voxel-based measurements using Dixon as the true
standard was not possible due to respiratory-based motion between the scans. Some errors can be seen in
the k-means approach inside the stomach presumably due to low SNR.

Figure 6-10 presents an example where our simulations predicted lower
specificity and DSC due to field inhomogeneity, which led to the misidentification of
liver tissue as lipid. At the interface between the liver and subcutaneous tissue there was
a measured field inhomogeneity of approximately 1.8 ppm. As seen in Figure 6-5, there
should be lower specificity (i.e., fewer true negatives) in the water map, which is seen in
Figure 6-10. From the errors introduced from this field inhomogeneity areas with similar
magnetic flux densities as liver (i.e., skin) was also incorrectly mapped as lipid. This
shows that although efficient mapping is possible, certain conditions can affect the
efficacy of the algorithm.
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Figure 6-10 Effects of high field inhomogeneity in vivo
A 1.8 ppm field shift was measured between the liver and muscle just posterior to the liver.

This

inhomogeneity caused lower specificity between distinguishing water and lipid in CSI images as predicted
by our simulation. The Dixon method correctly identified the liver as water-based tissue in contrast to
Figure 6-8.
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6.5 Demonstration of Thermal Therapy in Brain In Vivo
6.5.1 MATERIALS AND METHODS
We examined the feasibility of using the multi-parametric nature of the technique
for guiding MR thermal therapy interventions in a large animal model by using the MGE
acquisition to guide the application of laser induced thermal therapy in a canine brain in
vivo using a 1.5T scanner.

The animal used in this experiment was handled in

accordance with Institutional Animal Care and Use Committee requirements. A watercooled applicator containing a laser fiber (Biotex Inc., Houston, TX) with a 1-cm
diffusing tip (808 nm) was inserted into the right hemisphere of the canine brain using
MR guidance. Treatment was delivered using an exposure of 3.5 W/cm2 for 180 seconds
under continuous MGE monitoring (16-echoes, TR/TE0=69 ms/2.1 ms, flip angle=30 ,
receiver bandwidth = 244 Hz/pixel, acquisition matrix = 128 x 128, acceleration factor =
2, voxel size = 1.6 x 1.6 x 4.0 mm3, acquisition time = 4.4 s/image). The ESP was 3.3
ms, giving a spectral bandwidth of 303 Hz. Using the PRF map from the SM algorithm,
the shift in the PRF was measured to detect temperature changes (37) using a temperature
sensitivity of -0.0098 ppm/°C (157). In addition, T2* maps and T2*-corrected T1-W
images (signal extrapolated to TE=0 ms) were created from the data and analyzed to
demonstrate the potential usefulness.

6.5.2 RESULTS
The MGE acquisition (ETL=16) with SM algorithm processing was applied to
monitor a laser-induced thermal therapy in canine brain in vivo. Figure 7(a) shows the
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water proton field map, which is the source of the temperature images, and Figigure 7(b)
displays the temperature map. The SM algorithm calculated the noise in the temperature
map as 0.34 ± 0.09 °C in an unheated region contralateral to the therapy site. This is in
excellent agreement with the calculated CRLB (SNR=39.5, T2*=42.0 ms) of 0.35 °C.
Using the CPD of a single echo from the same acquisition at TE= T2* (which is the
optimal value for CPD), the uncertainty approximately doubled to 0.69 ± 0.18 °C (p<0.01
when compared to CSI). Unlike the CPD technique, the sensitivity of the CSI technique
is inherently driven by the SNR of the acquisition and is independent of the echo-time
used (apart from the impact on SNR). Figure 7(d) is the T1-W image, corrected for T2*
decay from our knowledge of the T2*, which was also calculated at each time point.
During treatment delivery, an anomalous artifact arose in the temperature images that
correlated with a hyperintense area seen near the laser source on the T1-W images. This
was suspicious for an acute hemorrhage induced by the treatment.

The suspected

hemorrhage was confirmed by a post-treatment T1-W SPGR acquisition [Figure 7(e)].
An image of the calculated T2* for water [Figure 7(c)] shows a clearly hypointense
lesion.
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Figure 6-11 Multi-parametric monitoring in LITT in canine brain in vivo
The water PRF map of a canine brain used to create the temperature maps had a temperature sensitivity
coefficient of -0.0098 ppm/°C (a). The temperature map for the thermal therapy in the canine brain (b). The
noise calculated in an unheated region contralateral to the therapy site was 0.34±0.09 °C. Using CPD at
TE=T2*, the uncertainty increased to a mean of 0.69±0.18 °C. A T2* map generated by the SM algorithm
(c). The T1-W images with T2* correction simultaneously calculated at each acquisition along with the
temperature maps (d). During treatment, a hyperintense area developed near the laser source, raising the
suspicion of a treatment-induced hemorrhage (indicated by an arrow). The hyperintense lesion, clearly
shown on (c), was confirmed as a treatment-induced hemorrhage on a posttreatment T1-W SPGR
acquisition (e). Reprinted with permission from the American Association of Physicists in Medicine,
(150).
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6.6 Demonstration of Thermal Therapy in Prostate In Vivo
6.6.1 MATERIALS AND METHODS
Laser-induced thermal therapy was performed in a canine prostate in vivo. As
with previous experiment, this experiment was approved by the Institutional Animal Care
and Use Committee. Two water-cooled interstitial lasers tuned to 980 nm (Biotex Inc.,
Houston, TX) were placed into the prostate from the anterior surface of the canine. The
anesthetized animal was placed in a 1.5T clinical scanner with a 12-channel torso coil.
Treatment was delivered under continuous MGE monitoring (16-echoes, TR/TE0=69
ms/2.1 ms, flip angle=30 , receiver bandwidth = 244 Hz/pixel, acquisition matrix = 128
x 128, acceleration factor = 2, voxel size = 1.9 x 1.9 x 4.0 mm3, acquisition time = 4.4
s/image). The ESP was 3.2 ms. The SM and k-means algorithms were used to identify
water and bulk methylene peaks to create temperature maps.

The precision of the

temperature estimates were recorded using the CSI and CPD techniques (TE=24.5 ms).
The mean time it took to process one acquisition was also recorded.

6.6.2 RESULTS
Using the k-means algorithm with the parameters found in the mathematical
phantom analysis, lipid and water was adequately separated. No lipid was found in the
prostate itself so the differences in the water PRF map were multiplied by -0.0097
ppm/°C to calculate temperature. Using CSI, the uncertainty in the temperature map
was 0.7 ± 0.2 °C whereas the CPD uncertainty was measured at 1.4 ± 0.3 °C (p=0.02).
The time to process one acquisition was 33.2 ± 5.2 seconds.
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Figure 6-12 Water, lipid and temperature maps in canine in vivo
Water and lipid were separated which some error in the rectum due to susceptibility (air/tissue interfaces)
and low SNR. The temperature maps were created using the difference of the water PRF map. The noise in
the CSI maps was roughly half of what was seen in CPD (0.7 ± 0.2 °C for CSI and 1.4 ± 0.3 °C for CPD
(p=0.02)).

6.7

Regional CSI for Real-Time Mapping

6.7.1 MATERIALS AND METHODS
To increase the temporal resolution while using computer processors which would
make the processing easily accessible, a user-defined regional k-means algorithm was
created. The parameters and code is the same as in the full FOV algorithm. However,
with this algorithm the user defines a ROI to process that region alone. Note that in
interventions we are usually focused only on the area of intervention.
The algorithm was tested on ex vivo bone marrow tissue as well as in vivo
prostate.

These tissues represent some of the more difficult areas to map due to

heterogeneous lipid and water content. Mapping was done using data from laser-induced
thermal treatments on ex vivo bone which was previously described in section 5.3.1. The
difference between the fluoroptic probe readings and CSI or CPD readings were also
138

measured. Temperature was calculated using bulk methylene as an internal reference (0.0087 ppm/°C).
In another canine, treatment was delivered using an endorectal high-intensity
focused ultrasound (HIFU) device (Insightec, Inc., Hefei, Isreal). Again, in a 1.5T
scanner, monitoring was done under continuous MGE acquisitions (16-echoes,
TR/TE0=69 ms/1.9 ms, flip angle=30 , receiver bandwidth = 244 Hz/pixel, acquisition
matrix = 128 x 128, acceleration factor = 2, voxel size = 1.9 x 1.9 x 5.0 mm3, acquisition
time = 4.4 s/image). In order to run in real-time, the SM and k-means algorithms were
adapted where processing could be performed in real-time (< 5 secs) by allowing the user
to define a ROI to make the maps. Water and lipid PRF maps were created in a region
encompassing the prostate and times to process were recorded.

6.7.2 RESULTS
Figure 6-13 shows the mapping in a small ROI around the heating region in bone.
Note that water and lipid were detected throughout the marrow parenchyma. There was a
low area of SNR due to the laser fiber placement which accounts for the voxels being
absent in the center of the images. A fluoroptic probe was in this specimen. The RMSE,
using the fluoroptic probe measurement as the true measurement, was 0.54 ± 0.13 °C for
CSI and 1.75 ± 0.42 °C for CPD (p=0.04). The uncertainty was measured as 0.68 ± 0.09
°C using bulk methylene as an internal reference and the uncertainty was 1.98 ± 0.18 °C

(p<0.01).

The time to process one acquisition was greatly reduced compared to full

FOV processing at 4.3 ± 0.2 seconds, which is adequate for real-time guidance.
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Figure 6-13 Water, lipid and temperature maps in canine bone marrow ex vivo
Water and lipid were separated in the bone marrow. The temperature maps were created using bulk
methylene as an internal reference. As seen in the measurements in chapter 5, the RMSE was lower in CSI
(0.54 ± 0.13 °C for CSI and 1.75 ± 0.42 °C for CPD (p=0.04)).

Areas of water, lipid and mixed voxels were seen in the in vivo prostate images
analyzed by the regional CSI algorithm. As with the bone, image processing time was
rapid at 4.7 ± 0.5 seconds per acquisition. Figure 6-14 shows the water and lipid PRF
maps as well as a map of where water and lipid is both present. For verification, a FFT
of voxels in each area were processed to confirm that there as indeed water and/or lipid
peaks in those areas.
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Figure 6-14 Water and lipid PRF maps in canine prostate in vivo
Areas of water and lipid were identified and confirmed by processing spectra manually in each area. One
area of error found was in the rectal area under the prostate which is an area of low SNR.
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6.8

Discussion
The primary aim of the research described in this section was to take advantage of

the wealth of multi-parametric data in order to provide robust mapping without requiring
certain constraints (i.e., constant chemical shift between lipid and water, equivalent T2*
between chemical shifts) which can affect the accuracy and precision of temperature
mapping.
In the post-processing of many CSI acquisitions, assumptions are made in order to
map a certain parameter. For example, in Dixon methods in addition to IDEAL (see
section 3.4) there is typically an assumption that the chemical shift between water and
lipid is constant. This is used in order to image the amplitude to either look at water-only
images or calculate the fraction of lipid in the image. In PRF-based temperature imaging,
the assumption of a constant chemical shift difference between water and lipid does not
hold since the water PRF shifts with temperature.

This shift, particularly at high

temperatures, can lead to errors in the image separation. In addition, field maps are
typically generated, which have been used to estimate temperature changes.

This,

however, does not give an independent map of the lipid field in order to correct for
susceptibility, field drift and motion.
The choice of the k-means algorithm for mapping is multi-faceted. In addition to
its known robustness in segmenting data it is computationally inexpensive, which is
important since this needs to be implemented in near-real time for MR interventional
procedures. It can be parallelized in order to decrease the processing time. The regional
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processing method presented can also be implemented since in interventional procedures
the site of the intervention is the primary point of interest and not the entire image.
The purpose of the mathematical phantom studies was to provide a highlycontrolled setup in order to test the performance of the algorithm.

From these

simulations, we were able to choose appropriate parameters, such as PRF ranges and
region sizes, to increase the sensitivity and specificity of the technique. Also, it was very
useful to determine extrinsic (algorithm-based) and intrinsic (subject-based (SNR,
inhomogeneity) parameters to show when the algorithm will fail. As an example, Figure
6-11 showed a misidentification of liver tissue as lipid.

This was caused by field

inhomogeneties which were shown to have lower specificity as seen in Figure 6-4. In
this case, the large field inhomogeneity was highly localized to areas around the liver,
which will make it difficult to properly map. In situations with field inhomogeneities
across the FOV, the image can easily be separated into 2-4 images in which each image
will presumably have a lower field inhomogeneity. This should work as long as lipid and
water is present in each section of the image.
Our in vivo data in the canine brain highlight some of the potential advantages of
multi-parametric monitoring for thermal therapy procedures because both physiologic
(temperature) and anatomic (T1-W, T2* maps) information are available. In this case, a
treatment-induced hemorrhage was monitored during treatment. In CPD techniques, the
optimal echo time is given by the T2* of the signal (38).

Magnitude images are,

therefore, contaminated by the T2*-weighting of the signal (exp(-TE/T2*)) which can
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obscure T1 changes in the image. This would make it difficult to observe the hemorrhage
and, more importantly, determine when it occurred during treatment. The T2* correction
with this technique allowed us to view a T1-W image at effectively TE=0, which, in this
case, allowed visualization of hyperintensity that was not seen on the magnitude images
at TE=T2*. This example shows that this technique can be performed in vivo and shows
increased precision compared to CPD. Accuracy in each in vivo experiment could not be
measured due to the lack of an invasive temperature probe in the heated region.
One of the challenging areas in which to map the PRF is in bone marrow. Figure
6-13 demonstrates the ability to accurately and precisely measure the temperature in these
areas. Currently, CPD-based MRTI is a challenge due to heavy lipid content. As seen in
the PRF calibrations, this CSI technique is particularly useful in lipid-containing tissues
in addition to tissues with no lipid, such as brain and kidney. The method is also useful
to map lipid around the prostate, which may be used to approximate the field in the
prostate.
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Chapter 7:

Conclusions and Future Directions

7.1 Concluding Remarks
Robust spectral processing and mapping algorithms have been developed,
validated and applied to a MGE acquisition in order to provide CSI-based temperature
imaging at higher spatiotemporal resolutions than what was previously available. In
previous techniques, the acquisition and processing strategies were limited by avoiding
spectral aliasing and by collecting enough samples to implement Fourier-based analysis
as seen in high spectral resolution CSI (45-47).

This degrades the spatiotemporal

resolution by requiring interleaved shots, especially at 3.0T, to reduce the echo-spacing.
A high number of samples (32 or higher) also requires a longer acquisition time. In
addition, receiver bandwidths are raised which reduces the SNR, and thus sensitivity, of
the technique (45-47).
After investigating the limitations of filtered Fourier methods, we researched
alternative methods to accurately and precisely determine the spectral parameters from a
low number of samples that could be translated into a rapid CSI acquisition. The ARMA
model was deemed as an appropriate model since, unlike Fourier techniques, accounts
not only for the PRF but also relaxation and noise. By incorporating this model, PRF,
T2* and amplitudes were measured accurately and precisely over a wide range of ETL
and SNR values.
Another important contribution in this investigation was the incorporation of the
CRLB not only to validate the model but also to use it to theoretically determine the
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sensitivity as a function of extrinsic and intrinsic acquisition parameters. Using CRLB
analysis, it was found that the sensitivity depends on more parameters than what is seen
in CPD techniques (equations 4.2-3). Unlike another CRLB derivation for PRF-CSI,
which looks only at the precision of the temperature estimate using lipid as a reference
(164), this CRLB analysis provides theoretical estimates of the PRF as well as T2* and
amplitudes for each peak in the spectra. Details on the CRLB can be found in Appendix
A. In both one-peak and two-peak models, measured uncertainties in phantom, ex vivo,
and in vivo tissues agreed well with what was predicted by the CRLB.
Another important finding in the ARMA approach was the remarkable precision
and accuracy even when the number of peaks in the model is underestimated. This
appears to be due to the analysis being performed in the z-domain. The information is
concentrated in poles in z-space, as seen in Figure 7-1. When one peak is chosen for the
model, the algorithm gravitates to the dominate peak thus giving an accurate estimate for
that peak.
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Figure 7-1 Z plot using a one and two peak ARMA model
The zeroes (o) and poles (X) for a one-peak (blue) and two-peak (red) ARMA model estimated by the SM
algorithm. A two-peak model was simulated. When a one-peak model was applied to the simulated signal,
the pole was calculated to be approximately where the two-peak model calculated to be. This shows that
even if the number of peaks is underestimated, the primary peaks are still calculated with high accuracy.

Overall, in terms of the first specific aim of developing, validating and
characterizing via simulation a model-based spectral analysis algorithm, we found that
the SM algorithm provided higher precision compared to CPD (Figure 4-16) and high
precision/accuracy (<1.0 °C) over a wide range of ETL and SNR values.

This is in

support of our hypothesis.
Using our CRLB analysis, we found that the SNR is directly proportional to the
precision and accuracy of the spectral processing algorithm. Thus, we investigated the
acquisition parameters that maintain high SNR in addition to acquisition parameters to
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avoid for accomplishing the goal of accurate and precise temperature imaging. After
several phantom experiments, we achieved the SNR that provided uncertainties that were
predicted using our CLRB analysis as well as simulations. Thus, we showed that the
MGE acquisition can provide the SNR and parameters necessary to use the ARMA
model for temperature estimation, which also supports our hypothesis.
In tissues with multiple chemical shifts, it is very important to accurately identify
the chemical shift in order to apply the correct, chemical shift-dependent, TSC for
accurate temperature imaging. By taking advantage of the multi-parametric data, we
utilized a clustering algorithm with high sensitivity and specificity while maintaining
reasonable processing times for real-time implementation. This k-means algorithm has
also been adapted to work with images across an entire FOV or in a smaller ROI defined
by the user.
With highly sensitive and specific mapping, we were able to measure temperature
changes and TSC values in a variety of phantoms and tissues.

In cases where a

temperature probe was used to compare between the CSI and CPD temperature estimates,
the CSI method had statistically higher accuracy and precision, which supports our
hypothesis.
In addition to higher precision in non-fatty tissues, an important and interesting
finding was the TSC measurements when bulk methylene was used as an internal
reference. If lipid is present in the tissue, the lipid susceptibility effect corrections are
necessary in order to give more accurate measurements. This is an important finding
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when CPD is used in certain organs, such as breast, bone marrow and, in some cases,
liver.

Basic suppression of lipid or selective excitation of water for PRF-based

temperature measurements will not suppress the effects from lipid since water will still
experience susceptibility from the lipid.

As seen in this work, correcting for the

susceptibility by using lipid as a reference provides higher accuracy and should be
considered when monitoring therapies in fatty tissues.
In addition to the findings in support of our hypothesis, another important finding
was discovered by measuring additional parameters calculated by the ARMA during
thermal ablations. This technique provided the unique opportunity to explore changes in
peak-specific T2* and T1-W amplitude simultaneously with PRF-based temperature
imaging at higher spatiotemporal resolutions than what was previously available. We
found statistically significant changes when Arrhenius rate dose model analysis predicted
thermal damage to the tissue. This could possibly be useful in verifying thermal damage
in ablations during delivery. Another potential use is to measure differences in these
curves in the presence of adjuvant therapies such as chemical ablations or irradiation.
Overall, through rigorous simulations and thermal treatments performed in
phantoms as well as ex vivo tissues with CSI and CPD measurements, the increased
precision and accuracy supports our hypothesis that through the use of a multi-gradient
echo acquisition coupled with model-based spectral processing algorithms, CSI-based
temperature maps can be generated with higher accuracy and precision compared to
standard CPD techniques without sacrificing spatiotemporal resolution.
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7.2 Future Directions
This research has opened doors for new investigations not only in thermal
therapies but also in other MR applications such as image-guided chemical ablations, T2*
mapping, and dynamic contrast enhancement. In terms of thermal therapies, there are
several avenues for future work. One is extrapolation of the lipid PRF map into wateronly areas to help correct for susceptibility, field drift and motion.

One excellent

example would be in thermal treatments of the prostate. If the lipid PRF map can be
fitted by a polynomial plane, it can be used as an internal reference instead of relying on
the changes in the water PRF alone. This is done much the same way as referenceless
thermometry is done with CPD-based temperature imaging (86, 158, 165).
Another area of research is the ability of using this technique for absolute
thermometry. One unanswered question in MR temperature imaging is if the differences
between water and lipid PRF values provide absolute temperature. One current problem
with this is a wide variation in the PRF difference between water and lipid. Authors have
cited several causes such as BOLD and J-coupling effects that affect the measurement in
vivo (37). This leads to yet another potential area of research in mapping with more than
two peaks. While the k-means algorithm used in this research focused on bulk methylene
and water, the algorithm can be further investigated to higher order models to account for
more peaks such as terminal methylene and methyl peaks. One possible means to
accomplish this is to look for these subsequent peaks after the primary lipid peak has
been identified.
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In light what was seen in our multi-parametric studies, more studies need to be
done in vivo to provide simultaneous temperature, T2* mapping and T1-W imaging to
validate the non-linearities seen in ex vivo tissues. This must be correlated with histology
to confirm damage as seen from the thermal dose and T2*/T1-W parametric imaging. The
goal of this work is to see if the T2* and/or T1-W imaging helps validate thermal damage
during the delivery and, as mentioned above, if adjuvant treatments change the T2*/T1-W
temperature sensitivities that are correlated with damage. In addition, in some tissues a
shift has been measured around 41 °C which corresponds to lipid bilayer disruption
(166).
From a computational standpoint, work is still needed to improve the computing
performance of the spectral processing and mapping algorithms to facilitate use in real
time for interventional procedures. Theoretically, a parallel implementation on a standalone or portable workstation, which can be easily adapted to the MR scanner, is
currently possible. For example, implementation of the algorithms on a single graphics
processing unit (GPU) can, at best, achieve a speed up factor of 125 (i.e., reduce the
processing time by a factor of 125).
The current implementation of the codes must be thoroughly profiled to find the
computing bottlenecks and the degree of parallelism inherent to this part of the current
algorithms must be critically evaluated. The peak performance and speed up gains could
be dramatically affected by the amount of inter-core communication needed by the
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algorithm. The possibility exists that completely different algorithms may perform better
on these parallel computing architectures.
Another major factor to consider is the programming language for the
implementation. We currently use MATLAB (MathWorks, Natick, MA) for our spectral
and image processing. Therefore, the quickest implementation would be to explore
Mathwork's planned GPU support and determine if the future GPU support would be
amenable to the goals of the project. As an alternative, several of the national lab code
projects have begun work implementing their open source software on GPU
architectures. Parallel implementation with respect to one of these code bases has several
potential advantages and drawbacks. For example, one code’s parallel interface hides
low-level commands from the user and casting the algorithms in terms of its interface
would allow future portabilty to both GPU and CPU clusters. The CPU cluster
environment could also be used as a fail safe for algorithms that fail in the GPU
environment. In this situation, remote visualization capabilities would have to be
incorporated. It is important to note that the SM and k-means algorithms must be coded
in C++ or be found in some other scientific computing library if it is to be implemented
in many parallel coding structures. The development of these codes in other languages is
possible and is a focus of future work.
Another application of this CSI technique is the monitoring of chemical ablations
since many chemicals used in these procedures have MR-detectable chemical shifts. To
demonstrate the feasibility for providing unique information for MR-guided chemical
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ablations, we used the MGE acquisition (16-echoes, TR/TE0=70 ms/2.1 ms, ESP=3.3 ms,
flip angle=60 , receiver bandwidth = 244 Hz/pixel, acquisition matrix = 128 x 128,
acceleration factor = 2, voxel size = 1.6 x 1.6 x 4.0 mm3, acquisition time = 4.5 s/image)
and the ARMA modeling to monitor the injection of 2 ml ethanol in an ex vivo bovine
liver sample.

Ethanol is a agent used in interventions because it induces coagulation

necrosis of tissue by protein denaturation, cellular dehydration and small vessel
thrombosis (167).

The location and the relative concentration of the ethanol were

determined by locating the methyl (CH3) peak versus the water peak. Changes in the
chemical shift, T2*, and amplitude of both the water peak and the ethanol-methyl peak
were measured over time in a ROI.
Figure 7-2 contains the pre and post T1-W images obtained with a fast spin echo
(FSE) sequence in addition to T1-W amplitude made from measurements taken during
real-time monitoring of the percutaneous injection. Figure 7-2(a) shows the T1-W FSE
image used to localize the needle. Figure 7-2(b) displays the water amplitude image 60
seconds into the ethanol injection, while Figure 7-2(c) illustrates a map of the amplitude
of the ethanol peak overlaid on a T1-W amplitude image of water at the same time point.
The region where the ethanol signal was located by the SM algorithm corresponds well
with intra-treatment, T2*-corrected, T1-W images calculated using the measurements
from the SM algorithm [Figure 7-2(b)] and the post-treatment T1-W FSE image [Figure
5(d)]. Figure 7-2(e) illustrates the spectrum provided by our algorithm for an averaged
signal over an ROI before and after the ethanol was percutaneously injected into the ex
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vivo liver sample. The methyl (CH3) peak from the ethanol is located 3.72 ppm away
from water. Note the similar aliasing as seen with the lipid-water phantom. Figure 7-3
illustrates the observed changes in the chemical shift (a), T2* (b), and amplitude (c) of the
untreated liver, treated liver, and the methyl peak of ethanol over time. The frequency
difference between the water and methyl group had an uncertainty of 0.021 ppm. The
chemical shifts in all three ROIs moved in the same direction after the injection,
indicating changes from field drifts or susceptibility. The T2* value for ethanol steadily
decreased [Fig. 7-3(b)], whereas the T2* of the liver tissue decreased to a value of
approximately 24 ms, which is 27% lower than the value before the injection. Figure 73(c) shows that a 39% reduction in the T1-W amplitude for water recovered by 16% as
the ethanol diffused from the region.
Noise estimates in the liver tissue were 0.0022 ± 0.0005 ppm, 0.861 ± 0.272 ms,
and 1.46 ± 0.24 % for the chemical shift, T2* and amplitude, respectively. The chemical
shift and T2* noise measurements, which encompassed the calculated CRLBs at the 95%
confidence level, were calculated as 0.0023 ppm for the chemical shift and 0.902 ms for
T2*. At the measured SNR (40.0) and T2* (30.7 ms), the CRLB of the amplitude
measurement was 0.34%. The mean amplitude noise estimates did not match the CRLB
at the 95% confidence level.
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Figure 7-2 CSI monitoring of chemical injection of ethanol
T1-W FSE acquisition used to localizing the injection needle (a). Image of the amplitude of water provided
by the SM algorithm demonstrates a decrease in signal where the ethanol was injected (b). Map of the
amplitude of the ethanol peak overlaid by a T1-W image for the amplitude of water (c). The ethanol was
located by detecting the presence of the methyl peak. Good correlation exists between areas of damage
shown by a posttreatment T1-W FSE acquisition (d) and measurements calculated with the SM algorithm
for amplitude (b) and chemical shift (c) Spectral parameters in the liver before (dashed line) and after (solid
line) the ethanol was percutaneously injected (e).

Reprinted with permission from the American

Association of Physicists in Medicine, (150).
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Figure 7-3 Changes in spectral parameters over time during injection of ethanol
The evolution of the chemical shift (a), T2* (b), and amplitude (c) for water (triangles) and ethanol’s methyl
peak (squares) over the entire treatment time. A susceptibility shift can be seen in the water chemical shift
in (a). The T2* for water decreased by 27% after the introduction of ethanol. (b). A 39% reduction in the
T1-W amplitude for water recovered by 16% as the ethanol diffused from the region (c). Reprinted with
permission from the American Association of Physicists in Medicine, (150).

Another area of future work is in the monitoring of nanoparticles that are used in
conjunction to thermal therapies. For instance, T2*-lowering superparamagnetic iron
oxide (SPIO) particles have been coated with gold at a thickness where it absorbs light in
the visible range (~808nm) to deliver thermal therapies (154). The SPIO cores were
added to the gold since gold is not MR-detectable but the SPIO cores give effective T2*
contrast. With the multi-parametric capabilities of our CSI technique, we can use the T2*
to possibly determine the concentration of nanoshells to plan the treatment and use the
PRF to measure the temperature during the treatment. This CSI technique can also be
used to determine if the increase in susceptibility from the SPIOs affect the temperature
sensitivity coefficient of water. In addition, this technique has the potential to monitor
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release of gadolinium from temperature-sensitive liposomes (168). These liposomes
release a T1-shortening gadolinium compound which could be monitored by the T1-W
imaging provided by the CSI technique while at the same time, monitoring temperature
changes via the PRF.
Along the same lines of gadolinium release, the simultaneous T1-W imaging and
T2* mapping makes this technique attractive for simultaneous dynamic contrast
enhancement (DCE) and dynamic susceptibility contrast (DSC) imaging. As an example,
Figure 7-3 shows maps when a double-bolus of gadolinium was injected into the canine
brain under MGE monitoring. The measurements over time are shown in Figure 7-4.
Although for now the spatiotemporal resolution is lower with this method compared to
other DCE methods, the use of fewer echoes as well as parallel imaging or undersampled
reconstruction methods may increase this resolution for efficient estimation for
simultaneous DCE and DSC measurements.
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Figure 7-4 PRF, T2* and T1-W imaging during contrast injection
The multi-parametric imaging provided by this technique allows simultaneous T1-W imaging and T2*
mapping while compensating for the field inhomogeneities by calculating the field map. The green box
displays a spectrum in normal canine brain parenchyma and the red box displays a spectrum from a
transmissible verneal tumor (TVT). In addition to the changes seen in the images, a shift in the PRF and
broadening of the linewidth due to T2* changes are seen when the gadolinium passes the blood-brain
barrier.
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Figure 7-5 PRF, T2* and T1-W measurements during contrast injection
The PRF, T2* and T1-W amplitude of water was measured in 30 consecutive MGE acquisitions over 150
seconds. Upon injection of contrast, there is a PRF shift as well as a decrease in T2* and an increase is the
T1-W signal.
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Appendix A: The Cramer-Rao Lower Bound for a Sum
of Complex, Damped Exponential
Functions
The Cramer-Rao lower bound (CRLB) (148, 149) provides the lower bound on
the uncertainty of parameter estimates from a certain model. In this research, the model
can be described discretely as
M

y (n) = ∑ Ck eiθk e

− ( i 2 π f k +α k ) n

+ w(n)

(A.1)

k =1

where M is the number of damped exponential functions, Ck, θk, fk and αk is the complex
amplitude, zero-order phase, frequency and damping factor, respectively. w is Gaussian
noise with zero mean. Each real and imaginary part of w has variance σ2. If β is the set
of parameters that approximates y, then the probability density function for the
measurements on the unknown parameter vector, β, can be written as

P( y β ) =

∑

1

( 2πσ 2 )

2

N −1
m
− i 2 π f k +α k )n 
 −1
y ( n ) − C k eiθ e (
 2σ 2

n=0
k =1



N

e

∑

(A.2)

where N is the number of samples. The CRLB states that for any unbiased estimate of β,

β̂ ,

( )

Var βˆ ≥

1
Ii , j ( β )

(A.3)
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where I is the Fisher information matrix defined by
 ∂2
Ii , j ( β ) = − E 
ln P ( y β )
 ∂βi ∂β j

β





(A.4)

From these equations, we see that a model can approximate parameters that contain a
lower bound in terms of uncertainty as shown in equation A-3. The key to this analysis is
to calculate and invert I in order to ascertain the lower bounds. Note that I represents the
natural logarithm of the likelihood function and E represents the expectation value. i and j
represent each variable approximated by the model. This will result in a 4Mx4M matrix
there are four parameters that are to be approximated. The matrix structure is as follows.
 I1,1
 IT
 1,2
T
I =  I1,3

 M
T
 I1,4
 M

I1,2
I 2,2
T
I 2,3

I1,3 K
I 2,3
I 3,3
O
L

I1,4 M 


M 


I 4 M ,4 M 

(A.5)

where T denotes the transpose of the matrix. Along the diagonal, Iii can be expressed as
C i2 pi ,i −1

0
I i ,i =  2
 Ci pi ,1

 0

0

Ci2 pi ,i
0

pi ,i −1
0
−Ci pi ,i

2
i

C pi ,i −1
0



−Ci pi ,i 
0 

2
Ci pi ,i +1 
0

(A.6)

where
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N

pi , j = ∑ n j e −2αi n

(A.7)

n=0

The non-diagonal elements describe the system where peaks interact with each other
where
CiC jγ j
 −C q
j i
I ij = 
 Ci C jγ i

Ci C j q j

CiC jγ i
−C j qi −1
CiC j γ i −1
Ci C j qi

Ci qi

γ i −1
Ci qi −1
−Ciγ i

−CiC jγ j 
−C jγ i 
−Ci C j qi 

CiC j γ j 

(A.8)

and
∆θ n = 2π ( f j − f i ) n + θ j − θi

(A.9)

N −1

− α +α ) n k
γk = ∑e (
n cos ( ∆θ n )
i

j

(A.10)

n =0

N −1

qk = ∑ e

(

)

− α i +α j n

n k sin ( ∆θ n )

(A.11)

n=0

(54). Once I is inverted, the elements in the diagonal can be multiplied by (σ/Ci)2 for the
CRLB of αi and Ci and (σ/2πCi)2 for fi. For example, when M=1, the diagonal of I-1 can
be described analytically to derive the CRLB for each parameter where

Var ( f 1 ) ≥

σ2
p10
2 2
4π C1 p10 p12 − p112

(A.12)
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Var (α 1 ) ≥

(

Var C1e

iθ1

σ2

p10
C p10 p12 − p112
2
1

σ2

)≥C

2
1

p12
p10 p12 − p112

(A.13)

(A.14)

This analytical solution with M=1 was verified using Mathematica (Wolfram Research,
Inc., Champaign, IL).

163

References
1.

Habash, R. W., R. Bansal, D. Krewski, and H. T. Alhafid. 2006. Thermal therapy,
part 1: an introduction to thermal therapy. Critical reviews in biomedical
engineering 34:459-489.

2.

Seegenschmiedt MH, V. C. 1995. A historical perspective on hyperthermia in
oncology.

In

Thermoradiotherapy

and

thermochemotherapy.

F.

P.

Seegenschmiedt MH, Vernon CC, editor. Springer Verlag, Berlin. 3-44.
3.

Diederich, C. J. 2005. Thermal ablation and high-temperature thermal therapy:
overview of technology and clinical implementation. Int J Hyperthermia 21:745753.

4.

Dewey, W. C. 1994. Arrhenius relationships from the molecule and cell to the
clinic. Int J Hyperthermia 10:457-483.

5.

Cheung, A. Y. 1982. Microwave and radiofrequency techniques for clinical
hyperthermia. The British journal of cancer 5:16-24.

6.

Babbs, C. F., and D. P. DeWitt. 1981. Physical principles of local heat therapy for
cancer. Medical instrumentation 15:367-373.

7.

Field, S. B., and C. C. Morris. 1983. The relationship between heating time and
temperature: its relevance to clinical hyperthermia. Radiother Oncol 1:179-186.

8.

Sapareto, S. A., and W. C. Dewey. 1984. Thermal dose determination in cancer
therapy. Int J Radiat Oncol Biol Phys 10:787-800.

164

9.

Kaouk, J. H., M. Aron, J. C. Rewcastle, and I. S. Gill. 2006. Cryotherapy: clinical
end points and their experimental foundations. Urology 68:38-44.

10.

Hildebrandt, B., P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R.
Felix, and H. Riess. 2002. The cellular and molecular basis of hyperthermia. Crit
Rev Oncol Hematol 43:33-56.

11.

Lepock, J. R., H. E. Frey, and K. P. Ritchie. 1993. Protein denaturation in intact
hepatocytes and isolated cellular organelles during heat shock. The Journal of cell
biology 122:1267-1276.

12.

Lepock, J. R. 2004. Role of nuclear protein denaturation and aggregation in
thermal radiosensitization. Int J Hyperthermia 20:115-130.

13.

Lepock, J. R. 2005. How do cells respond to their thermal environment? Int J
Hyperthermia 21:681-687.

14.

Goldstein, L. S., M. W. Dewhirst, M. Repacholi, and L. Kheifets. 2003.
Summary, conclusions and recommendations: adverse temperature levels in the
human body. Int J Hyperthermia 19:373-384.

15.

Michels, A. A., B. Kanon, A. W. Konings, K. Ohtsuka, O. Bensaude, and H. H.
Kampinga. 1997. Hsp70 and Hsp40 chaperone activities in the cytoplasm and the
nucleus of mammalian cells. The Journal of biological chemistry 272:3328333289.

16.

Habash, R. W., R. Bansal, D. Krewski, and H. T. Alhafid. 2006. Thermal therapy,
part 2: hyperthermia techniques. Critical reviews in biomedical engineering
34:491-542.
165

17.

Raaphorst, G. P. 1990. Fundamental aspects of hyperthermic biology. In An
introduction to the practical aspects of clinical hyperthermia. H. J. Field SB,
editor. Taylor & Francis, London. 10-54.

18.

Falk, M. H., and R. D. Issels. 2001. Hyperthermia in oncology. Int J
Hyperthermia 17:1-18.

19.

Hettinga, J. V., W. Lemstra, C. Meijer, N. H. Mulder, A. W. Konings, E. G. de
Vries, and H. H. Kampinga. 1994. Hyperthermic potentiation of cisplatin toxicity
in a human small cell lung carcinoma cell line and a cisplatin resistant subline. Int
J Hyperthermia 10:795-805.

20.

Huang, Q., J. K. Hu, F. Lohr, L. Zhang, R. Braun, J. Lanzen, J. B. Little, M. W.
Dewhirst, and C. Y. Li. 2000. Heat-induced gene expression as a novel targeted
cancer gene therapy strategy. Cancer research 60:3435-3439.

21.

Huang, Q., and C. Li. 2001. [Using Hsp70 promoter to regulate target gene
expression in tumor]. Zhonghua bing li xue za zhi Chinese journal of pathology
30:198-201.

22.

Gerner, E. W., E. M. Hersh, M. Pennington, T. C. Tsang, D. Harris, F.
Vasanwala, and J. Brailey. 2000. Heat-inducible vectors for use in gene therapy.
Int J Hyperthermia 16:171-181.

23.

Lohr, F., K. Hu, Q. Huang, L. Zhang, T. V. Samulski, M. W. Dewhirst, and C. Y.
Li. 2000. Enhancement of radiotherapy by hyperthermia-regulated gene therapy.
Int J Radiat Oncol Biol Phys 48:1513-1518.

166

24.

Kinuya, S., K. Yokoyama, T. Michigishi, and N. Tonami. 2004. Optimization of
radioimmunotherapy interactions with hyperthermia. Int J Hyperthermia 20:190200.

25.

Henriques, F. C. 1947. The predictability and significance of thermally induced
rate processes leading to irreversible epidermal injury. Arch Pathol 43:489.

26.

Welch, A. J. 1984. The thermal response of laser irradiated tissue. IEEE Journal
of Quantum Electronics QE-20:11.

27.

Henle, K. J., and L. A. Dethlefsen. 1980. Time-temperature relationships for heatinduced killing of mammalian cells. Annals of the New York Academy of
Sciences 335:234-253.

28.

Vosburgh, K. G., and F. A. Jolesz. 2003. The concept of image-guided therapy.
Acad Radiol 10:176-179.

29.

Daniels, M. J., T. Varghese, E. L. Madsen, and J. A. Zagzebski. 2007. Noninvasive ultrasound-based temperature imaging for monitoring radiofrequency
heating-phantom results. Phys Med Biol 52:4827-4843.

30.

Fallone, B. G., P. R. Moran, and E. B. Podgorsak. 1982. Noninvasive
thermometry with a clinical x-ray CT scanner. Med Phys 9:715-721.

31.

Salomir, R., F. C. Vimeux, J. A. de Zwart, N. Grenier, and C. T. Moonen. 2000.
Hyperthermia by MR-guided focused ultrasound: accurate temperature control
based on fast MRI and a physical model of local energy deposition and heat
conduction. Magn Reson Med 43:342-347.

167

32.

Denis de Senneville, B., B. Quesson, and C. T. Moonen. 2005. Magnetic
resonance temperature imaging. Int J Hyperthermia 21:515-531.

33.

Rieke, V., and K. Butts Pauly. 2008. MR thermometry. J Magn Reson Imaging
27:376-390.

34.

Hindman, J. C. 1966. Proton resonance shift of water in the gas and liquid states.
Journal of Chemical Physics 44:4582-4592.

35.

Schneider, W. G., Bernstein, H.J., Pople, J.A. 1958. Proton Magnetic Resonance
Chemical Shift of Free (gaseous) and Associated (liquid) Hydride Molecules. J.
Chem. Phys. 284:601.

36.

de Zwart, J. A., P. van Gelderen, D. J. Kelly, and C. T. Moonen. 1996. Fast
magnetic-resonance temperature imaging. J Magn Reson B 112:86-90.

37.

Kuroda, K. 2005. Non-invasive MR thermography using the water proton
chemical shift. Int J Hyperthermia 21:547-560.

38.

Ishihara, Y., A. Calderon, H. Watanabe, K. Okamoto, Y. Suzuki, and K. Kuroda.
1995. A precise and fast temperature mapping using water proton chemical shift.
Magn Reson Med 34:814-823.

39.

de Senneville, B. D., C. Mougenot, B. Quesson, I. Dragonu, N. Grenier, and C. T.
Moonen. 2007. MR thermometry for monitoring tumor ablation. Eur Radiol
17:2401-2410.

40.

Kuroda, K., K. Oshio, A. H. Chung, K. Hynynen, and F. A. Jolesz. 1997.
Temperature mapping using the water proton chemical shift: a chemical shift
selective phase mapping method. Magn Reson Med 38:845-851.
168

41.

de Zwart, J. A., F. C. Vimeux, C. Delalande, P. Canioni, and C. T. Moonen. 1999.
Fast lipid-suppressed MR temperature mapping with echo-shifted gradient-echo
imaging and spectral-spatial excitation. Magn Reson Med 42:53-59.

42.

Hynynen, K., O. Pomeroy, D. N. Smith, P. E. Huber, N. J. McDannold, J.
Kettenbach, J. Baum, S. Singer, and F. A. Jolesz. 2001. MR imaging-guided
focused ultrasound surgery of fibroadenomas in the breast: a feasibility study.
Radiology 219:176-185.

43.

De Poorter, J. 1995. Noninvasive MRI thermometry with the proton resonance
frequency method: study of susceptibility effects. Magn Reson Med 34:359-367.

44.

De Poorter, J. D. W., C. De Deene, Y. Thomsen, C. Stahlberg, F. Achten, E.
1994. The proton-resonance-frequency-shift method compared with molecular
diffusion for quantitative measurement of two-dimensional time-dependent
temperature distribution in a phantom. J Magn Reson B 103:234.

45.

McDannold, N., K. Hynynen, K. Oshio, and R. V. Mulkern. 2001. Temperature
monitoring with line scan echo planar spectroscopic imaging. Med Phys 28:346355.

46.

Kuroda, K., Y. Suzuki, Y. Ishihara, and K. Okamoto. 1996. Temperature mapping
using water proton chemical shift obtained with 3D-MRSI: feasibility in vivo.
Magn Reson Med 35:20-29.

169

47.

Kuroda, K., R. V. Mulkern, K. Oshio, L. P. Panych, T. Nakai, T. Moriya, S.
Okuda, K. Hynynen, and F. A. Jolesz. 2000. Temperature mapping using the
water proton chemical

shift:

self-referenced method with echo-planar

spectroscopic imaging. Magn Reson Med 43:220-225.
48.

Mulkern, R. V., L. P. Panych, N. J. McDannold, F. A. Jolesz, and K. Hynynen.
1998. Tissue temperature monitoring with multiple gradient-echo imaging
sequences. J Magn Reson Imaging 8:493-502.

49.

Candy, J. V. 2006. Model-Based Signal Processing. John Wiley & Sons, Inc.,
Hoboken, NJ.

50.

Koehl, P. 1999. Linear Prediction Spectral Analysis of NMR Data. Progress in
Nuclear Magnetic Resonance Spectroscopy 34:257-299.

51.

Belkic, D., and K. Belkic. 2005. The fast Pade transform in magnetic resonance
spectroscopy for potential improvements in early cancer diagnostics. Phys Med
Biol 50:4385-4408.

52.

Williamson, D. C., Hawesa, H., Thacker, N.A., Williams, S.R. 2006. Robust
Quantification of Short Echo Time 1H Magneic Resonance Spectra using the
Pade' Approximant. Magnetic Reson Med:762-771.

53.

Taylor, B. A., K. P. Hwang, A. M. Elliott, A. Shetty, J. D. Hazle, and R. J.
Stafford. 2008. Dynamic chemical shift imaging for image-guided thermal
therapy: analysis of feasibility and potential. Med Phys 35:793-803.

170

54.

Kumaresan, R., Tufts D.W., . 1982. Estimating the Parameters of Exponentially
Damped Sinusoids and Pole-Zero Modeling in Noise. IEEE Trans Acoustics,
Speech, Sig, Processing 30:833-840.

55.

Bammer, R. 2003. Basic principles of diffusion-weighted imaging. Eur J Radiol
45:169-184.

56.

Morvan, D., A. Leroy-Willig, A. Malgouyres, C. A. Cuenod, P. Jehenson, and A.
Syrota.

1993.

Simultaneous

temperature

and

regional

blood

volume

measurements in human muscle using an MRI fast diffusion technique. Magn
Reson Med 29:371-377.
57.

Bleier, A. R., F. A. Jolesz, M. S. Cohen, R. M. Weisskoff, J. J. Dalcanton, N.
Higuchi, D. A. Feinberg, B. R. Rosen, R. C. McKinstry, and S. G. Hushek. 1991.
Real-time magnetic resonance imaging of laser heat deposition in tissue. Magn
Reson Med 21:132-137.

58.

Moseley, M. E., Y. Cohen, J. Mintorovitch, L. Chileuitt, H. Shimizu, J.
Kucharczyk, M. F. Wendland, and P. R. Weinstein. 1990. Early detection of
regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted
MRI and spectroscopy. Magn Reson Med 14:330-346.

59.

Johnson, F. E., H. Stover, B. 1974. Theory of rate processes in biology and
medicine. John Wiley & Sons, New York, NY.

60.

Chen, J., B. L. Daniel, and K. B. Pauly. 2006. Investigation of proton density for
measuring tissue temperature. J Magn Reson Imaging 23:430-434.

171

61.

Gultekin, D. H., and J. C. Gore. 2005. Temperature dependence of nuclear
magnetization and relaxation. J Magn Reson 172:133-141.

62.

Bloembergen, N. P., E.M. Pound, R.V. . 1948. Relaxation effects in nuclear
magnetic resonance absorption. Phys Rev 73:679-712.

63.

Matsumoto, R., R. V. Mulkern, S. G. Hushek, and F. A. Jolesz. 1994. Tissue
temperature monitoring for thermal interventional therapy: comparison of T1weighted MR sequences. J Magn Reson Imaging 4:65-70.

64.

Parker, D. L., V. Smith, P. Sheldon, L. E. Crooks, and L. Fussell. 1983.
Temperature distribution measurements in two-dimensional NMR imaging. Med
Phys 10:321-325.

65.

Hynynen, K., N. McDannold, R. V. Mulkern, and F. A. Jolesz. 2000. Temperature
monitoring in fat with MRI. Magn Reson Med 43:901-904.

66.

Matsumoto, R., K. Oshio, and F. A. Jolesz. 1992. Monitoring of laser and
freezing-induced ablation in the liver with T1-weighted MR imaging. J Magn
Reson Imaging 2:555-562.

67.

Lewa, C. J., and Z. Majewska. 1980. Temperature relationships of proton spinlattice relaxation time T1 in biological tissues. Bulletin du cancer 67:525-530.

68.

Cline, H. E., K. Hynynen, C. J. Hardy, R. D. Watkins, J. F. Schenck, and F. A.
Jolesz. 1994. MR temperature mapping of focused ultrasound surgery. Magn
Reson Med 31:628-636.

172

69.

Peller, M., H. M. Reinl, A. Weigel, M. Meininger, R. D. Issels, and M. Reiser.
2002. T1 relaxation time at 0.2 Tesla for monitoring regional hyperthermia:
feasibility study in muscle and adipose tissue. Magn Reson Med 47:1194-1201.

70.

Graham, S. J., M. J. Bronskill, and R. M. Henkelman. 1998. Time and
temperature dependence of MR parameters during thermal coagulation of ex vivo
rabbit muscle. Magn Reson Med 39:198-203.

71.

Wolff, S. D., and R. S. Balaban. 1989. Magnetization transfer contrast (MTC) and
tissue water proton relaxation in vivo. Magn Reson Med 10:135-144.

72.

Young, I. R., J. W. Hand, A. Oatridge, and M. V. Prior. 1994. Modeling and
observation of temperature changes in vivo using MRI. Magn Reson Med 32:358369.

73.

Graham, S. J., G. J. Stanisz, A. Kecojevic, M. J. Bronskill, and R. M. Henkelman.
1999. Analysis of changes in MR properties of tissues after heat treatment. Magn
Reson Med 42:1061-1071.

74.

Haacke, E. M., R. W. Brown, M. R. Thompson, and R. Venkatesan. 1999.
Magnetic Resonance Imaging : Physical Principles and Sequence Design. John
Wiley & Sons, Inc., New York City, NY.

75.

McDannold, N. 2005. Quantitative MRI-based temperature mapping based on the
proton resonant frequency shift: review of validation studies. Int J Hyperthermia
21:533-546.

173

76.

Peters, R. D., R. S. Hinks, and R. M. Henkelman. 1999. Heat-source orientation
and geometry dependence in proton-resonance frequency shift magnetic
resonance thermometry. Magn Reson Med 41:909-918.

77.

Peters, R. D., and R. M. Henkelman. 2000. Proton-resonance frequency shift MR
thermometry is affected by changes in the electrical conductivity of tissue. Magn
Reson Med 43:62-71.

78.

McDannold, N. J., R. L. King, F. A. Jolesz, and K. H. Hynynen. 2000. Usefulness
of MR imaging-derived thermometry and dosimetry in determining the threshold
for tissue damage induced by thermal surgery in rabbits. Radiology 216:517-523.

79.

Peters, R. D., R. S. Hinks, and R. M. Henkelman. 1998. Ex vivo tissue-type
independence in proton-resonance frequency shift MR thermometry. Magn Reson
Med 40:454-459.

80.

Cady, E. B., P. C. D'Souza, J. Penrice, and A. Lorek. 1995. The estimation of
local brain temperature by in vivo 1H magnetic resonance spectroscopy. Magn
Reson Med 33:862-867.

81.

Corbett, R. J., A. R. Laptook, G. Tollefsbol, and B. Kim. 1995. Validation of a
noninvasive method to measure brain temperature in vivo using 1H NMR
spectroscopy. Journal of neurochemistry 64:1224-1230.

82.

Conturo, T. E., and G. D. Smith. 1990. Signal-to-noise in phase angle
reconstruction: dynamic range extension using phase reference offsets. Magn
Reson Med 15:420-437.

174

83.

Stafford, R. J., R. E. Price, C. J. Diederich, M. Kangasniemi, L. E. Olsson, and J.
D. Hazle. 2004. Interleaved echo-planar imaging for fast multiplanar magnetic
resonance temperature imaging of ultrasound thermal ablation therapy. J Magn
Reson Imaging 20:706-714.

84.

Morikawa, S., T. Inubushi, Y. Kurumi, S. Naka, K. Sato, K. Demura, T. Tani, and
H. A. Haque. 2004. Feasibility of respiratory triggering for MR-guided
microwave ablation of liver tumors under general anesthesia. Cardiovascular and
interventional radiology 27:370-373.

85.

Lepetit-Coiffe, M., B. Quesson, O. Seror, E. Dumont, B. Le Bail, C. T. Moonen,
and H. Trillaud. 2006. Real-time monitoring of radiofrequency ablation of rabbit
liver by respiratory-gated quantitative temperature MRI. J Magn Reson Imaging
24:152-159.

86.

Rieke, V., K. K. Vigen, G. Sommer, B. L. Daniel, J. M. Pauly, and K. Butts.
2004. Referenceless PRF shift thermometry. Magn Reson Med 51:1223-1231.

87.

Young, I. R., J. V. Hajnal, I. G. Roberts, J. X. Ling, R. J. Hill-Cottingham, A.
Oatridge, and J. A. Wilson. 1996. An evaluation of the effects of susceptibility
changes on the water chemical shift method of temperature measurement in
human peripheral muscle. Magn Reson Med 36:366-374.

88.

El-Sharkawy, A. M., M. Schar, P. A. Bottomley, and E. Atalar. 2006. Monitoring
and correcting spatio-temporal variations of the MR scanner's static magnetic
field. Magma (New York, N.Y 19:223-236.

175

89.

De Poorter, J., C. De Wagter, Y. De Deene, C. Thomsen, F. Stahlberg, and E.
Achten. 1995. Noninvasive MRI thermometry with the proton resonance
frequency (PRF) method: in vivo results in human muscle. Magn Reson Med
33:74-81.

90.

Das, S. K., J. Macfall, R. McCauley, O. Craciunescu, M. W. Dewhirst, and T. V.
Samulski. 2005. Improved magnetic resonance thermal imaging by combining
proton resonance frequency shift (PRFS) and apparent diffusion coefficient
(ADC) data. Int J Hyperthermia 21:657-667.

91.

Hussain, K., and H. B. El-Serag. 2009. Epidemiology, screening, diagnosis and
treatment of hepatocellular carcinoma. Minerva gastroenterologica e dietologica
55:123-138.

92.

Mulkern, R. V., A. H. Chung, F. A. Jolesz, and K. Hynynen. 1997. Temperature
monitoring of ultrasonically heated muscle with RARE chemical shift imaging.
Med Phys 24:1899-1906.

93.

McDannold, N., A. S. Barnes, F. J. Rybicki, K. Oshio, N. K. Chen, K. Hynynen,
and R. V. Mulkern. 2007. Temperature mapping considerations in the breast with
line scan echo planar spectroscopic imaging. Magn Reson Med 58:1117-1123.

94.

Bankson, J. A., R. J. Stafford, and J. D. Hazle. 2005. Partially parallel imaging
with phase-sensitive data: Increased temporal resolution for magnetic resonance
temperature imaging. Magn Reson Med 53:658-665.

176

95.

Du, W., Y. P. Du, X. Fan, M. A. Zamora, and G. S. Karczmar. 2003. Reduction of
spectral ghost artifacts in high-resolution echo-planar spectroscopic imaging of
water and fat resonances. Magn Reson Med 49:1113-1120.

96.

Lu, W., H. Yu, A. Shimakawa, M. Alley, S. B. Reeder, and B. A. Hargreaves.
2008. Water-fat separation with bipolar multiecho sequences. Magn Reson Med
60:198-209.

97.

Mansfield, P. 1984. Spatial mapping of the chemical shift in NMR. Magn Reson
Med 1:370-386.

98.

Posse, S., G. Tedeschi, R. Risinger, R. Ogg, and D. Le Bihan. 1995. High speed
1H spectroscopic imaging in human brain by echo planar spatial-spectral
encoding. Magn Reson Med 33:34-40.

99.

Duyn, J. H., and C. T. Moonen. 1993. Fast proton spectroscopic imaging of
human brain using multiple spin-echoes. Magn Reson Med 30:409-414.

100.

Mulkern, R. V., H. Chao, J. L. Bowers, and D. Holtzman. 1997. Multiecho
approaches to spectroscopic imaging of the brain. Annals of the New York
Academy of Sciences 820:97-122.

101.

Oshio, K., W. Kyriakos, and R. V. Mulkern. 2000. Line scan echo planar
spectroscopic imaging. Magn Reson Med 44:521-524.

102.

Bonekamp, D., M. A. Smith, H. Zhu, and P. B. Barker. 2010. Quantitative
SENSE-MRSI of the human brain. Magn Reson Imaging 28:305-313.

177

103.

Tsai, S. Y., R. Otazo, S. Posse, Y. R. Lin, H. W. Chung, L. L. Wald, G. C.
Wiggins, and F. H. Lin. 2008. Accelerated proton echo planar spectroscopic
imaging (PEPSI) using GRAPPA with a 32-channel phased-array coil. Magn
Reson Med 59:989-998.

104.

Hu, S., M. Lustig, A. P. Chen, J. Crane, A. Kerr, D. A. Kelley, R. Hurd, J.
Kurhanewicz, S. J. Nelson, J. M. Pauly, and D. B. Vigneron. 2008. Compressed
sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. J
Magn Reson 192:258-264.

105.

Hu, S., M. Lustig, A. Balakrishnan, P. E. Larson, R. Bok, J. Kurhanewicz, S. J.
Nelson, A. Goga, J. M. Pauly, and D. B. Vigneron. 2010. 3D compressed sensing
for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to
transgenic mouse models of cancer. Magn Reson Med 63:312-321.

106.

Abragam, A. 1961. The Principles of Nuclear Magnetism. Clarendon Press,
Oxford.

107.

Hoch, J. C. S., A.S. 1996. NMR Data Processing. Wiley-Liss, New York.

108.

Bracewell, R. 1978. The Fourier Transform and its Applications. McGraw-Hill,
Inc., New York.

109.

Vanhamme, L., T. Sundin, P. V. Hecke, and S. V. Huffel. 2001. MR spectroscopy
quantitation: a review of time-domain methods. NMR in biomedicine 14:233-246.

110.

van der Veen, J. W., R. de Beer, P. R. Luyten, and D. van Ormondt. 1988.
Accurate quantification of in vivo 31P NMR signals using the variable projection
method and prior knowledge. Magn Reson Med 6:92-98.
178

111.

Vanhamme, L., A. van den Boogaart, and S. Van Huffel. 1997. Improved method
for accurate and efficient quantification of MRS data with use of prior knowledge.
J Magn Reson 129:35-43.

112.

Osborne, M. 1972. Some aspects of non-linear least squares calculatons. . In
Numerical Methods for Non-linear Optimization. Academic Press, London.

113.

Poullet, J. B., D. M. Sima, and S. Van Huffel. 2008. MRS signal quantitation: a
review of time- and frequency-domain methods. J Magn Reson 195:134-144.

114.

Sandgren, N., Y. Selen, P. Stoica, and J. Li. 2004. Parametric methods for
frequency-selective MR spectroscopy-a review. J Magn Reson 168:259-272.

115.

de Graaf, A. A., and W. M. Bovee. 1990. Improved quantification of in vivo 1H
NMR spectra by optimization of signal acquisition and processing and by
incorporation of prior knowledge into the spectral fitting. Magn Reson Med
15:305-319.

116.

Marshall, I., J. Higinbotham, S. Bruce, and A. Freise. 1997. Use of Voigt
lineshape for quantification of in vivo 1H spectra. Magn Reson Med 37:651-657.

117.

Belkic, D. 2005. Quantum-Mechanical Signal Processing and Spectral Analysis.
Institute of Physics Publishing, London.

118.

Belkic, D. 2006. Exponential convergence rate (the spectral convergence) of the
fast Pade transform for exact quantification in magnetic resonance spectroscopy.
Phys Med Biol 51:6483-6512.

119.

Barbosa, R. S. T. M., J.A.; Silva, M.F. 2006. Time domain design of fractional
differintegrators using least-squares. Signal Processing 86:2567-2581.
179

120.

Jackson, L. B. 1996. Digital Filters and Signal Processing with Matlab Exercises.
Kulwer Academic Publishers.

121.

Steiglitz, K., and L. McBride. 1965. A technique for the identification of linear
systems. IEEE Transactions on Automatic Control 10:461-464.

122.

Amindavar, H., and A. M. Reza. 2005. A New Simultaneous Estimation of
Directions of Arrival and Channel Parameters in a Multipath Environment. IEEE
Transactions on Signal Processing 53:471-483.

123.

Kwock, L., J. K. Smith, M. Castillo, M. G. Ewend, F. Collichio, D. E. Morris, T.
W. Bouldin, and S. Cush. 2006. Clinical role of proton magnetic resonance
spectroscopy in oncology: brain, breast, and prostate cancer. The lancet oncology
7:859-868.

124.

Haase, A., J. Frahm, W. Hanicke, and D. Matthaei. 1985. 1H NMR chemical shift
selective (CHESS) imaging. Phys Med Biol 30:341-344.

125.

Schick, F. 1998. Simultaneous highly selective MR water and fat imaging using a
simple new type of spectral-spatial excitation. Magn Reson Med 40:194-202.

126.

Bydder, G. M., J. M. Pennock, R. E. Steiner, S. Khenia, J. A. Payne, and I. R.
Young. 1985. The short TI inversion recovery sequence--an approach to MR
imaging of the abdomen. Magn Reson Imaging 3:251-254.

127.

Dixon, W. T. 1984. Simple proton spectroscopic imaging. Radiology 153:189194.

180

128.

Glover, G. H., and E. Schneider. 1991. Three-point Dixon technique for true
water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med
18:371-383.

129.

Bley, T. A., O. Wieben, C. J. Francois, J. H. Brittain, and S. B. Reeder. 2010. Fat
and water magnetic resonance imaging. J Magn Reson Imaging 31:4-18.

130.

Skinner, T. E., and G. H. Glover. 1997. An extended two-point Dixon algorithm
for calculating separate water, fat, and B0 images. Magn Reson Med 37:628-630.

131.

Coombs, B. D., J. Szumowski, and W. Coshow. 1997. Two-point Dixon
technique for water-fat signal decomposition with B0 inhomogeneity correction.
Magn Reson Med 38:884-889.

132.

Ma, J. 2008. A single-point Dixon technique for fat-suppressed fast 3D gradientecho imaging with a flexible echo time. J Magn Reson Imaging 27:881-890.

133.

Xiang, Q. S., and L. An. 1997. Water-fat imaging with direct phase encoding. J
Magn Reson Imaging 7:1002-1015.

134.

Ma, J., J. B. Son, J. A. Bankson, R. J. Stafford, H. Choi, and D. Ragan. 2005. A
fast spin echo two-point Dixon technique and its combination with sensitivity
encoding for efficient T2-weighted imaging. Magn Reson Imaging 23:977-982.

135.

Ma, J. 2004. Breath-hold water and fat imaging using a dual-echo two-point
Dixon technique with an efficient and robust phase-correction algorithm. Magn
Reson Med 52:415-419.

181

136.

Ma, J., C. M. Costelloe, J. E. Madewell, G. N. Hortobagyi, M. C. Green, G. Cao,
F. Sun, and V. Kundra. 2009. Fast dixon-based multisequence and multiplanar
MRI for whole-body detection of cancer metastases. J Magn Reson Imaging
29:1154-1162.

137.

Reeder, S. B., A. R. Pineda, Z. Wen, A. Shimakawa, H. Yu, J. H. Brittain, G. E.
Gold, C. H. Beaulieu, and N. J. Pelc. 2005. Iterative decomposition of water and
fat with echo asymmetry and least-squares estimation (IDEAL): application with
fast spin-echo imaging. Magn Reson Med 54:636-644.

138.

Yu, H., C. A. McKenzie, A. Shimakawa, A. T. Vu, A. C. Brau, P. J. Beatty, A. R.
Pineda, J. H. Brittain, and S. B. Reeder. 2007. Multiecho reconstruction for
simultaneous water-fat decomposition and T2* estimation. J Magn Reson
Imaging 26:1153-1161.

139.

Yu, H., A. Shimakawa, C. A. McKenzie, E. Brodsky, J. H. Brittain, and S. B.
Reeder. 2008. Multiecho water-fat separation and simultaneous R2* estimation
with multifrequency fat spectrum modeling. Magn Reson Med 60:1122-1134.

140.

Srinivasan, A., C. J. Galban, T. D. Johnson, T. L. Chenevert, B. D. Ross, and S.
K. Mukherji. 2010. Utility of the k-means clustering algorithm in differentiating
apparent diffusion coefficient values of benign and malignant neck pathologies.
Ajnr 31:736-740.

182

141.

Deoni, S. C., B. K. Rutt, A. G. Parrent, and T. M. Peters. 2007. Segmentation of
thalamic nuclei using a modified k-means clustering algorithm and highresolution quantitative magnetic resonance imaging at 1.5 T. NeuroImage 34:117126.

142.

Filzmoser, P., R. Baumgartner, and E. Moser. 1999. A hierarchical clustering
method for analyzing functional MR images. Magn Reson Imaging 17:817-826.

143.

Carano, R. A., A. L. Ross, J. Ross, S. P. Williams, H. Koeppen, R. H. Schwall,
and N. Van Bruggen. 2004. Quantification of tumor tissue populations by
multispectral analysis. Magn Reson Med 51:542-551.

144.

Lloyd, S. P. 1982. Least squares quantization in PCM. IEEE Transactions on
Information Theory 28:129-137.

145.

MacQueen, J. B. 1967. Some methods for classification and analysis of
multivariate observations. In Fifth Berkeley Symposium on Mathematical
Statistics and Probability. University of California Press. 281-297.

146.

Landini, L., Positano, V, Santarelli, MF. 2005. Advanced Image Processing in
Magnetic Resonance Imaging. Taylor and Francis, Boca Raton, FL.

147.

Johnson, R. 2000. Miller and Freund's Probability and Statistics for Engineers.
Prentice Hall, Upper Saddle River, NJ.

148.

Cramer, H. 1946. Mathematical Methods of Statistics. Princeton Univ. Press.

149.

Rao, C. 1945. Information and the accuracy attainable in the estimation of
statistical parameters. Bull. Calcutta Math. Soc. 37:81-89.

183

150.

Taylor, B. A., K. P. Hwang, J. D. Hazle, and R. J. Stafford. 2009. Autoregressive
Moving Average Modeling for Spectral Parameter Estimation from a MultiGradient Echo Chemical Shift Acquisition. Med Phys 36:753-764.

151.

Oude Engberink, R. D., S. M. van der Pol, E. A. Dopp, H. E. de Vries, and E. L.
Blezer. 2007. Comparison of SPIO and USPIO for in vitro labeling of human
monocytes: MR detection and cell function. Radiology 243:467-474.

152.

Shmatukha, A. V., P. R. Harvey, and C. J. Bakker. 2007. Correction of proton
resonance frequency shift temperature maps for magnetic field disturbances using
fat signal. J Magn Reson Imaging 25:579-587.

153.

Akhlaghpoor, S., A. Tomasian, A. Arjmand Shabestari, M. Ebrahimi, and M. R.
Alinaghizadeh. 2007. Percutaneous osteoid osteoma treatment with combination
of radiofrequency and alcohol ablation. Clinical radiology 62:268-273.

154.

Ji, X. S., R; Elliott, A.M.; Stafford, R.J.; Esparza-Coss, E.; Bankson, J.A., Liang,
G; Luo Z.P.; Park, K.; Markert, J.T.; Li, C. . 2007. Bifunctional gold nanoshells
with a superparamagnetic iron oxide-silica core suitable for both MR imaging and
photothermal therapy J. Phys. Chem. C. 111:6245-6251.

155.

Machann, J., N. Stefan, and F. Schick. 2008. (1)H MR spectroscopy of skeletal
muscle, liver and bone marrow. Eur J Radiol 67:275-284.

156.

Schick, F. 1996. Bone marrow NMR in vivo. J Prog Nuc Mag Spect 29:169-227.

157.

Chen, L., J. P. Wansapura, G. Heit, and K. Butts. 2002. Study of laser ablation in
the in vivo rabbit brain with MR thermometry. J Magn Reson Imaging 16:147152.
184

158.

Rieke, V., A. B. Ross, W. H. Nau, C. J. Diederich, G. Sommer, and K. Butts.
2004. MRI-temperature mapping during ultrasound prostate ablation using fat for
phase estimation. Conf Proc IEEE Eng Med Biol Soc 4:2500-2502.

159.

Carpentier, A., R. J. McNichols, R. J. Stafford, J. Itzcovitz, J. P. Guichard, D.
Reizine, S. Delaloge, E. Vicaut, D. Payen, A. Gowda, and B. George. 2008. Realtime magnetic resonance-guided laser thermal therapy for focal metastatic brain
tumors. Neurosurgery 63:ONS21-28; discussion ONS28-29.

160.

McNichols, R. J., A. Gowda, M. Kangasniemi, J. A. Bankson, R. E. Price, and J.
D. Hazle. 2004. MR thermometry-based feedback control of laser interstitial
thermal therapy at 980 nm. Lasers in surgery and medicine 34:48-55.

161.

Mallamace, F., S. H. Chen, M. Broccio, C. Corsaro, V. Crupi, D. Majolino, V.
Venuti, P. Baglioni, E. Fratini, C. Vannucci, and H. E. Stanley. 2007. Role of the
solvent in the dynamical transitions of proteins: the case of the lysozyme-water
system. The Journal of chemical physics 127:045104.

162.

Bouchard, L. S., and M. J. Bronskill. 2000. Magnetic resonance imaging of
thermal coagulation effects in a phantom for calibrating thermal therapy devices.
Med Phys 27:1141-1145.

163.

Dice, L. R. 1945. Measures of the amount of ecologic association between
species. Ecology 26:297-302.

164.

Li, C., X. Pan, K. Ying, Q. Zhang, J. An, D. Weng, W. Qin, and K. Li. 2009. An
internal reference model-based PRF temperature mapping method with CramerRao lower bound noise performance analysis. Magn Reson Med 62:1251-1260.
185

165.

Rieke, V., A. M. Kinsey, A. B. Ross, W. H. Nau, C. J. Diederich, G. Sommer, and
K. B. Pauly. 2007. Referenceless MR thermometry for monitoring thermal
ablation in the prostate. IEEE Trans Med Imaging 26:813-821.

166.

Bischof, J. C., J. Padanilam, W. H. Holmes, R. M. Ezzell, R. C. Lee, R. G.
Tompkins, M. L. Yarmush, and M. Toner. 1995. Dynamics of cell membrane
permeability changes at supraphysiological temperatures. Biophysical journal
68:2608-2614.

167.

Poon, R. T., S. T. Fan, F. H. Tsang, and J. Wong. 2002. Locoregional therapies
for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Annals of surgery 235:466-486.

168.

Peller, M., A. Schwerdt, M. Hossann, H. M. Reinl, T. Wang, S. Sourbron, M.
Ogris, and L. H. Lindner. 2008. MR characterization of mild hyperthermiainduced gadodiamide release from thermosensitive liposomes in solid tumors.
Invest Radiol 43:877-892.

186

Vita

Brian Allen Taylor, son of Ricky and Rosemarie Taylor, was born in Hayti,
Missouri, on January 25, 1983. He is the brother of Aaron Taylor. After graduating from
Portageville High School in 2001, Brian attended Union University in Jackson,
Tennessee, where he earned the Bachelor of Science degree with a double-major in
Mathematics and Physics. In 2005, Brian matriculated into the Medical Physics program
at the University of Texas Graduate School of Biomedical Sciences at Houston.

Permanent Address:
4554 State Highway F
Portageville, MO 63873

187

